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The purpose of the present study was to further examine the relationship between
adolescent psychiatric pathology and SMI by assessing the relationship between prior
mental health services before the age of 18 and time of assessment on people’s insight
into their illnesses. A secondary relationship between adolescent psychiatric pathology
and functioning in a variety of domains before, during, and after treatment was assessed.
Overall, there was an inconsistent pattern of results and partial support of hypotheses.
The current study was a retrospective longitudinal study in which assessments were given
to 308 participants in an inpatient psychiatric rehabilitation unit every 6 months. Results
indicated that those with service use during adolescence were younger at admission to
CTP, have slightly lower levels of education, had an earlier age of onset, and
significantly more previous hospitalizations. A relationship between Axis I and II
diagnoses and service use was also identified. Improvements in neurocognitive,
sociocognitive, insight, and behavioral functioning measures are evident over the course
of treatment, however are not consistent for all groups and all measures used within this

study. Contrary to the hypothesis, those adults with service usage in adolescence did not
endorse differing overall insight or ability to relabel symptoms scores over the course of
treatment. However, as hypothesized, there were no differences between those with and
without service usage in adolescence on any measure of insight after one year of
psychiatric rehabilitation. In general, the CTP participants endorsed lower insight into
need for treatment scores across treatment. Also, analyses revealed no significant
relationship between whether or not someone used services in adolescence or APP
severity level and rate of rehospitalization or discharge location restrictiveness.
In summary, this study was exploratory in nature and inconsistent results and mixed
support of hypotheses was found. This field of research has numerous implications for
increasing insight and bettering outcomes for persons with SMI.
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CHAPTER 1 – INTRODUCTION AND LITERATURE REVIEW
Exploratory Analyses of a Developmental Conceptualization of Insight and Treatment
outcomes of Individuals with Serious Mental Illness in Psychiatric Rehabilitation

Individuals with Serious Mental Illnesses (SMI) are commonly observed to have
an extreme lack of awareness of their condition, the consequences of their mental illness,
and their need for treatment. Freud (1940) perceived that those with a diagnosis in the
schizophrenia spectrum were acutely unaware of their own affect and cognitions. The
WHO International Pilot Study of Schizophrenia validated earlier observations by finding
that poor insight is one of 12 symptoms or signs selected to identify Schizophrenia and
was found to be a statistically significant discriminator (Carpenter, Strauss, & Bartko,
1973). Since these early findings, there has been resurgence in recent years of research
studying the concept of insight and its impact on recovery in the SMI population
(Carpenter, Strauss, & Bartko, 1973; Ghaemi & Pope, 1994; Lysaker, Bell, Milstein,
Bryson, & Beam-Goulet, 1994; Schwartz, 1998; Smith et al, 1999).

Definitions of Insight
The concept and definition of insight has changed over time. Jaspers (1963) was
one of the first researchers to differentiate awareness of illness from insight, with
awareness of illness being defined as the feeling of being “ill and changed.” Insight was
differentiated by Jaspers (1963) as an “objectively correct estimate of the severity of the
illness (and) an objectively correct judgment of its particular type” (p. 419). Jaspers
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thought that only when all of these features are present could the patient be considered to
have insight (Jaspers, 1963; cited in Rusch & Corrigan, 2002).
Recent studies suggest that insight is not dichotomous, but multidimensional
(Amador, Strauss, Yale, & Gorman, 1991; David, 1990; David & Kemp, 1997). David
(1990) proposed that three dimensions comprise the construct of insight: recognition that
one has a mental illness, the ability to re-label unusual mental events as pathological, and
the belief that one needs treatment and actual adherence to treatment. These dimensions
are not concrete but instead are overlapping, dynamic trends that account for diverse
variations along the course of the illness. The model proposed by David (1990) has face
validity and thus is commonly used in research studying insight (McGorry &
McConville, 1999; Schwartz, 1998).
Amador et al. (1991) proposed another multidimensional model that differentiates
between unawareness of illness and incorrect attribution of deficit or consequence of
illness, and treats insight as a complex phenomenon with separate but interrelated
mechanisms. Amador et al. (1993) concluded that the best way to define poor insight is
as a construct consisting of multiple components much like the symptoms associated with
SMI.
Insight can also be thought of as the ability to relate to professionals’ views and
the ability to meaningfully converse about the subject (Rusch & Corrigan, 2002).
Markova and Berrios (1995) conceptualized insight, as assessed in clinical interviews
and observations, as a combination of the person’s perception of his or her own
condition, the clinician’s perception of the individual’s condition, and the clinician’s
own conceptual understanding of the construct of insight. Consequently, evaluating a
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person’s insight can be affected by the person and clinician’s attitudes and beliefs,
therapeutic alliance, sociocultural differences and backgrounds, and the clinician’s
working definition of insight.
Many differing techniques have been used to operationally define and measure
insight. Objectively measuring and identifying symptoms and the degree of insight is
important for reliably using valid results to inform diagnosis and treatment decisions
throughout the course of illness. Although most current researchers agree that insight
needs to be defined and measured as a multidimensional construct, some researchers
continue to treat it as a dichotomous construct Amador et al. (1991) try to measure the
multidimensional nature insight throughout the course of illness by designing tools like
the Scale to Assess Unawareness of Mental Disorders (SUMD), a delineated 5-point
scoring method that rates responses to controlled stimuli during a semi-structured
interview. The SUMD assesses current and past insight as well as the individual’s insight
into the future course of their disorder and treatment. The SUMD includes a systematic
assessment of historical records and other sources to determine what symptoms have
actually been present. Although this may seem a prerequisite to assessing insight, such
systematic accounting is not always included, and the SUMD has an advantage over other
instruments in this regard. Also, Amador and colleagues (1993) proposed an additional
dimension of insight, as assessed by the SUMD, that is capable of measuring the time and
memory dimensions of insight, with full insight including the past, present, and possible
future course (need for future treatment, risk of relapse, etc.) of the disorder. Thus, for
example, an individual may understand that current hallucinations are illusory while fully
believing the validity of past hallucinations.
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Recently, researchers such as Frith (1992) and Lysaker et al. (2005) have begun to
examine metacognition, the ability to think about thinking, and its relationship with the
common signs and symptoms of schizophrenia. Some researchers regard metacognition
as a component of insight, with the assumption that when a person’s ability for
metacognition is poor their degree of insight is lower. Examining metacognition often
involves theory of mind tasks. Theory of mind is defined as the ability to form a
representation of the consciousness of others and be able to draw conclusions about their
motives and make inferences as to others’ internal feelings (Lysaker et al., 2005).
Research examining theory of mind tasks have shown that greater impairment is linked
with deficits in visual and verbal memory and poorer flexibility for abstract thought
(Greig et al., 2004). In a study by Lysaker et al. (2005), 61 men with schizophrenia were
interviewed to examine the relationship between their scores on the metacognition
assessment scale and quality of life, neurocognition, and insight. When age and gender
were controlled, it was concluded that higher levels of metacognition, as defined as
purposeful problem solving, were associated with less emotional withdrawal and
paranoia and better social functioning, verbal memory, and insight (Lysaker et al., 2005).
Therefore, when an individual with SMI is able to use purposeful problem solving and
metacognition he or she is able to better conceptualize his or her illness. However, it is
still unclear whether deficits in one’s own awareness are a separate property from third
person metacognition.

Etiology of Impaired Insight
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If insight is a multidimensional construct, a single etiology is unlikely. Several
causes are suspected to interact in complex ways and are expressed in different ways in
the heterogeneous SMI population. It has been proposed that lack of insight in those that
have schizophrenia is analogous to the neurocognitive deficits in the traumatic brain
injury (TBI) population. Several researchers have observed and measured the
unawareness of deficits in those with TBI, and have linked this lack of awareness to
defects in the right hemisphere (Amador et al., 1991; McGlynn & Schacter, 1989;
Prigatano & Schacter, 1991 as cited in Rusch and Corrigan, 2002); yet, some researchers
studying schizophrenia did not find a relationship between defects in the right hemisphere
and lack of insight (David et al., 1995; Kemp & David, 1996; McEvoy et al., 1996).
Researchers studying the schizophrenia spectrum have found that the left hemisphere is
affected more than the right in the SMI population. There is one finding of a correlation
between poor insight and increased ventricle-to-brain ratios (Takai et al., 1992), and poor
insight into one’s disorder has been associated with lesions in the parietal lobe (McEvoy
et al., 1996) and smaller brain size (Flashman, et al. 2000). Using MRI, Flashman et al.
(2000) found that patients with poorer insight had smaller brain size and intracranial
volumes than patients with higher levels of insight or the comparison subjects.
Researchers are currently divided as to whether or not unawareness of illness in
the SMI population is best understood as the consequence of cognitive deficits that
complicate the person’s ability to understand confusing aspects of their mental illness and
everyday life. Lysaker et al. (1994) and McEvoy et al. (1996) found that poor insight is
related to frontal lobe deficits as measured by poorer performance on tests of
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neurocognition and executive functioning, but others have failed to find a relationship
(Cuestra et al., 1995; Freudenreich et al., 2004).
A different view of the etiology of impaired insight, not necessarily incompatible
with neuropsychological views, is that it is a coping mechanism. McGlashan et al.
(1975) showed that there are two distinct recovery styles for those that are experiencing
psychosis. The first group, the “integrators,” incorporates their mental illness into their
everyday lives and has a high sense of awareness of the course that their illness has taken.
The second group, or those that “seal over,” refuse to discuss or even think about their
mental illness and thus are inclined to have lower levels of awareness of their deficits,
course of illness, and consequences of illness. These differences could be understood to
reflect different coping style preferences. In a follow-up study of 30 “recovered”
patients, McGlashan and Carpenter (1981) found that the absence of a negative attitude
towards illness and symptoms was critical to achieving a positive outcome.
Due to the heterogeneous SMI population and the multifaceted nature of insight,
insight as a coping mechanism may be more useful for some individuals, as well as more
helpful in coping with some symptoms than others. Using the SUMD to measure
symptoms, Mohammed et al. (1999) concluded that poor insight into negative symptoms
(e.g. alogia, affective flattening, avolition) is associated with poor executive functioning
while poor insight into positive symptoms (e.g. delusions, hallucinations, disorganized
speech or thinking, grossly disorganized behavior, catatonic behaviors) is not associated
with poor executive functioning. Therefore, it can be theorized that unawareness of
negative symptoms may be due to neurocognitive deficits related to the frontal lobe and
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executive functioning, while unawareness of positive symptoms may mainly act as a
coping mechanism.
Poor insight as a coping method may also serve a protective role for individuals
grappling with trying to understand their disorder who are experiencing higher levels of
depression (Lysaker et al., 2005). Coping by having poor insight can allow the individual
to avoid reality and as a result improve self-esteem and circumvent depression. Greater
use of a form of coping, labeled accommodation or adaptation, was also a significant
predictor of adjustment, providing support for the role of coping as a protective factor for
people with schizophrenia (Lecomte & Mercier, 2005).

Insight and Suicide Risk
The role of poor insight as a coping method also suggests that good insight may
paradoxically be a risk factor for depression and suicide. Individuals with a disorder in
the schizophrenia spectrum have a 20 percent higher chance of attempting suicide than
the general population and have a lifetime suicide attempt rate of 20 to 40% (Meltzer,
Anad, & Alphs, 2000). In the SMI population, suicidal ideation and behavior have been
linked to depression (Amador et al., 1994; Caldwell & Gottesman, 1990). Research has
indicated that higher levels of insight lead to lower self-esteem and greater depression,
thus increasing risk of suicide attempts (Amador et al., 1994; Caldwell & Gottesman,
1990; Evren & Evren, 2004; Pompili et al., 2004). Baechler (1979; restated in Pompili et
al., 2004) stated that “schizophrenics do not kill themselves insofar as they are
schizophrenic but insofar as they are persons who know they are schizophrenic or are
threatened with becoming so and who wish to avoid this fated outcome.” Amador et al.
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(1996) reported that in their study of 218 patients with schizophrenia, 169 individuals did
not have suicidal behavior whereas 49 had suicidal behaviors or ideologies. Amador and
colleagues (1996) found in their study that patients who have more awareness of their
delusions, blunted affect, and anhedonia were more likely to commit suicide. In a study
by Evren and Evren (2004), sixty individuals with schizophrenia were interviewed and
their clinical case summaries were reviewed. About half of the sample, 45%, had
experienced suicidal ideation, had made one or more suicide attempts, had lower negative
symptom scores, and had been diagnosed as depressed at one point in time. For these
individuals, their mean scores on the three components of insight were statistically
significantly higher than for those who did not have a history of suicidal ideation or
attempts. Evren and Evren (2004) replicated other studies (e.g. Caldwell & Gottesman,
1990) that indicated that those that did attempt suicide and those that did not attempt
suicide did not differ on demographic characteristics such as age, gender, marital status,
educational status, and employment history.

The Role of Insight in Treatment and Recovery
While increased levels of insight have been shown to be a risk factor for suicide,
moderate levels of insight can also act as an important factor in treatment and recovery.
Poor insight can create a barrier between practitioner and patient that may affect the
alliance during therapy and the patient’s chance for long-term success. Poor insight has
been associated with poor work skills, more noncompliance, and more readmissions to
hospitals (Lysaker et al., 1994). Several studies have shown that high levels of insight
are associated with improved outcome, fewer hospitalizations, better post-hospital
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adjustment, and better medication compliance both in psychiatric in-patient settings and
outpatient settings (Amador et al., 1993; Schwartz, 1998). These findings support the
view that increasing insight early during the course of treatment can increase the
probability of treatment being successful.

Insight and Human Development
To fully understand insight into adult SMI, attention must be paid to the
emotional, physical, and mental health difficulties that people experience as they
transition from adolescence to adulthood. Research indicates that one in five children
have some form of a diagnosable mental, emotional, or behavioral disorder, yet 70
percent of those children do not receive mental health services (Kenny et al., 2002). In
addition to a lack of a common approach to detecting and following these children across
systems, the neglect of services seems to be due to factors such as the varying definitions
and classifications of childhood psychiatric disorders, research with heterogeneous child
samples, using differing age groups for studies examining “adolescence,” and multidisciplines disagreeing on what constitutes child and adolescence psychosis and
emotional disorders.
The term Serious Emotional Disturbance, applied to people under age 18, is
comparable to Serious Mental Illness applied to adults. Both terms are used colloquially
and legislatively to describe people who are diagnosed with a psychiatric disorder
according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
(American Psychiatric Association, 1994), when the diagnosed condition results in
severely impaired functioning and disability.
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Children and adolescents can be diagnosed with different diagnoses as they progress
through the lifespan even though their symptomatology may be similar; they can be
deemed as having SED prior to age 18 and after they are 18 they can be deemed again as
having SMI. Therefore, it is difficult to estimate the rates of SED and SMI in the
population age 16 – 21 (Jonikas, Laris, & Cook, 2003) and hence it is difficult to estimate
the amount of the population that is not receiving mental health services.
Research into SMI has demonstrated that disorders in the schizophrenia spectrum
are chronic and that poor outcome is often linked to earlier onset (Helgeland &
Torgensen, 2005). Helgeland and Torgensen (2005) also found diagnostic stability from
adolescence psychiatric pathology to adulthood for schizophrenia spectrum disorders.
Other researchers disagree with this finding, concluding that it is impossible to have valid
diagnostic consistency between schizophrenia and psychosis in childhood (Chen, Swann,
& Burt, 1996). Due to these inconsistent results it is clear that further research into the
transition from SED to SMI is needed.
The transition from adolescence to adulthood can be understood in terms of
developmental and institutional transitions (Vander Stoep, Davis, & Collins, 2000).
Developmental transitions are biological and social in nature while institutional
transitions refer to changes in service settings, legal, or bureaucratic status. Research by
Vander Stoep et al. (2000) suggests that establishing and maintaining peer and family
relationships, employment, high levels of functioning, treatment adherence, and transition
back into a community setting can be impeded or delayed throughout the lifespan by SED
or psychiatric pathology in childhood or adolescence.
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According to Helgeland and Torgersen (2005), SMI in adulthood is associated
with developmental hardships such as complications during pregnancy,
neurodevelopmental abnormalities, and delayed motor and language development, thus
suggesting schizophrenia is a developmental mental illness with relative stability in
childhood and adolescence and onset in early adulthood. As a result it can be deduced
that individuals with adolescent psychiatric pathology (APP) that have poor levels of
insight may continue to have poor levels of insight once in the SMI population. Clinical
characteristics such as degree of psychopathology, length of previous hospitalizations,
and age of first hospitalization are also associated with patterns of psychosocial treatment
response and insight into one’s illness (Kupper and Hoffmann, 2000; Peer and Spaulding,
2007). Although research has not conceived a developmental theory of insight, it can be
assumed that valuable information that can inform recovery decisions can be gleaned
from future research viewing insight in a developmental context.
Simply having APP can hinder an individual’s level of functioning and course of
illness factors such as treatment adherence, but failure to engage in services can also be
attributed to lack of insight (Carpenter, Strauss, & Bartko, 1973; Ghaemi & Pope, 1994;
Lysaker et al., 1994; Shwartz, 1998; Smith et al., 1999). Developmental impairments are
more ubiquitous in those with symptoms in adolescence or APP than in those with late
onset schizophrenia (Helgeland & Torgersen, 2005), thus indicating a possible more
biologically severe subtype of the SMI population. Individuals that have the lowest
degrees of insight and a history of APP may have more severe symptoms and may,
despite receiving mental health services during adolescence, continue to have poor
insight as adults receiving in-patient services.
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Families are often a source of emotional support for those with a mental illness.
Research has shown that individuals with APP have more dysfunctional family
relationships as well as increased perceptions that their families are distant and do not
offer support (Jonikas et al., 2003). While adolescence individuals may seek support
from other sources such as friends or significant others; for adolescents with mental
illnesses this may not be possible due to poor social skills, paranoia, stigma associated
from having a mental illness, blunted affect, and aggressive behaviors towards peers.
Failure to establish or maintain relationships may force the person to manage their illness
differently; poor insight may develop as a coping mechanism in adolescence to substitute
for the lack of support from family and peers. This method of coping may continue
throughout the course of the illness and contribute to the individual’s insight remaining
low after being admitted to inpatient treatment settings.
In a study Van Meijel et al. (2002) healthcare professionals and families of
patients with schizophrenia were interviewed. All interviewees agreed that in order to
improve outcomes for those with SMI earlier intervention and symptom recognition is
needed. Furthermore, all participants in the study agreed that a certain level of insight is
needed to accomplish early recognition and intervention for the SMI population (Van
Meijel et al., 2002). Those that have lower levels of insight in adolescence while meeting
criteria for SED may, with the help of mental health services and psychopharmacology,
increase their levels of insight while making the transition into the SMI population. This
increased understanding of the need for services, ability to understand their mental
illness, and the ability to re-label unusual mental events as pathological can have
important implications for treatment and the chronicity of states of psychosis that the

13
patient experiences and copes with, as well as the number of times that they must be
hospitalized. However, individuals with extremely poor insight during adolescence and
into adulthood may, despite intensive intervention, not be able to understand and re-label
their illness and may be more likely to have poorer treatment outcomes. Further research
needs to accurately longitudinally measure, conceptualize, and define insight in order to
inform our decisions for early identification and intervention strategies, as well as help
explain the developmental transition from SED to SMI and the impact insight may have
on this population with greater symptom severity. The conclusion can be drawn that
further analysis into the relationship of insight and the transition from SED or APP to
SMI can create new contexts in which SED and SMI and the mental health services for
each can be viewed.
To date, there has been only one exploratory study conducted in a clinical setting
that compares the characteristics of people with APP to those without. In a study by
Wynne (2009) the relationship between APP and SMI was examined by assessing the
relationship between prior mental health services before the age of 18 and time of
assessment on people’s insight into their illnesses as adults participating in a psychiatric
rehabilitation. The sample consisted of 112 patients recruited from an inpatient
psychiatric rehabilitation unit at a state psychiatric hospital. Results indicated that those
with service use during adolescence were found to be younger at admission, have slightly
lower levels of education, have an earlier age of onset, and significantly more previous
hospitalizations. A relationship between Axis II diagnosis and service use was also
identified, indicating that having an Axis II diagnosis in adulthood and APP may signify
that individuals had particularly noticeable symptoms that increased their chances of
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being served in adolescence.
Wynne (2009) also found that improvements in neurocognitive functioning were
not evident over the course of treatment. Although improvements in insight were
evident over the course of treatment for the general CTP population, adults with SMI
who used mental health services before the age of 18 did not significantly differ from
those who did not use services before the age of 18 with respect to level of insight; except
for awareness of illness at 6 months as measured by the IS. Results of analyses on insight
measures over the course of treatment by APP severity level suggest that increases in
measures of insight are not evident for the medium and high APP severity groups and
changes in total insight and insight into need for treatment are different for the no
services in adolescence and low APP severity groups over time. This field of research
has numerous implications for measuring and increasing insight among persons with SMI
and may have implications for treatment success within institutions and treatment
outcomes once discharged into the community.
A major factor contributing to the paucity of research in this area is the substantial
methodological problems associated with this kind of research. The impact of prior
mental health services in adolescence on SMI takes years to demonstrate full, measurable
effects. Obtaining historical information from treatment providers who served
individuals during adolescence also proves problematic, as by the time this information
has been requested by the adult’s treatment provider, long periods of time may have
passed and the clinical information destroyed. Furthermore, it takes years to accumulate
the needed data in order to be able to understand this process. Although the study by
Wynne (2009) used data from a nine year period, there was low power for several key
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analyses due to missing data and/or changes in the clinical assessment battery. The use
of multivariate analyses in this study was undermined by a low number of valid cases on
many of the variables over time. Therefore, conclusions about differences between
groups, or the lack thereof, over the course of treatment are tentative due to insufficient
power. Even though there was low power the presence of several interactions between
service use and APP severity levels and insight measures across treatment approaching
statistical significance indicates that effects were “missed.” At any rate, this study
explored the relationship between service use and insight such that future studies in this
area can make more informed research hypotheses using stricter constraints in research
design to circumvent problems related to lack of power and missing data. Thus further
study using a greater amount of participants completing repeated measures over time
could overcome low power problems and find statistically significant relationships
between APP severity groupings and insight over time in treatment.
In summary, previous research has indicated that psychosocial functioning (e.g.,
social competence, social interest) in SMI is a product of complex relationships between
factors such as neurocognitive functioning (Brekke, Kohrt, & Green, 2001) and
sociocognitive variables, such as locus of control, and that both of these domains have
been implicated in the research on the concept of insight. A greater understanding of the
interrelationships between these factors, utilizing the developmental conceptualization of
insight proposed by Wynne (2009) may aid not only in improving conceptualization of
insight and psychosocial functioning during treatment in adolescence and adulthood, but
also treatment outcomes once individuals are in the community functioning as adults
(Hoffmann & Kupper, 2002; Kupper & Hoffman, 2000; Smith et al., 1999). Also, better
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understanding of these complex relationships may be able to aid in improving treatment
outcomes for those with SMI without solely depending on improving a person’s insight
into their illness.

Present Study
The purpose of the present study was to further examine the relationship between
adolescent psychiatric pathology, often captured by the term of art SED, and SMI by
assessing the relationship between prior mental health services before the age of 18 and
time of assessment on people’s insight into their illnesses. Earlier understanding of
degrees of insight in the SED population has important ramifications for the lifelong
diagnosis and treatment of those with SMI. Whereas poor levels of insight in
adolescence in some individuals with more severe symptomatology may continue to be
stable into adulthood despite receiving psychological services, some individuals with the
help of mental health services may be able to increase their levels of insight over time
and improve their likelihood of successful treatment outcome and transition into the
community. However, there are also reasons to believe these APP severity groups do not
differ. The reasons for which an individual interacts with mental health service systems
are complicated and there is no one path to treatment. For example, family involvement
for people with SMI varies greatly. If one person has an active family and another does
not, the former may be more likely to have a receive services or be screened for APP than
the latter, independent of their functional abilities, simply because a family member
advocated for the appointment. Alternatively, an individual may repeatedly encounter
mental health professionals in adolescence, typifying a more chronic course that may be
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better served through guardianship, but no interested party seeks guardianship on behalf
of the individual. These confounds suggest that we need to know more about the concept
of insight and APP and its correlates to the clinical picture for these same people as they
transition and receive adult psychiatric services.

The present study had two primary objectives:
1. To determine if there was a pattern of differential functioning for adults with SMI with
or without mental health service use during adolescence across various levels of
functioning. In general, it was anticipated that individuals with adolescent psychiatric
pathology would demonstrate lower overall functioning than those without adolescent
psychiatric pathology. As described above, these are individuals that for various
unknown reasons, received mental health services during adolescence. Research indicates
that this population may represent individuals experiencing more severe
symptomatology, and that adolescent psychiatric pathology can impede treatment success
in adulthood. Because of this, hypothesis 1 predicted that those individuals who had
various levels of APP will show demonstrably lower functioning in the clinical setting.
Thus, it was hypothesized that the APP severity would correlate with clinical functioning.
Specifically, the groups would differ in statistically significant ways across all domains
of functioning measured (neurocognitive, social cognitive, symptomatology, and
behavioral functioning).
A. Upon Admission. Hypothesis 2 predicts that at the time of admission, individuals with
adolescent psychiatric pathology would demonstrate lower overall functioning than those
without adolescent psychiatric pathology on neurocognitive, social cognitive, and
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behavioral functioning measures. However, hypothesis 3 predicted that because of prior
contact with services, those individuals with adolescent psychiatric pathology would have
higher levels of insight into their disorder at admission than those without adolescent
psychiatric pathology. In addition, hypothesis 4 anticipated that those with adolescent
psychiatric pathology would have higher levels of symptomatology. When analyses
using different levels of adolescent psychiatric pathology were conducted, hypothesis 5
predicted that those with adolescent psychiatric pathology that required hospitalization in
adolescence or high mental health service utilization in adolescence would have higher
levels of insight into their disorder at admission than those with none or less adolescent
psychiatric pathology. However, hypothesis 6 predicted this group would also have the
highest levels of symptomatology and would have the lowest scores on neurocognitive
and sociocognitive measures.
B. Over the course of treatment. Hypothesis 7 predicted that overall differences in
functioning, symptomatology, and treatment adherence would not remain over the course
of treatment. It was hypothesized that as a result of psychiatric rehabilitation there would
be an increase in neurocognitive functioning, insight into disorder, internal locus of
control, and behavioral functioning and a decrease in external locus of control and
symptomatology for those with and without adolescent psychopathology. That is, it is
hypothesis 8 anticipated that both groups would show improvement in functioning over
the course of psychiatric rehabilitation. It was predicted that significant differences at
admission or six months would not remain between those with adolescent psychiatric
pathology and those without adolescent psychiatric pathology in all areas after 12 months
of treatment. However, it was predicted that those individuals with adolescent
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psychiatric pathology would demonstrate higher symptomatology after 12 months of
rehabilitation. Furthermore, when different levels of adolescent psychiatric pathology
were used in analyses, hypothesis 9 predicted that as adolescent psychiatric pathology
becomes more severe functioning will decrease, there would be more severe
symptomatology. Overall, while it was hypothesized there would be differences in a
variety of domains it was also hypothesized that differences in insight upon admission
would not remain one-year after beginning psychiatric rehabilitation.
2. To determine if there is a pattern of differential outcome following discharge for
individuals with adolescent psychiatric pathology from those without. While previous
research had not been conducted to inform hypotheses in this area, it was generally
hypothesized that there would be differences between groups in terms of treatment
outcome. Specifically:
C. Discharge disposition. Hypothesis 10 predicts that discharge disposition would differ
between the two groups in that individuals with severe adolescent psychiatric pathology
would be discharged to a more restrictive setting. This hypothesis was based on the idea
that those individuals who used high amounts of mental health services or were
hospitalized during adolescence may have represented a group with more severe
symptomatology and may have been hospitalized more and for longer periods of time
during the course of their illness. These individuals may, though frequent
hospitalizations, been reinforced to fulfill the “patient role” and have been
institutionalized, thus representing a group or participants who take a longer time to
transition into the community and may influence treatment providers’ notions such that
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there is an assumption that individuals who were hospitalized during adolescence require
higher levels of care and supervision.
D. Rehospitalization rate. Hypothesis 11 predicted that there would be a greater rate of
rehospitalization for those with APP than those without APP. Furthermore, when
analyses were conducted between the different APP severity groups, hypothesis 12
predicted that those individuals in the medium and highest APP severity groups would
have a greater rate of rehospitalization than those in the low to no APP severity groups.
In addition, hypothesis 12 predicted that those in the highest APP severity group would
have the greatest rate of rehospitalization, as these individuals may represent a subgroup
experiencing more severe and refractory symptoms that can be potential barriers to living
in the community for extended periods.

Based on the results of these analyses, exploratory analyses were undertaken to
glean additional information about the role of service use and APP severity level in the
psychiatric rehabilitation and insight of individuals with SMI. This data was
accumulated over the course of thirteen years, allowing for a preliminary look at the
therapeutic consequences of prior mental health service usage and the longitudinal effects
of psychiatric rehabilitation treatment for these individuals. The archival database
utilized in this proposed study was ideal for this type of research. It afforded the
opportunity to study populations with different service histories under a similar set of
clinical circumstances over an extended period of time. Although one previous study
(Wynne, 2009) sought to better understand the relationship between mental health service
utilization during adolescence on insight scores across treatment in adulthood, it should
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be reiterated that the proposed study built on the previous study by Wynne (2009), was
highly exploratory in nature, and sought to expand the scope of previous research by
including a larger sample size and more assessment measures that have been implicated
as important to the study of the concept of insight and in the treatment outcome for those
with SMI. This was a critical first step in the analysis of the role of mental health service
usage during adolescence and adolescent psychiatric pathology in the treatment of adults
with SMI and these adult’s insight into their mental illness.
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CHAPTER 2 - METHOD
Design Overview
The primary purpose of this study was to assess the relationship of mental health
service usage and adolescent psychiatric pathology severity with insight before, during,
and after treatment. In addition, a secondary relationship between adolescent psychiatric
pathology and functioning in a variety of domains before, during, and after treatment was
assessed. The participants with adolescent psychiatric pathology were compared to those
without to determine if any differences existed. Also, when adolescent psychiatric
pathology was separated into three separate groups by the amount and type of services
utilized during adolescence, these three different levels of adolescent psychiatric
pathology were compared to those without. Univariate and multivariate analyses were
conducted within and between the two groups service groups (service use vs. no service
use in adolescence) and the four APP severity level groups with respect to overall
functioning using multiple measures described below.
Setting
The Psychiatric Rehabilitation Program, formerly known as and will continue to
be referred to in this paper as the Community Transition Program (CTP), was an inpatient
unit at the Lincoln Regional Center (LRC) a public state psychiatric hospital in Lincoln,
Nebraska. This 40-bed inpatient unit hosted a comprehensive psychiatric rehabilitation
program for those most disabled by mental illness in the State of Nebraska. Individuals
were typically discharged to a less restrictive setting after a 9 to 18 month period of
intensive treatment, with the average length of stay being 12 months. Treatment
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engagement was encouraged through the use of contingency management based on social
learning theory. The regimen included pharmacotherapy, psychoeducational groups and
classes to target improved management of symptoms and disorder, and training aimed at
improving occupational, leisure, and social skills. The treatment was designed to target
multiple levels and domains of functioning for individuals with SMI, rather than only
targeting an isolated area of deficit (e.g., symptoms). Thus, treatment did not focus on
clinical diagnosis. Rather, treatment plans using functional analysis were individualized
and based on making step-wise improvements in deficient areas of functioning and
capitalizing on observed and participant perceived areas of relative strength of the
individual. Treatment plans were designed by a multidisciplinary treatment team
including nurses, social workers, psychiatrists, occupational therapists, psychologists, and
psychiatric technicians. In addition, program participants were encouraged to be active
members of their own treatment team for the purpose of increased engagement in
treatment and to promote the concept of recovery in the therapeutic milieu. Consequently,
the CTP referred to individuals as “participants” instead of patients, reinforcing the idea
of active engagement of participants in their treatment. For a detailed outline on the
theoretical foundation and practical applications of this innovative, state-of-the-art
treatment technology read Treatment and Rehabilitation of Severe Mental Illness
(Spaulding et al., 2003).
The Lancaster County Community Mental Health Center (LCCMHC) also
contributed data to the archival database. Since a majority of participants from CTP are
served by LCCMHC upon discharge, ongoing program evaluation using records at
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LCCMHC yielded data pertaining to outcome such as rehospitalization rate, discharge
location, and use of services in the community.

Participants
Participants discharged from the CTP program from 1996 through March 2009
contributed data to the archival database utilized in this study. The CTP program
participants were not directly involved in any specific research procedure. Rather, the
database included the ongoing clinical data collected as part of the routine assessment
process described further below at the CTP and additional data gathered through chart
review.
Participants of the CTP must have had as part of the criterion for admission an
Axis I major mental disorder administrative designation as SPMI. This sample represents
a severe and treatment refractory subpopulation. They were referred to the CTP because
of either extended institutionalization in custodial settings or repeated re-hospitalizations
with no stable community functioning. The sample consisted of 354 participants. All
subjects met DSM-IV (American Psychiatric Association, 1994) criteria for
schizophrenia, schizoaffective disorder, or bipolar disorder. Participants were between
the ages of 18 and 60.
DSM-IV (American Psychiatric Association, 1994) diagnoses for patients with
schizophrenia, schizoaffective disorder, and bipolar disorder were confirmed prior to the
study by interviews with the participants, chart reviews, reviews of historical
documentation, and consultation with the program director and treatment team. Patient
data was used only when ratings from these different sources produced the same
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diagnosis. All patients were on various combinations of antipsychotics, mood stabilizers,
and anxiolytic medications during the study.
Initially, the archival database had 354 participants. Because available outcome
data in the database pertained to the most recent admission to CTP and multiple
individuals in the database received rehabilitation at various stages in their life and
disorder, all previous admissions before the most recent admission were excluded from
analyses to maximize the number of valid cases available for analyses. Also, participants
with lengths of stay in the CTP program of less than six months were excluded from
analyses since treatment effects were captured as there was not adequate time to
participate in the CTP rehabilitation program or have multiple assessment administrations
within six months time.
A vast majority of CTP participants were either civilly committed or admitted by
a legal guardian. Either way, treatment was typically viewed as involuntary in that most
did not decide for themselves to enter the program. This was particularly important in
developmental analyses of insight due to individuals being hospitalized in adolescence
being made wards of the state at an earlier age. Involuntary treatment may play a role in
the concept of “insight,” as some researchers have suggested that insight is often viewed
in clinical contexts as an individual’s degree of agreement with treatment providers
(Rusch & Corrigan, 2002). Analyses took this variable into account and determined
differences amongst those with and without mental health service use in adolescence and
between the different APP severity levels.

Measures
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Demographic and Clinical Characteristics
Through chart review at CTP, information regarding the demographic and clinical
characteristics of participants was included in the archival database. These variables
included gender, age, years of education, race/ethnicity, marital status, legal status,
number of previous hospitalizations in the participant’s lifetime, age of first
hospitalization, Axis I and Axis II psychiatric diagnoses, comorbid Axis I diagnoses,
length of stay at CTP, and other relevant variables.

Neurocognition Measures
1) Repeatable Battery for the Assessment of Neuropsychological Status (RBANS;
Randolph, 1997). The RBANS is a brief neurocognitive screening assessment
(approximately 25 minutes) ideal for individuals who may lack levels of attention needed
to complete longer assessments. There are two forms of the RBANS (Form A and Form
B), intended to minimize the practice effects of repeated administrations. The twelve
subtests of the RBANS are grouped into five neurocognitive domains. The five domain
scores of the RBANS include immediate memory, delayed memory, attention, language,
and visuospatial/constructional functioning. In addition, a total index score represents
overall cognitive functioning. Convergent validity has been established in people
diagnosed with schizophrenia for the RBANS with other neuropsychological constructs,
like memory and intelligence (Gold, Queern, Iannone, & Buchanan, 1999; Hobart,
Goldberg, Bartko, & Gold, 1999). In addition, sensitivity to patterns of cognitive
impairment in SMI and general reliability and validity have been evaluated (Gold et al.,
1999; Hobart et al., 1999).
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2) COGLAB (Spaulding, Garbin, & Dras, 1989). COGLAB was created as a
computerized test battery comprised of tests common in the psychopathology literature.
The WCST, a measure of executive functioning, was used in an effort to understand the
subject’s ability for abstract thought, cognitive flexibility, and to replicate past studies
that have found a significant relationship between the WCST and insight (Lysaker et al.,
1994; McEvoy et al., 1996). CTP standard assessment included two of the tests from the
battery; however, for the current study the Card Sorting Task (WCST; an adaptation of
the Wisconsin Card Sorting Task, Heaton et al., 1993) was used. The WCST is a
computerized neuropsychological test of “set shifting” in which participants are asked to
display their ability to be flexible when exposed to changing schedules of reinforcement
by matching a target card to one of four stimulus cards without being told the matching
principle of color, shape, or number that changes frequently without warning to the
subject. The WCST was used to measure executive functioning and its known sensitivity
to impairment in concept formation, cognitive flexibility, and abstract thought (Lysaker
et al., 1994; Lysaker et al., 1998). The WCST allows clinicians and researchers to assess
frontal lobe functions such as strategic planning, organized searching, utilizing
environmental feedback to shift cognitive sets, goal oriented or problem solving
behavior, and decreasing impulsive responses. The computerized WCST takes
approximately 12-20 minutes to complete and provides objective measures of overall
success by computing the number of categories achieved, number of trials, number of
errors, number of perseverative errors, percentage of perseverative errors, and the
consolidation index as a measure of set-shifting.
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Good discriminant validity was demonstrated between individuals diagnosed with
schizophrenia and controls in an early study of the COGLAB (Spaulding et al., 1989).
Results from large multivariate studies conducted with normal and “patient” populations
indicate overall acceptable psychometric properties of the COGLAB (Spaulding,
Hargrove, Crinean, & Martin, 1981; Spaulding et al., 1989).
3) Rey Auditory Verbal Learning Test (RAVLT; Schmidt, 1996). The RAVLT,
is a seven trial list-learning task with alternative forms consisting of 15 words presented
in an auditory format. Participants were instructed to recall as many words as they can
from the list immediately following each of five trials. A distractor trial was then
presented consisting of a different list of 15 words and participants are required to recall
as many words from this distractor list. Finally, participants were required to recall as
many words as possible from the original list without it being presented again. In
general, the RAVLT provides a measure of verbal memory. The number of words
remembered after the fifth trial is the most commonly used RAVLT score. Acceptable
discriminant validity between memory impaired vs. memory intact patients and normal
vs. neurological patients has been demonstrated, as well as adequate test-retest validity
(Schmidt, 1996).
4) Rey-Osterrieth Complex Figure Test (RCFT; Rey, 1941). This is a test of
visuoconstructional ability and nonverbal memory. It is comprised of four tasks: a copy
trial, immediate recall trial, delayed recall trial, and a recognition task. Figures were
scored using the 18-point scoring system, originally developed by Osterrieth (1944), and
outlined in Meyers & Meyers (1995).
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5) The Trailmaking Test (A&B) (Army Individual Battery, 1944). This two
component test assesses attention, visual scanning, and information processing. In Part
A, individuals connected circles numbered 1 through 25 by drawing a line sequentially
from 1 to 25 as quickly as possible. In Part B, individuals completed a similar task
alternating sequentially between numbers and letters (e.g. 1 to A, A to 2, 2 to B, B to 3).
Performance was measured by subtracting the number of errors from the total possible
score, resulting in two scores, one for each trial.
6) Neuropsychological Assessment Battery Screening Memory Domain (NAB)
(Stern & White, 2001). The NAB Screening Memory Domain score is a composite
measure of the participant’s verbal and visual memory functioning, based on the sum of
the Screening Shape Learning Immediate Recognition, Screening Shape Learning
Delayed Recognition, Screening Story Learning Immediate Recall, and the Screening
Story Learning Delayed Recall scores. The Screening Memory Domain score is used as
an indicator of an individual’s verbal explicit learning, visual explicit learning, verbal
free recall after a brief delay, and visual delayed recognition memory after a brief delay
(Stern & White, 2001). The reliability coefficient of the Screening Memory Domain
score is .79 (Stern & White, 2001).
7) Controlled Oral Word Association Test (COWAT or FAS) (Benton &
Hamsher, 1976). The COWAT measures verbal fluency and word generating ability, or
the ability to rapidly generate and organize verbal information. In a series of 60-s trials,
participants were asked to name as many words as possible that began with specified
letters of the alphabet F, A, and S. Total number of words generated was scored.
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Theory of Mind Measures
1) Hinting Task (Corcoran, Mercer & Frith, 1995). The Hinting Task measures
theory of mind abilities and requires working memory, verbal comprehension, and verbal
production abilities. A summary score was generated based on ability and facility of
comprehension and interpretation of social implications. Limited psychometric data is
available, however, the Hinting Task is sensitive to deficits in schizophrenia, correlates
with other ToM measures and has good face validity in studies with seriously mentally ill
participants (Corcoran & Frith, 2003).
Socialcognition Measures
1) Inventory for the Measurement of Self-Efficacy and Externality (I-SEE or
FKK; Krampen, 1991). The I-SEE provides a measure of global attributional style, or
locus of control. It is comprised of 32 items which were each rated on a six point Likert
scale ranging from strongly disagree to strongly agree. The measure consists of four
main scales: “internality” (i.e., “whether I have an accident is based on my own
behavior”); “self-concept of one’s own competence” or “self-efficacy” (i.e. “I can do
many things to protect my self-interest”); “powerful others’ in controlling beliefs” (i.e.,
“other people often prevent my plans from becoming reality”); and “chance in controlling
beliefs” (i.e., “whether I fall ill is a matter of chance”). These scales were combined to
yield two composite scales a general external scale (“externality”) and a general internal
scale (“self-concept of one’s own efficacy”) which represents participant’s beliefs about
their self-efficacy. Krampen (1991) established reliability for the two composite scales.
2) The Internal, Personal, Situational Attribution Questionnaire (IPSAQ)
(Kinderman & Bentall, 1997) assesses a more interpersonal attributional style based on
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participants explanations of positive and negative social scenarios. It yields two
measures: an externalizing bias (Eb) score (the degree to which persons attribute negative
events to external factors and attribute positive events to themselves) and personalizing
bias (Pb) (the degree to which persons attribute negative events to other people as
opposed to situational factors).
3) The Coping Strategies Task (CST) (Mindt & Spaulding, 2002). The CST is
used for assessing coping-related cognition in individuals with schizophrenia-spectrum
disorders. The CST is comprised of four coping subscale scores including: Social
Support Seeking, Self-Controlling, Escape Avoidance, and Planful Problem Solving.
Reliability analyses reveal that the CST and its subscales demonstrated adequate
reliability, although one subscale (Behavior Reaction) demonstrated less robust split-half
and test-retest reliabilities. Concurrent validity was evaluated by analyzing the
relationship between the CST and measure of stress, observed behavior, and
neurocognition. Correlational analyses have revealed that coping attributions, as
measured by the CST, were found to be association with perceived stress, observed
behavior, and executive functioning.

Insight Measures
1) Insight Scale (IS; Birchwood, Smith, Drury, Healy, Macmillan, & Slade,
1994). This brief self-report measure (8 items) allows participants to choose one of three
responses: agree, disagree or unsure, for each item. It yields a total score and three
subscale scores representing David’s (1990) three domains of insight. The correct answer
for each was counted as one point and each dimension is scored on a scale of 0-4, with an
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overall insight score ranging from 0 to 12 with higher scores indicating higher levels of
insight. The three subscales, therefore, are: “need for treatment” (i.e., “I do not need
medication”), “ability to relabel psychotic experiences” (“some of my symptoms were
made by my mind”), and “awareness of illness” (“I am mentally well”). This measure of
insight focused on insight into functional impairment rather than specific illness
categorizations. This self-report questionnaire is well validated and used extensively
with the SMI population, with test-retest reliability equaling .90 (Birchwood et al., 1994).
2) The Self-Appraisal of Illness Questionnaire (SAIQ) (Marks, Fastenau, Lysaker,
& Bond, 2000). The SAIQ is a self-report instrument designed to assess attitudes toward
mental illness among persons receiving psychiatric treatment. The SAIQ is a pencil and
paper self-report instrument composed of 17 items. The format for each item is a
statement or a question. The items addressed acknowledgment of illness, beliefs about the
outcome of illness, acknowledgment of a need for psychiatric treatment, and extent of
worry about illness and about illness related issues. Participants were asked to respond to
the statements and questions using a four-point Likert scale, which varies according to
the statement or question content. The validity of the SAIQ was examined through a
factor analysis. Three factors emerged: Need for Treatment, Worry, and
Presence/Outcome of Illness. The three SAIQ subscales are correlated with researcher
rated insight scales and neuropsychological tests. Results indicate that the Need for
Treatment and Presence/Outcome subscales were significantly correlated with both
researcher-rated insight scales and with neuropsychological tests of executive
functioning. The Worry subscale has been found to not be related to either researcherrated insight scales or neuropsychological tests (Marks, et al., 2000).
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Behavioral Functioning Measures
1) Nurse Observation Scale for Inpatient Evaluation (NOSIE-30; Honigfeld,
Roderic, & Klett, 1966). The NOSIE is a 30-item behavioral checklist format completed
by nursing staff at CTP, with responses ranging from zero (never) to four (always). Two
psychiatric technicians completed the checklist weekly for each participant. Items cover
six areas of unit (“ward”) functioning: social competence (“refuses to do ordinary things
expected of him or her”), social interest (“tries to be friendly with others”), neatness
(“keeps clothes neat”), irritability (“gets angry or easily annoyed”), psychoticism (“talks,
mutters, or mumbles to self”), and motor retardation (“is slow-moving or sluggish”).
When combined, these six areas represent a total assets score. Adaptive functioning
scales (i.e., social interest) were positively weighted and maladaptive scales (i.e.,
irritability) were negatively weighted when determining the total assets score. This
measure has been widely used as part of the psychiatric rehabilitation treatment and was a
routine assessment in the treatment program. Analyses within the CTP population have
yielded Pearson correlations between 0.68 and 0.72 for all scales (Penn, Mueser,
Spaulding, Hope, & Reed, 1995; Spaulding et al., 1999b). Also, a more recent reliability
update of this measure confirmed it remains reliable in modern treatment settings, with
inter-rater reliability on the total assets score at 0.76, on maladaptive scales at 0.68, and
adaptive scales at 0.75 (Lyall, Hawley, & Scott, 2004).

Symptomatology Measures Over Course of Treatment

34
1) The Brief Psychiatric Rating Scale – Extended Versions (BPRS-E; Lukoff,
Nuechterlein, & Ventura, 1986; Van der Does, Linszen, Dingemans, Nugter, & Scholte,
1993). Used to evaluate symptoms, the BPRS-E was used routinely every six months at
CTP. In general, the BPRS-E is widely used to assess changes in psychiatric symptoms.
Using a Likert scale from 1 (symptom is not present) to 7 (symptom is very severe),
clinicians rated individuals based on interview content and general, observed behavior on
24 items. The BPRS-E is a widely used instrument and reliability and validity have been
demonstrated (Bailley, Lachar, Rhoades, Diefenbach, Espadas, & Varner, 2004). Factor
analyses on the former 18-item version and the newer 24-item version have yielded four,
five, and six factor solutions of symptom items (e.g., Spaulding, Reed, Sullivan,
Richardson, & Weiler, 1999a; Perlick, et al., 1999; Burger et al., 1997). The six-factor
solution validated by Spaulding, Fleming, Reed, Sullivan, Storzbach, & Lam (1999a) was
used in this study because the original validation took place with the same population at
CTP. A standard principal component analysis of the BPRS (Spaulding et al., 1999a)
yielded six factors: Psychotic Disorganization, Hallucinations/Delusions, Paranoia,
Emotional Blunting, Agitation/Elation and Anxiety/Depression.

Symptomatology Measures at Admission
The following assessments were administered at time of admission to CTP and as
deemed necessary by the treatment team. In order to obtain the largest sample, only
admission scores on the following assessments was used.
1) The Beck Hopelessness Scale (BHS) (Beck & Steer, 1988). The BHS is a selfreport instrument that consists of 20 true-false statements designed to assess the extent of
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positive and negative beliefs about the future during the previous week and takes less
than five minutes to complete. Each of the 20 statements was scored 0 or 1. A total score
was calculated by summing the pessimistic responses for each of the 20 items. The BHS
has been standardized using psychiatric inpatients and outpatients (Beck et al., 1974;
Beck & Steer, 1988). Beck and Steer (1988) report high internal reliability across diverse
clinical and nonclinical populations with reliabilities ranging from .87 to .93. The BHS
has adequate one-week test-retest reliability in a psychiatric outpatient sample (r = .69;
Beck & Steer, 1988). Correlation coefficients between the BHS and the Beck Depression
Inventory pessimism item range from .42 to .64 in clinical samples (Beck & Steer, 1988).
2) Beck Depression Inventory-II (BDI-II) (Beck, Steer, & Brown, 1996). The
BDI-II is a 21-item self-report assessment of depressive symptoms. The respondent was
asked to rate how much he or she has been bothered by each symptom on a 4-point scale
ranging from 0 to 3. Each item consists of four statements that reflect gradations in the
intensity of a particular depressive symptom. The respondent chooses the statement that
best corresponds to the way that he or she has felt for the past two weeks. The
psychometric properties of the inventory have been reviewed by Beck, Steer, and Brown
(1996).
3) Suicide Probability Scale (SPS) (Cull & Gill, 1988). The SPS is a 36-item selfreport measure of current suicidal ideation, hopelessness, negative self-evaluation, and
hostility that takes approximately 10 minutes to administer. Subjects answered each item
on a 4-point scale ranging from 1 (“None or a little of the time”) to 4 (“Most or all of the
time”). There are three summary scores: A Suicide Probability Score, a total weighted
score and a normalized T-score. The Suicide Probability Score can be adjusted to reflect
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different a priori base rates for particular clinical populations. The internal reliability for
the SPS is high (Cronbach alpha = .93) and has high test-retest reliability over a threeweek period (r = .92; Cull & Gill, 1988). Although the SPS was designed to be a
measure of suicide risk, there is a paucity of research studies that have tested the
predictive validity of this measure.

Outcome Measures
1) Rehospitalization rate. One of the primary goals, often inappropriately cited as
the only goal, of treatment programs is the prevention of future hospitalizations and the
decrease of inpatient hospital days and use of emergency services (Cook, Pickett,
Razzano, Fitzgibbon, Jonikas, & Cohler, 1996; Anthony, Cohen, & Vitalo, 1978). The
inclusion of data from LCCMHC was a critical part of analyzing outcome from the CTP
program since a majority of participants were served through LCCMHC upon discharge
from CTP. Program evaluation activity at the LCCMHC has in the past, and hopefully in
the future, established a rehospitalization data-tracking program. The data available for
participants prior to 2005 was cross-checked with chart reviews at CTP and chart reviews
and interviews with staff at LCCMHC. The data for participants from 2005-2009 was
obtained and/or cross-checked from LCCMHC. Since the archival database in this study
included people discharged from CTP in 1996 to people discharged from CTP in 2009,
people may range in the possible amount of time since discharge. This study explored
ways of addressing this such as the percentage of hospital days out of all hospitals and
non-hospital days since discharge and the survival rate (or how long before the first
rehospitalization).
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2) Discharge disposition. The restrictiveness and nature of the setting to which
individuals were discharged from the CTP can also serve as a measure of outcome.
There were at least 35 different discharge locations to which people went following CTP.
Less restrictiveness (e.g., independent living) was characteristic of better outcome and
less symptomatology. For the purposes of this study, there were essentially four
categories of discharge location from most restrictive to least restrictive: 1) Regional
Center transfer, 2) Psychiatric Residential Rehabilitation, 3) Assisted Living, and 4)
Independent living. These categories were based on interviews with the CTP program
director and CTP social workers who were primarily responsible for discharge planning
and most familiar with community services as part of previous research in the
construction of the archival database. These four categories did not encompass all
discharges from CTP such as those to nursing homes or developmentally disabled (DD)
group homes. Few individuals were discharged to nursing homes, which were considered
more restrictive than even psychiatric residential rehabilitation. Discharges to nursing
homes from CTP were rare and typically due to the persons’ medical rather than
psychiatric condition, and therefore were not included in analysis. Similarly, very few
people were discharged to DD settings because one of the exclusion criteria from
admission to CTP was developmental disability.

Procedure
Data Collection
An archival longitudinal database was used in this study. Approval for
construction of this deidentified archival clinical data for research purposes was obtained
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from the university IRB and the state hospital research committee. Most of the archival
data came from the CTP clinical archives, but additional data pertaining to outcome and
community functioning was collected from Lancaster County Community Mental Health
Center. Clinical data was routinely collected as part of the CTP program and contributed
significantly to the database.
In addition, extensive chart review at both CTP and LCCMHC added additional
data regarding hospitalization history and general clinical and demographic
characteristics. In addition to the initial interview in which participants were asked about
what mental health services they received before the age of 18, a large amount of
historical information was gathered from a review of participants’ past records and social
history reports. Prior mental health services usage before the age of 18, coded as no
service use vs. service use, was derived from whether or not a participant received any
type of mental health services before age 18 (therapy, medications used for mental
illnesses, special behavioral school classes or programs, institutionalization during
adolescence, etc.). These prior history variables addressed whether or not the participant
had any DSM diagnosis, displayed prolonged characteristics pertinent to the
schizophrenia spectrum prior to age 18, or if they could have been termed has having
“serious emotional disturbance” during pre-adolescence or adolescence.
Information regarding symptoms at onset, whether or not the patient had
premorbid behavioral problems, and number of previous hospitalizations was also
obtained. Although instances of violence and delinquency in adolescents were noted,
individuals were not assessed as having SED or APP in adolescence simply due to
delinquency or aggression. These variables, taken into account with the other historical
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variables, were used to assess categorize individuals who used services prior to the age of
18 into different APP severity level groupings. Those participants that did not receive
services or have any historical variables indicating APP were coded as not having APP in
adolescence. Individuals with one or two instances of mental health service use (i.e. met
with a mental health provider once for evaluation,) were coded as the low severity APP
group while individuals with more frequent or longer duration of mental health services
prior to the age of 18 were coded as the moderate APP group. Those participants that
were institutionalized during childhood and or adolescents and had received extensive
mental health services at that time were coded as the high severity APP group. , Data
from 354 participants discharged from the CTP program between 1996 and March 2009
were used in analyses.
Assessments at CTP. All participants completed a comprehensive clinical
assessment upon admission to the CTP program and most of these assessments were
repeated at six month intervals throughout a person’s hospitalization in order to monitor
treatment response and inform future treatment planning decisions. These assessments
primarily included measures of neurocognitive and social cognitive functioning. Clinical
psychology graduate students or trained clinical assistants administered and scored all
measures according to standardized instructions. Scoring was assisted by several
computerized scoring programs. One significant change occurred in the routine
assessment battery during the thirteen-year period from which the archival data was
extracted. The RBANS, the IS, and social cognitive measures were added to the
assessment battery between 2000 and 2001 when new admissions arrived during that
time. The RAVLT, and SAIQ were phased out at that time in order to maintain that the
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assessment battery could be completed in a manageable amount of time or in favor of
newer assessment measures with stronger psychometric properties. Therefore,
individuals discharged before 2000 did not have RBANS and social cognitive data.
Likewise, people who entered the program at the time of the change did not have
RAVLT, and SAIQ data. The RBANS was phased out in 2005-2006 and the NAB was
used instead. Therefore, individuals discharged after 2000 and before 2006 had RBANS
data while those participants entering the program between 2006 and 2009 had NAB
data. Results using the RBANS and NAB were analyzed separately. Assessments
continued to be collected at six-month intervals and therefore biannual neurocognitive
and/or social cognitive data, as well as insight data was available for most participants.
Analyses were conducted for the different APP severity groups on the various
psychological assessments available at CTP during those participant’s involvement with
the program. Comparisons between and within groups were conducted across the
different domains of assessments for different time points.
In addition, assessments of various areas of functioning and overall functioning
were regularly completed in the context of the general milieu. Psychiatric technicians
completed NOSIE assessments on a weekly basis. The monthly average of weekly
ratings was included in the present database, making monthly NOSIE data pertaining to
each person’s unit functioning available. Data entry and management was completed by
a trained clinical psychology graduate student on a monthly basis to be used in treatment
progress meetings. At the time of extraction, the data was subjected to fidelity checks to
monitor if the behaviors are being correctly recorded and contingencies implemented as
intended by the treatment team.
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The current study was a retrospective longitudinal study in which three
assessments were taken from all participants in the study during the intake within two
weeks of admission, at 6 months, and a year after admission. The 12 month time period
was selected because the average length of stay at CTP is around 12 to 14 months which
maximizes the amount of data available at any given time point. The greater part of
treatment in skills training is also delivered within this time frame. All participants were
interviewed and given the BHS, BDI-II, socialcognition battery, neurocognition battery,
BPRS, and insight measures within the first two-weeks of their stay in the in-patient unit.
Patients were interviewed again at 6-months for their semi-annual review, and at oneyear for their annual review and given the BPRS, socialcognition and neurocognition
batteries, and insight measures at each time point. The NOSIE was completed by
psychiatric technicians weekly for each participant. Average monthly scores were
computed for the six areas and total assets score on the NOSIE. NOSIE scores within
two weeks of admission, after six months of treatment, and after one year of treatment
were used in the present study.
LCCMHC. Comprehensive chart review and interviews with LCCMHC staff
were completed by a clinical psychology graduate student involved in program
evaluation activity as part of a practicum placement at LCCMHC. After collecting
hospitalization data, the data was cross-checked with LRC records through chart review
to ensure its accuracy. Not all CTP participants were served by LCCMHC upon
discharge, nor has discharge data been obtained for those individuals served from 20062009. Whenever possible data for these individuals was obtained through LRC records.
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After the archival database was completed with data from both settings, two
graduate students completed additional quality assurance checks. Data was subjected to
cross-checking with original and computerized archival data to ensure its reliability and
accuracy. Once outcome data was obtained or completed for those individuals served
from 2006 to 2009 the same methods described above were used to ensure reliability and
accuracy.
Data Cleaning
Before analyses, data was examined for skewness and potential outliers. It was
necessary to ensure normal distribution of the dependent variables because most of the
analyses that were used in this study assume normality. Distributional skewing and
asymmetrical outliers can both produce skew and therefore transformation and/or outlier
windsorizing was applied only after examining the nature of the skew. Any dependent
variables that demonstrated a skewed distribution (skewness > +/- 1.00) without outliers
was normalized using conservative transformation procedures. Using Tukey’s Hinges,
the data was systematically screened for outliers. All outliers were included after a
windsorizing procedure which replaces extreme values with the highest acceptable value
was applied (Hoaglin, Mosteller & Tukey, 1983). All variables were cleaned to within
acceptable skewness range with the exception of the rehospitalization and previous
hospitalizations data. A few variables required both square root transformation and
windsorizing of extreme outliers in order to normalize the distribution. Using the above
procedures, all variables were cleaned to within acceptable skewness range with the
exception of the rehospitalization data. The nature of this data prevented transformation
or windsorizing. Therefore, the rehospitalization data were analyzed disregarding skew.
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However, follow-up analyses were conducted by creating categorical variables to further
corroborate the results.
Data Analysis
This study was exploratory in nature. In general, the study aimed to determine if
there are differences between those who have different levels of adolescent psychiatric
pathology and those who do not, and in particular to follow-up preliminary research
(Wynne, 2009). The thirteen hypotheses of this study are evaluated with combinations of
group contrast and correlational analyses. A hierarchical strategy for data analysis was
used, starting with omnibus multivariate analyses of variance (MANOVA) performed
within the domains of measurement selected for analysis (clinical, cognitive, behavioral,
etc), then continuing to ANOVA’s on specific measures and scales, followed by planned
comparison cell contrasts, and finally correlational analysis. Analysis of variance
(ANOVA) and its variants were the primary statistic used in order to replicate earlier
results (Wynne, 2009). One-way ANOVAs with time 1 or time 2 covariates were used
whenever possible. Whether or not individuals used services in adolescence, and further
analyses utilizing Adolescent psychiatric pathology groupings were the between-subjects
factor and each set of measures were the within-subjects factors. One tailed t-tests were
used in analyses because of specific directional hypotheses. In addition, evaluating the
relationships between categorical variables was accomplished through Chi square
analysis. Also, results were compared across the different assessment measures used at
different time periods at CTP, possibly providing results for future results on different
factors or clusters of neurocognitive, socialcognitive, symptom, and insight measures that
can be grouped together to better capture the multidimensional, and perhaps
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developmental nature of insight in individuals who had varying levels of APP and are
now participating in psychiatric rehabilitation as adults.
Because this is an exploratory study of a very complex database and there was an
unusual amount of missing data, appropriate use of MANOVA was prevented.
Significant omnibus MANOVA results were not strictly interpreted as necessary for
further group comparisons. Since the specific analyses relate to the respective study
hypotheses in complex ways, the results will be organized according to the hypotheses,
with the relevant analyses identified and described for the respective hypotheses in turn.
Unequal n correction. Due to the significant differences in the number of
participants in each condition, a correction of unequal n’s was performed. The most
accepted procedure that best fits the collected data was used during analysis.
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CHAPTER 3 – RESULTS
The overall purpose of this study is to determine if there is a pattern of differential
functioning for adults with SMI with or without a history of using mental health services
in adolescence, and further delineated into APP severity groupings, across various levels
of functioning. Before proceeding to evaluate the hypotheses, descriptive analyses of the
demographic and clinical characteristics of people with different amounts of service use
during adolescence are described.
Demographic and Clinical Characteristics of People at CTP
Of the 320 participants in this study, 171 (53.4%) used or had contact with mental
health services during adolescence, see Tables 1-3. Of the people who did not use
services during adolescence, 63.1% (n = 94) are male and 35.6% (n = 53) are female. Of
the people who did use services 64.1% (n = 109) are male and 35.9% (n = 61) are female;
the difference in gender proportions between service users and non-users is not
statistically significant, X2(1) = 0.001, p = .98.
Analyses using the No Service Use in adolescence vs. Service Use in adolescence
distinction reveals a pattern of relationships among several demographic variables.
There is a significant relationship between diagnostic subtype and mental health service
use, X2 (8) = 19.14, p = .01 (see Table 4). Those diagnosed with Schizophrenia,
Chronic/Undifferentiated Type, Schizoaffective Disorder, and “other” are more likely to
have used mental health services during adolescence than those diagnosed with
Schizophrenia, Paranoid Type. Also, there is a significant relationship between Axis II
diagnostic subtype and service use, X2 (9) = 18.14, p = .03 (see Table 5). Those
diagnosed with Paranoid Personality Disorder are less likely to have received services
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during adolescence than those diagnosed with Borderline Personality Disorder. Those
diagnosed with Borderline Personality Disorder are more likely to have received services
during adolescence than those without an Axis II diagnosis, which are more likely to
have not used services during adolescence.
There is not a significant relationship between race and service use, X2 (5) = 2.37,
p = .797 (see Table 6). When those participants identified as African American,
Hispanic, Asian American, or Other are combined into one category and compared to
those identified as Caucasian, or “White,” there is not a significant relationship with
service use, X2 (1) = .007, p = 0.93. This suggests that people who are“Non-White” are
just as likely as those who are “White” to receive or have access to mental health services
during adolescence. There is not a significant relationship between marital status and
service use, X2 (4) = 6.29, p = .18 (see Table 7).
Finally, analyses between service use and age, length of stay at CTP, age at first
hospitalization, number of previous hospitalizations in lifetime, and years of education
reveal significant relationships. The means and standard deviations for each group for
these variables are shown in Table 8. Analyses using one-way ANOVAs reveal a
significant difference between groups in age F (1, 306) = 42.20, p < .001; number of
years of education, F (1, 281) = 24.31, p < .001; the number of previous hospitalizations,
F (1, 296) = 4.46, p = .04; and in the age of onset, F (1, 246) = 71.82, p < .001. There is
no significant difference between groups on length of stay, F (1, 135) = 2.33, p = .13.
To summarize the results of the descriptive analyses, those with service use
during adolescence tend to be younger at admission to CTP, have slightly lower levels of
education, and have an earlier age of onset and more previous hospitalizations, as

47
expected. A relationship between Axis I and Axis II diagnoses and service use was
identified. Those diagnosed with Schizophrenia, Chronic/Undifferentiated Type,
Schizoaffective Disorder, and “other” are more likely to have used mental health services
during adolescence than those diagnosed with Schizophrenia, Paranoid Type. Those
diagnosed with Paranoid Personality Disorder are less likely to have received services
during adolescence than those diagnosed with Borderline Personality Disorder; whereas
those diagnosed with Borderline Personality Disorder are more likely to have received
services during adolescence with “other” or no diagnosis. These results are consistent
with expectations previously outlined and support the reliability of the distinctions made
between who did or did not use mental health services prior to the age of 18 used in this
study

Hypothesis 1
The first hypothesis of this study is to determine if there is a pattern of differential
functioning between adults with SMI with or without mental health service use during
adolescence across various levels of functioning both at admission and across treatment.
In general, it is anticipated that individuals with adolescent psychiatric pathology will
demonstrate lower overall functioning than those without adolescent psychiatric
pathology. Because of this, hypothesis 1 predicts that those individuals who used mental
health services in adolescence will show demonstrably lower overall functioning in the
clinical setting than individuals who did not use mental health services during
adolescence. Thus, it is hypothesized that the service usage will correlate with clinical
functioning. Specifically, the groups (No Service Use vs. Service Use) will differ across
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all domains of functioning measured (neurocognitive, social cognitive, symptomatology,
and behavioral functioning) at admission and over the course of treatment.

Functioning at Admission
Neurocognitive Functioning
The RBANS, RCFT, RAVLT, COGLAB Card Sort, Trails A & B, COWAT/FAS,
and NAB were included in analyses as measures of neurocognitive functioning.
Bivariate correlations between whether or not individuals used mental health services
prior to age 18 and the neurocognitive variables included in analyses are shown in Table
9.
Between groups ANOVAs were conducted to maximize the power available to
detect any differences between individuals who used mental health services in
adolescence vs. those who did not use services on the neurocognitive variables (Tables 10
and 11). Contrary to all hypotheses, on all measures of neurocognition individuals with
SMI who used services prior to the age of 18 do not demonstrate poorer neurocognitive
functioning than those who did not use services, all Fs < 3.33, all ps > .07. Of the 14
tests, one significant test is expected. Two reached trend level, p = .07-.08. However,
when planned comparisons were made as expected better performance on RCFT
Recognition was attained by individuals who did not use services prior to the age of 18
(M = 20.54) than by individuals who had used services prior to age 18 (M = 18.17), t (71)
= 1.82, p = .04. Furthermore, as hypothesized better performance on Trails B was
achieved by individuals without service use prior to age 18 (M = 105.14) than by
individuals who had used services prior to age 18 (M = 125.24), t (114) = -1.63, p = .05.
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Also as hypothesized, scores on RBANS Total were greater for individuals without
service usage in adolescence (M = 75.50) than by individuals who had used services prior
to age 18 (M = 69.74), t (92) = 1.77, p = .04. These significant planned comparisons
indicate analyses utilizing ANOVAs did not have enough power in some instances to
detect significant differences.
Furthermore, when individuals who used services prior to age 18 are grouped
based on adolescent psychiatric pathology, APP severity groups do not differ in
statistically significant ways on neurocognitive measures at admission, all Fs < 2.18, all
ps >.10 (Table 11). Of the 14 tests, one significant test is expected. However, no tests
reached trend level. Overall, contrary to hypotheses, these results suggest that participants
with low, medium, and high APP severities do not significantly differ from those without
APP at the time of admission, with respect to neurocognitive functioning.

Social cognitive functioning
The I-SEE (FKK), a measure of attributional style, the Hinting Task, a measure of
theory of mind, the IPSAQ, a measure of interpersonal attributional style, and the CST, a
measure of coping-related cognition, were used to examine social cognitive differences
between individuals with SMI who used services in adolescence and those who did not
use services prior to the age of 18. It is hypothesized that people who used services prior
to the age of 18 would demonstrate lower overall sociocognitive functioning than those
who did not use services. Furthermore, when analyses utilize APP severity groupings it
is hypothesized that individuals in the high APP severity group will have the lowest
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scores on social cognition measures at admission. Bivariate correlations can be found in
Table 12.
Despite not having any significant MANOVA results, univariate ANOVAs were
conducted to maximize the power available to detect any differences in the
neurocognitive variables because an extremely low number of valid cases in the
MANOVA analyses may have prevented any significant differences from being detected.
Exploratory analyses using one-way between groups ANOVAs reveal no significant
differences between those who did and did not use services prior to the age of 18 on
measures of social cognition at admission, all Fs < 2.58, all ps > .12 (Table 13). Of the 17
tests, one significant test is expected. However, no tests reached trend level. When
planned comparisons were completed, no significant differences exist between the
groups.
Furthermore, when APP severity grouping were considered in analyses groups do
not differ in statistically significant ways on socialcognition measures at admission, all Fs
< 2.49, all ps >.07 (Table 14). Of the 14 tests, one significant test is expected. Two
reached trend level, p = .07-.08. Overall, contrary to hypotheses, these results suggest that
participants who used mental health services in adolescence do not significantly differ
from those without service use in adolescence at the time of admission, with respect to
social cognitive functioning. In addition, there do not appear to be substantial differences
in social cognitive functioning at admission for the various APP severity levels.

Insight
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The Birchwood Insight Scale (IS), a measure of insight representing David’s
(1990) three domains of insight, and the Self-Appraisal of Illness Questionnaire, a
measure designed to assess attitudes towards mental illness among people receiving
psychiatric treatment, were used to examine insight differences between individuals with
SMI who used services in adolescence and those who did not use services prior to the age
of 18. It is hypothesized that because of prior contact with services, those individuals
with contact with mental health services in adolescence have higher levels of insight into
their disorder at admission than those who did not use mental health services in
adolescence. Furthermore, when analyses utilize APP severity groupings, it is
hypothesized that individuals in the high APP severity group would have greater insight
scores at admission than individuals with no, low, or medium APP. The bivariate
correlation matrix for the insight measures and their subscales can be found in Table 15.
Exploratory analyses using one-way ANOVAs reveal no significant differences
between those who did and did not use services prior to the age of 18 on measures of
insight at admission, all Fs < 2.56, all ps > .13 (Table 16). Of the seven tests, one
significant test is expected yet none reached trend level. When planned comparisons were
completed, as expected scores on SAIQ Presence/Outcome of Illness subscale scores
were greater for individuals with service usage in adolescence (M = 14.29) than for
individuals who did not use services prior to age 18 (M = 12.20), t (15) = -1.60, p = .05.
Furthermore, analyses utilizing APP severity groupings indicate APP severity
groups do not differ in statistically significant ways on insight measures at admission, all
Fs < 1.59, all ps >.20 (Table 17). Overall, contrary to hypotheses, these results suggest
that participants who used mental health services prior to the age of 18 do not

52
significantly differ from those who did not use services in adolescence at the time of
admission, with respect to insight. In addition, there are not significant differences in
insight at admission for the various APP severity levels. Note in Table 17 one significant
F test is expected and only one reached trend level at p = .06 - .08.

Behavioral functioning
The NOSIE total assets score was used as a measure of general behavioral
functioning. Bivariate correlation of NOSIE subscales can be found in Table 18. It is
expected that those who used mental health services prior to the age of 18 would
demonstrate poorer behavioral functioning at admission than those who did not use
services in adolescence. Contrary to the hypothesis, a one-way ANOVA does not reveal
a significant difference, F (1, 119) = 2.46, p = .12, on total assets between individuals
without mental health service usage in adolescence (M = 157.68, SD = 24.13) and those
who used mental health services in adolescence (M = 150.50, SD = 26.26) (Table 18). Of
the seven tests, one significant test is expected yet none reached trend level. When
planned comparisons were completed, no significant differences between those with
mental health service usage in adolescence and those without mental health service usage
in adolescence.
In addition, it is hypothesized that individuals in the high APP severity group
demonstrate poorer functioning on behavioral functioning measures. When NOSIE total
assets are examined across APP severity groups using a one-way ANOVA, contrary to
hypotheses individuals with more severe adolescent psychiatric pathology do not
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demonstrate poorer behavioral functioning at admission than those individuals with none,
low, and medium APP, F (3, 117) = 1.60, p = .19 (Table 19).
Because the NOSIE is comprised of three adaptive functioning scales and three
maladaptive functioning scales, further exploratory analyses were conducted to determine
if differences were apparent across all areas of functioning assessed by the NOSIE or
whether the differences were specific to particular subscales. Pearson correlations reveal
significant intercorrelations among all subscales and the total assets score. The bivariate
correlation matrix can be found in Table 17.
Follow-up analyses did not reveal significant differences between those with
mental health service use prior to age 18 and those without mental health service use
prior to age 18 on the NOSIE subscales at admission, all Fs < 2.46, all ps >.12 (see Table
18). When NOSIE subscales were examined across APP severity groups using a oneway ANOVA, contrary to hypotheses individuals with more severe adolescent
psychiatric pathology do not demonstrate poorer behavioral functioning on five of six
subscales at admission than those individuals with none, low, and medium APP, all Fs <
2.15, all ps > .09. Differences between APP severity groups are found for the NOSIE
Motor Retardation subscale, F (3, 117) = 2.70, p = .05 (see Table 19 for means and
standard deviations). However, contrary to hypotheses, individuals in the high APP
group have lower NOSIE Motor Retardation scores, thus indicating better functioning,
than those in the medium and low APP groups and had NOSIE Motor Retardation scores
equivalent to those without APP (LSD minimum mean difference = 2.1).
Overall, results of NOSIE analyses do not support hypotheses that those with
mental health service use in adolescence demonstrate poorer behavioral functioning upon
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admission than those without mental health service use in adolescence. Furthermore,
hypotheses are not supported that differences in behavioral functioning at admission exist
between the different APP severity groupings. Although significant difference was found
on the NOSIE Motor Retardation subscale, results were opposite to hypothesized and the
high APP severity group received lower scores than individuals in the low and medium
APP severity groups.

Symptomatology
It was hypothesized that individuals who used mental health services in
adolescence would have a higher level of symptomatology at admission than those who
did not use services prior to the age of 18 . Contrary to hypothesis, a one-way ANOVA
reveals no significant mean difference, F (1, 154) = 0.10, p = .75, in overall
symptomatology at admission as measured by the BPRS total score between those who
used mental health services prior to age 18 (M = 48.29, SD = 14.62) and those who did
not use services prior to age 18 (M = 47.60, SD = 12.15). Also it was hypothesized that
when APP severity groupings are considered those individuals with the most severe APP
demonstrate a higher level of symptomatology than those with less severe APP. Contrary
to hypothesis, there is no significant mean difference, F (1, 154) = 0.10, p = .75, in
overall symptomatology between those without APP and the various levels of APP
severity (Tables 22 and 23).
Six factor scores for the BPRS were computed in order to evaluate symptom
groupings as opposed to the gross overall measure of symptomatology provided by the
total score. The six factors used were Psychotic Disorganization,
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Hallucinations/Delusions, Paranoia, Emotional Blunting, Agitation/Elation and
Anxiety/Depression. One-way ANOVAs for each of the BPRS factor scores were
conducted to determine whether differences existed between groups in symptom areas.
There are no significant differences between individuals who used mental health services
prior to the age of 18 and those who did not use services prior to age 18 for any of the
symptom factor scores, all Fs < 2.65, all ps >.11, see Table 22. Of the six tests, one
significant test is expected yet none reached trend level. When planned comparisons were
completed, contrary to hypothesis scores on BPRS Paranoia Factor scores were greater
for individuals without service usage in adolescence (M = 9.00) than for individuals who
did use services in adolescence (M=8.14), t (155) = 1.63, p = .05. Furthermore, when
analyses consider differences between APP severity groupings, there are no significant
mean differences for any symptom factor scores, all Fs < 1.48, all ps >.22, see Table 23.
Of the six tests, one significant test is expected yet none reached trend level.
Finally, one-way ANOVAs for each of the 24 BPRS items were conducted to
determine if there were differences in any specific symptoms between individuals who
used mental health services prior to age 18 and those individuals who did not use
services. Two significant differences emerged. People who used mental health services
in adolescence (M = 1.79, SD = 1.37) have a higher rating of Suicidality, F (1, 156) =
10.36, p = .002, than those who did not use mental health services in adolescence (M =
1.23, SD = .62). Although a significant difference occurs between the groups on
Uncooperativeness, F (1, 155) = 3.91, p = .05, contrary to hypothesis those who did not
use services in adolescence (M = 1.83, SD = 1.23) have a higher rating of
Uncooperativeness than those individuals who used services in adolescence (M = 1.49,
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SD = .91). Results of all the one-way ANOVAs can be found in Table 24. Of the 24
analyses, one is expected to be significant. Two analyses were significant and three
analyses reached trend level, p = .06. When planned comparisons were completed, as
hypothesized scores on BPRS Suicidality item scores were greater for individuals with
service usage in adolescence (M = 1.79) than for individuals who did not use services in
adolescence (M = 1.23), t (156) = -3.22, p < .001. Also, as hypothesized BPRS Guilt
item scores were greater for individuals with service usage in adolescence (M = 2.19)
than for individuals who did not use services in adolescence (M = 1.84), t (156) = -1.69, p
= .05. As hypothesized, BPRS Hallucination item scores were greater for individuals
with service usage in adolescence (M = 2.41) than for individuals who did not use
services in adolescence (M = 1.87), t (156) = -1.91, p = .03. Also, as hypothesized BPRS
Self-Neglect item scores were greater for individuals with service usage in adolescence
(M = 2.39) than for individuals who did not use services in adolescence (M = 2.05), t
(156) = -1.89, p = .03. Contrary to hypotheses, BPRS Grandiosity item scores were
lower for individuals with service usage in adolescence (M = 1.63) than for individuals
who did not use services in adolescence (M = 2.13), t (156) = 1.88, p = .03. Also
contrary to hypotheses, BPRS Suspiciousness item scores were lower for individuals with
service usage in adolescence (M = 2.33) than for individuals who did not use services in
adolescence (M = 2.77), t (156) = 1.62, p = .05. Finally, contrary to hypotheses BPRS
Uncooperativeness item scores were lower for individuals with service usage in
adolescence (M = 1.49) than for individuals who did not use services in adolescence (M =
1.83), t (155) = 1.95, p = .03. Results of these planned comparisons indicated analyses
using ANOVAs did not have enough power to detect significant differences.
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One-way ANOVAs for each of the 24 BPRS items were conducted to determine
if there are differences in any specific symptoms between those with no APP, low APP,
medium APP, and high APP and two significant differences emerged. Partial support for
hypotheses is found as people with medium or high APP have a higher rating on
Suicidality, F (3, 154) = 5.34, p = .002, than those without APP or low APP. A
significant difference is found between the groups on Disorientation, F (3, 153) = 3.73, p
= .01. Contrary to hypothesis, those with no, medium, or high APP receive lower ratings
of Disorientation than those with low APP. Results of all the one-way ANOVAs can be
found in Table 24. Of the 24 analyses, one is expected to be significant. Two analyses
were significant and no analyses reached trend level.
Further analyses of symptomatology measures at admission included the SPS,
BDI-II, and the BHS. Again, it was anticipated that individuals who used services in
adolescence would have a higher level of symptomatology at admission than individuals
who did not use services in adolescence. One-way ANOVAs for the BDI-II, BHS, SPS
Suicidality scale, SPS Negative Self-Evaluation scale, and the SPS Hostility scale at
admission reveal no significant mean differences, all Fs < 3.30, all ps > .07 (Table 22).
Two significant differences emerge for the SPS Total score and the SPS Hopelessness
scale score. As hypothesized, people who used mental health services in adolescence (M
= 61.02, SD = 10.22) receive higher symptomatology scores as measured by the SPS
Total score, F (1, 122) = 7.41, p = .01, than those who did not use mental health services
in adolescence (M = 56.02, SD = 10.19), and further directional planned compairisons
also found this result, t (122) = -2.72, p < .01. Also, as hypothesized, people who used
mental health services in adolescence (M = 57.48, SD = 13.09) received higher
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symptomatology scores as measured by the SPS Hopelessness score, F (1, 122) = 3.76, p
= .05, than those who did not use mental health services in adolescence (M = 53.33, SD =
10.42), planned comparisons for this variable were also significant, t (122) = -1.94, p =
.03. Further planned comparisons found as hypothesized SPS Hostility scores were
higher for individuals with service usage in adolescence (M = 56.88) than for individuals
who did not use services in adolescence (M=52.81), t (121) = -1.82, p = .04.
One-way ANOVAs were also conducted to determine if there were differences in
any specific symptoms between those with no APP, low APP, medium APP, and high
APP and two significant differences emerged. Partial support for hypotheses is found as
people with medium or high APP (which were equivalent to each other) are rated with a
higher level of symptomatology as measured by the SPS Total score, F (3,120) = 3.34, p
= .02, than those without APP or low APP. Results of all the one-way ANOVAs and
means and standard deviations can be found in Table 23.
Overall, results of analyses using the BPRS total, BPRS factor scores, and BPRS
items suggest that only a significant relationship exists on two BPRS items for service
use and level of symptomatology. The amount of significant differences between those
who used services in adolescence and those who did not use services in adolescence is
close to what is expected to occur by chance, thus lowering confidence that these
differences occur due to specific differences between the groups on measures of
symptomatology. Although those who used services prior to adolescence receive higher
suicidality scores than those who did not use services, those who did not use services in
adolescence are deemed more uncooperative than individuals who did use mental health
services in adolescence. Planned comparisons found that individuals with service usage
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in adolescence are rated higher on suicidality, guilt, hallucinations, and self-neglect.
However, contrary to hypotheses results from planned comparisons indicate individuals
with mental health service usage are rated lower on grandiosity, suspiciousness, and
uncooperativeness. When analyses are conducted between APP severity level and BPRS
total, BPRS factor scores, and BPRS items only two significant differences emerge.
Again as hypothesized, those individuals with medium or high APP receive higher
suicidality scores than those without APP or in the low APP severity group.
Results of analyses of symptomatology at admission using the BDI-II, BHS, and
SPS Total and SPS scales suggest several differences exist. As hypothesized, individuals
who had mental health services in adolescence demonstrate more symptomatology at
admission than those who did not have services in adolescence as measured by the SPS
Total and SPS Hopelessness scale scores. Planned comparisons also found that
individuals with mental health service usage in adolescence have more hostility as
measured by the SPS Hostility scale. When analyses are conducted between
symptomatology measures and APP severity levels, partial support for hypotheses is
found, as individuals with medium or high APP receive higher SPS Total scores than
those with no or low APP.

Functioning Over the Course of Treatment
When analyzing difference over the course of treatment, it is predicted that
overall differences in functioning and symptomatology, and will not remain over the
course of treatment. It is hypothesized that as a result of psychiatric rehabilitation there
will be an increase in neurocognitive functioning, insight into disorder, internal locus of
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control, and behavioral functioning and a decrease in external locus of control and
symptomatology for those who did and did not use services in adolescence. That is, it is
hypothesized that both groups will show improvement in functioning over the course of
psychiatric rehabilitation. However, it is predicted that those individuals who used
services prior to age 18 will demonstrate higher symptomatology after 12 months of
rehabilitation. Furthermore, when different levels of adolescent psychiatric pathology are
used in analyses, it is predicted that as adolescent psychiatric pathology becomes more
severe functioning will decrease and there will be higher symptomatology. Overall,
while it is hypothesized there will be differences in a variety of domains it is also
hypothesized that differences in insight upon admission will not remain one-year after
beginning psychiatric rehabilitation.

Neurocognitive Functioning Across Treatment.
As described above, it was anticipated that while there will be difference in
neurocognitive functioning between those who used mental health services in
adolescence and those who did not use services in adolescence, neurocognitive
functioning will improve over the course of treatment for both groups, and there will be
no differences between groups on neurocognitive measures after one year of treatment.
A 2 (service use) x 3 (assessment time) repeated measure ANOVA was completed for
each measure.
There is not an interaction of assessment time and service use as they relate to
WCST Correct score (F(2, 72) = .64, p = .53). Contrary to hypotheses, there is no main
effect for WCST correct over time (F(2, 72) = .66, p = .52) or for service use (F(1, 36) =
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1.35, p = .25). However, when planned comparisons were analyzed contrary to
hypothesis WCST correct scores were higher for individuals with service usage in
adolescence (M = 24.66) than for individuals who did not use services in adolescence (M
= 21.74), t (58) = -2.01, p = .02. There is not an interaction between assessment time and
service use as they relate to WCST Perseverative Errors (F(2, 112) = 1.36, p = .26).
Contrary to hypotheses, there is no main effect of time for WCST Perseverative Errors
(F(2, 112) = 2.53, p = .08). However, there is a main effect for service use (F(1, 56) =
5.13, p = .03), with more overall WCST Perseverative errors made by those who did not
use services prior to age 18 (M = 26.72, SD = 16.00) than from those individuals who did
use services prior to the age of 18 (M = 20.52, SD = 11.58) (LSD minimum mean
difference = 3.90). However, this pattern of the main effect is only descriptive for
performance after six months and one year of participating in a psychiatric rehabilitation
program
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Figure 3.1 Service Main Effect for Service Usage Groups on WCST Perseverative Error Score Across
Treatment
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There is no interaction between assessment time and service use as they relate to
WCST Random Errors over time (F(2, 112) = 0.17, p = .84). As hypothesized, there is a
main effect for WCST Random Errors over time (F(2, 112) = 3.66, p = .03), with more
random errors made at admission than after six to twelve months of rehabilitation,
representing an increase in neurocognitive functioning (LSD minimum mean difference =
2.98). This pattern is descriptive for both those that did and did not use mental health
services in adolescence. As hypothesized, a main effect for service use is not found (F(1,
56) = 0.71, p = .41) and differences do not exist between those who did and did not use
mental health services in adolescence after one year of treatment.
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Figure 3.2 Time Main Effect for Service Usage Groups on WCST Random Error Score Across Treatment

There is not an interaction between assessment time and service use as they relate
to WCST Consolidation Index scores (F(2, 72) = .10, p = .91). Contrary to hypothesis
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there is no main effect for WCST Consolidation Index scores over time (F(2, 72) = 1.92,
p = .15) or for service use (F(1, 36) = .71, p = .40). Results of repeated measure
ANOVAs and means and standard deviations can be found in Tables 26, 29 - 32.
There is an interaction of assessment time and service use as they relate to
RAVLT scores (F(2, 18) = 5.25, p = .02, Mse = 2.34). The pattern of this interaction is
that RAVLT performance increased over time as hypothesized for those that did not use
mental health services in adolescence, whereas contrary to hypothesis individuals who
did use services in adolescence demonstrate no significant difference on RAVLT scores
from admission to 6 and scores decrease at one year of treatment (LSD minimum mean
difference = 1.37). However, individuals who used mental health services in adolescence
receive higher RAVLT scores at admission and six months than those who did not
services in adolescence and as hypothesized this difference between groups does not exist
after one year of treatment (Table 27, 33). Planned comparisons found no difference
between groups at time one, however contrary to hypothesis RAVLT scores were higher
for individuals with service usage in adolescence (M = 9.50) than for individuals who did
not use services in adolescence (M=6.43), t (30) = -2.61, p = .01. Again, as hypothesized
planned comparisons found no differences in RAVLT scores between groups after one
year of treatment There is no main effect for RAVLT over time (F(2, 18) = .24, p = .79)
or for service use (F(1, 9) = 2.19, p = .17).
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RAVLT Scores Across Treatment
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Figure 3.3 Interaction Between Service Usage Groups on RAVLT Scores Across Treatment

Contrary to hypotheses, there is not an interaction of assessment time and service
use as they relate to NAB total score (F(2, 26) = .47, p = .63, Mse = 52.61). Contrary to
hypotheses, there was no main effect for NAB total scores over time (F(2, 26) = 1.74, p =
.20) or for service use (F(1, 13) = .28, p = .61) (Tables 27 and 34).
There is no interaction of assessment time and service use as they relate to RCFT
Copy score (F(2, 60) = .19, p = .82, Mse = 18.89) or RCFT Recognition score (F(2, 60) =
.63, p = .54, Mse = 11.58). There is no main effect for RCFT Copy scores over time
(F(2, 60) = 1.75, p = .18) or for RCFT Recognition scores over time (F(2, 60) = .55, p =
.58). Also there is no main effects for service use for RCFT Copy scores (F(1, 30) = .32,
p = .58) or RCFT Recognition scores (F(1, 30) = .04, p = .85).
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There is no interaction between assessment time and service use as they relate to
RCFT Immediate Memory scores over time (F(2, 60) = 1.37, p = .26, Mse = 186.63). As
hypothesized, there is a main effect for RCFT Immediate Memory scores over time (F(2,
60) = 4.62, p = .01), with no significant difference on scores from admission to six
months however improvement in scores occurred at one year (LSD minimum mean
difference = 6.83). However, this pattern is only descriptive for those who used mental
health services in adolescence. A main effect for service use is not found (F(1, 30) =
3.60, p = .07).
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Figure 3.4 Time Main Effect for Service Usage Groups on RCFT Immediate Memory Scores
Across Treatment

There is no interaction between assessment time and service use as they relate to
RCFT Delayed Memory scores over time (F(2, 60) = .13, p = .88, Mse = 30.90). As
hypothesized, there is a main effect for RCFT Delayed Memory scores over time (F(2,
60) = 4.89, p = .01), with no significant difference on scores from admission to six
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months and improvement in scores at one year (LSD minimum mean difference = 2.78).
This pattern is descriptive for those who did and did not use services in adolescence. A
main effect for service use is not found (F(1, 30) = 1.69, p = .20). Results of repeated
measure ANOVAs and means and standard deviations can be found in Tables 28, and 39
- 42.

RCFT Delayed Memory Scores Across Treatment

RCFT Delayed Memory
Score

25
20
15

No Service Use

10

Service Use

5
0
Time 1

Time 2

Time 3

Assessment Time
Figure 3.5 Time Main Effect for Service Usage Groups on RCFT Delayed Memory Scores Across
Treatment

There is an interaction of assessment time and service use as they relate to Trails
A performance (F(2, 110) = 3.38, p = .04, Mse = 165.13). As hypothesized, the pattern
of this interaction is that Trails A performance was slower, and thus worse, at admission
than at 6 months and one year (which were equivalent to each another) (LSD minimum
mean difference = 2.78) for those who used mental health services in adolescence.
However, partial support is found for hypotheses for those who did not use mental health
services prior to age 18, as their performance worsens from admission to six months,
however improves from six to twelve months. At admission, those who did not use
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mental health services prior to age 18 demonstrate poorer performance on Trails A than
those who did not use mental health services in adolescence.. At six months, those who
did not use services prior to age 18 demonstrate poorer performance than those who did
use services prior to age 18, however, as hypothesized after one year of treatment
differences in Trails A performance do not exist between the two groups. There is no
overall main effect for Trails A over time (F(2, 110) = .51, p = .60) or for service use
(F(1, 55) = .004, p = .95).
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Figure 3.6 Interaction Between Service Usage Groups on Trails A Performance Across Treatment

There is no interaction between assessment time and service use as they relate to
Trails B performance (F(2, 110) = .53, p = .59. Contrary to predictions, there is no
overall main effect for Trails B over time and both groups do not demonstrate better
performance over the course of treatment (F(2, 110) = .12, p = .89). There is also no
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main effect for service use (F(1, 55) = .20, p = .66). Results of repeated measure
ANOVAs and means and standard deviations can be found in Tables 27, and 35-36.
There is an interaction between assessment time and service use as they relate to
COWAT/FAS score over time (F(2, 114) = 3.02, p = .05, Mse = 44.09). Contrary to
hypothesis, the pattern of this interaction is that although COWAT/FAS performance
improves from six months to one year for those who did not use mental health services in
adolescence, performance at one year is lower than at admission (LSD minimum mean
difference = 1.41). However, for those who did use mental health services in adolescence
performance is equivalent from admission to six months, however improves from six to
twelve months. While those who did not use services prior to age 18 perform better on
the COWAT/FAS at admission, this difference does not exist at six months. Contrary to
hypotheses, after one year of treatment those who did use services prior to age 18
demonstrate better performance than those who did not use services prior to age 18. Also,
contrary to hypotheses there is no overall main effect for COWAT/FAS over time (F(2,
114) = 1.91, p = .15) or for service use (F(1, 57) = .06, p = .82). Results of repeated
measure ANOVAs and means and standard deviations can be found in Tables 27 and 37.
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Figure 3.7 Interaction Between Service Usage Groups on COWAT Scores Across Treatment

There is an interaction of assessment time and service use as they relate to
RBANS Total score (F(2, 108) = 3.65, p = .03, Mse = 51.18). Partial support for
hypotheses is found, as the pattern of this interaction is that RBANS Total score
improves from admission to six months but does not improve from 6 months to one year
for those who used mental health services prior to age 18, although scores at one year are
better than at admission (LSD minimum mean difference = 3.82). For those who did not
use services prior to age 18, performance does not improve from admission to six
months, however improves from six to twelve months. As hypothesized, there is a main
effect for overall RBANS Total score over time (F(2, 108) = 9.82, p < .001), with
performance remaining the same from admission to six months but improving from six to
twelve months of rehabilitation (LSD minimum mean difference = 2.70). This pattern is
only descriptive for those who did not use services in adolescence. There is no overall
main effect for service use (F(1, 54) = 1.67, p = .20). Results of repeated measure
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ANOVAs and means and standard deviations can be found in Tables 27 and 38. When
planned comparisons were completed, as hypothesized and previously stated individuals
without mental health service usage had higher RBANS scores at admission than those
who used mental health services in adolescence. However, contrary to hypotheses,
differences existed between groups after one year of treatment. Individuals without
mental health service usage in adolescence had higher RBANS scores (M = 81.60) than
for individuals who did not use services in adolescence (M=75.71), t (73) = 1.64, p = .05.
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Figure 3.8 Time Main Effect and Interaction Between Service Usage Groups on RBANS Total Scores
Across Treatment

When 4 (APP Severity Level) x 3 (assessment time) repeated measures ANOVAs
are conducted using APP severity levels, no interactions, assessment time main effects, or
APP severity level main effects are found for the following neurocognition measures:
WCST Correct, WCST Perseverative Errors, WCST Random Errors, WCST
Consolidation Index, NAB Screener Total score, RCFT Copy, RCFT Recognition, Trails
A and B, and COWAT/FAS (all Fs < 2.66, all ps > .06). Contrary to hypotheses,
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increases in neurocognitive functioning over treatment as measured by the previously
mentioned measures are not found when analyses included APP severity levels. Also,
contrary to hypotheses those with more severe levels of APP do not demonstrate poorer
neurocognitive functioning on these measures at any assessment time. However, as
hypothesized differences do not remain amongst the groups after one year of treatment.
Results of repeated measure ANOVAs utilizing APP severity levels and means and
standard deviations can be found in Tables 44 - 59.
There is an interaction between assessment time and APP severity level as they
relate to RAVLT scores (F(4, 16) = 3.88, p = .02, Mse = 2.11). No individuals in the low
APP severity group completed RAVLT assessments and therefore are not included in
analyses. RAVLT performance for individuals with no APP does not change from
admission to six months, however, performance increases from six to twelve months. For
individuals in the medium APP severity group, RAVLT performance does not change
during treatment, whereas for those in the high APP severity group RAVLT performance
increases from admission to six months but decreases from six to twelve months (which
was equivalent to performance at admission) (LSD minimum mean difference = 2.27).
RAVLT performance at admission is equal for the no APP group and medium APP group
and for the medium and high APP groups, however contrary to hypotheses individuals in
the high APP severity group demonstrate better performance than those in the no APP
group on the RAVLT at admission. At six months, contrary to hypotheses those in the
high APP severity group demonstrate the highest performance on the RAVLT, followed
by those in the medium APP severity group. As hypothesized, these differences in
RAVLT performance do not remain after one year of treatment. There is no main effect
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for RAVLT over time (F(2, 16) = .15, p = .86) or for APP severity level (F(2, 8) = 1.06, p
= .39). Results of repeated measure ANOVAs and means and standard deviations can be
found in Tables 45, 50.
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Figure 3.9 Interaction Between APP Severity Levels on RAVLT Scores Across Treatment

There is no interaction between assessment time and APP severity levels as they
relate to RCFT Immediate Memory scores (F(6, 56) = 1.76, p = .12, Mse = 175.91).
There is an overall main effect for RCFT Immediate Memory scores over time (F(2, 56)
= 5.66, p = .01), with no significant difference on scores from admission to six months
and partial support for hypotheses as there are improvements in performance from six to
twelve months. While performance for all APP severity groups remains the same from
admission to six months, improvements in RCFT Immediate Memory scores from six to
twelve months only occur for those in the low and high APP severity levels (LSD
minimum mean difference = 6.70). A main effect for APP severity level is not found
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(F(3, 28) = 1.27, p = .31). Results of repeated measure ANOVAs and means and
standard deviations can be found in Tables 46, 57.
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Figure 3.10 Time Main Effect for APP Severity Levels on RCFT Immediate Memory Scores Across
Treatment

There is no interaction between assessment time and APP severity levels as they
relate to RCFT Delayed Memory scores (F(6, 56) = 2.14, p = .06, Mse = 27.06). There is
an overall main effect for RCFT Delayed Memory scores over time and partial support
for hypotheses (F(2, 56) = 6.23, p < .01), with no significant difference on scores from
admission to six months and improvements in performance from six to twelve months.
This pattern of performance is only descriptive for no APP and high APP severity groups
(LSD minimum mean difference = 2.63). A main effect for APP severity level is not
found (F(3, 28) = .55, p = .65). Results of repeated measure ANOVAs and means and
standard deviations can be found in Tables 46, 58.
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Figure 3.11 Time Main Effect for APP Severity Levels on RCFT Delayed Memory Scores Across
Treatment

There is an interaction between assessment time and APP severity level as they
relate to RBANS total scores (F(6, 104) = 2.40, p = .03, Mse = 49.84). RBANS
performance for individuals with no or low APP does not change from admission to six
months, however performance increases from six to twelve months. For individuals in
the medium APP severity group, RBANS performance does not change during treatment,
whereas for those in the high APP severity group RBANS performance increases from
admission to six and twelve months (which were equivalent to each other) (LSD
minimum mean difference = 5.34). RBANS performance at admission is equal for the
no, low, and medium APP groups; however as hypothesized, individuals in the high APP
severity group have lower RBANS total scores than those in the no APP group at
admission. At six months, RBANS performance is equivalent for all APP severity
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groups. After one year of treatment, contrary to hypotheses, those in the no and low APP
severity groups have higher RBANS total scores than those in the medium and high APP
severity groups and those in the high APP severity group have higher RBANS total
scores than those in the medium APP severity group. There is an overall main effect for
RBANS total score over time (F(2, 104) = 6.37, p < .01) with RBANS performance
remaining the same from admission to six months but improving by one year of
treatment. However, this main effect is only descriptive for individuals in the no and low
APP severity groups. There is not a main effect for APP severity level (F(3, 52) = .80, p
= .50). Results of repeated measure ANOVAs and means and standard deviations can be
found in Tables 45, 55.
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Figure 3.12 Time Main Effect and Interaction Between APP Severity Levels on RBANS Total Scores
Across Treatment

In summary, results of analyses between those who used mental health services
prior to age 18 and those who did not use services and neurocognitive functioning at
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admission and over the course of treatment suggest that improvements in neurocognitive
functioning are evident over the course of treatment on WCST Random Errors, for
individuals who did not use services prior to age 18 on the RAVLT, for individuals who
did use services in adolescence on RCFT Immediate Memory, for both groups on RCFT
Delayed Memory, for individuals that used services in adolescence on Trails A, for those
who used services on adolescence on COWAT/FAS, and for both groups on RBANS
total. Results of analyses between assessment time and APP severity level indicate
improvements in neurocognitive functioning occur over the course of treatment on the
RAVLT for those without APP, for those with low or high APP on RCFT Immediate
Memory, for those with none or high APP on RCFT Delayed Memory, and for those in
the none, low, or high groups on RBANS total performance.
When analyses are conducted between those who used services in adolescence
and those who did not use services in adolescence, as hypothesized no differences exist
between groups after one year of psychiatric rehabilitation on the following measures:
WCST Correct, WCST Perseverative Errors, WCST Random Errors, WCST
Consolidation Index, RCFT Copy, RCFT Recognition, RCT Immediate and Delayed
Memory, NAB total, RAVLT, and Trails A and B performance. Contrary to hypotheses,
individuals who used mental health services in adolescence demonstrate better
performance on the COWAT/FAS after one year of treatment than individuals who did
not user services in adolescence. However, individuals who did not use services in
adolescence demonstrate poorer performance on the RBANS total after one year of
treatment than those who did use mental health services in adolescence.
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Finally, when analyses are conducted utilizing APP severity level, as
hypothesized no differences exist between groups after one year of psychiatric
rehabilitation on the following measures: WCST Correct, WCST Perseverative Errors,
WCST Random Errors, WCST Consolidation Index, RCFT Copy, RCFT Recognition,
RCT Immediate and Delayed Memory, NAB total, RAVLT, and Trails A and B
performance. Contrary to hypotheses, individuals with high APP demonstrate better
performance on the RAVLT at admission and six months, however as hypothesized this
difference does not remain after one year of treatment. As hypothesized, those
individuals with high APP demonstrate poorer performance on the RBANS total at
admission. However, contrary to hypotheses difference remain between the groups at
twelve months and those without APP or low APP perform better on the RBANS than
those in the medium or high APP severity groups.

Social Cognitive Functioning Across Treatment
It is anticipated that individuals with and without mental health service usage in
adolescence demonstrate an increase in functioning, a decrease in external locus of
control, and a increase in internal locus of control. Furthermore, when different levels of
adolescent psychiatric pathology are considered, it is hypothesized as APP becomes more
severe functioning decreases, however any differences will not remain between groups
after one year of treatment. A 2 (service use) x 3 (assessment time) repeated measure
ANOVA was completed for each measure.
There is not interaction between assessment time and service use as they relate to
Hinting scores over time (F(2, 102) = .21, p = .81, Mse = 6.32) (Table 61, 63). As
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hypothesized, there is a main effect for Hinting scores over time (F(2, 102) = 8.32, p <
.001), with improvement on scores from admission to six months and one year (which
were equivalent to each other) (LSD minimum mean difference = .98). This pattern was
descriptive for both those with and without mental health service usage in adolescence.
A main effect for service use is not found (F(1, 51) = .01, p = .93).
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Figure 3.13 Time Main Effect for Service Usage Groups on Hinting Task Scores Across Treatment

There is not an interaction between service use and assessment time as they relate
to FKK Internal Locus of Control (F(2, 50) = .80, p = .46, Mse = 21.14). Contrary to
hypotheses, there is no main effect for FKK Internal Locus of Control scores over time
and internal locus of control does not increase over treatment for either group (F(2, 50) =
.27, p = .77). There is also not a main effect for service use (F(1, 25) = .06, p = .82).
There is not an interaction between service use and assessment time as they relate to FKK
Self Concept scores (F(2, 50) = .71, p = .50, Mse = 12.23). Contrary to hypotheses, there
is no main effect for FKK Self Concept, a subscale of FKK Internal Locus of Control,
scores over time (F(2, 50) = 1.14, p = .33). There is not a main effect for service use
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(F(1, 25) = .33, p = .57). There is not an interaction of assessment time and service use as
they relate to FKK Self Efficacy scores (F(2, 50) = .48, p = .62, Mse = 44.46). Contrary
to hypotheses, there is no main effect for FKK Self Efficacy scores over time (F(2, 50) =
.11, p = .90). There is no main effect for service use (F(1, 25) = .25, p = .62). Results of
repeated measure ANOVAs and means and standard deviations can be found in Tables
60, and 64 - 66.
There is not an interaction between assessment time and service use as they relate
to FKK Powerful Others (F(2, 50) = .90, p = .41, Mse = 18.42). Contrary to hypotheses
that performance on this subscale of FKK External Locus of Control would decrease over
time, there is no main effect for FKK Powerful Others scores over time (F(2, 50) = 1.04,
p = .36). There is also no main effect for service use (F(1, 25) = .33, p = .57).
There is an interaction of assessment time and service use as they relate to FKK
Chance scores (F(2, 50) = 5.29, p = .01, Mse = 19.93). Partially supporting hypotheses,
the pattern of this interaction is that FKK Chance scores remained the same across
treatment for those without mental health service usage in adolescence, whereas as
hypothesized FKK Chance scores were highest (more external locus of control) at
admission than at 6 months to one year (which were equivalent to each other) for those
who used mental health services in adolescence (LSD minimum mean difference = 3.47).
While FKK Chance scores are equivalent to one another at admission for those with and
without mental health service usage in adolescence, contrary to the hypothesis those
without mental health service usage in adolescence have higher FKK Chance scores at
six and twelve months than those who used mental health services in adolescence.
Planned comparisons also found this result at six months, t (46) = 1.87, p = .03, and at
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one year, t (34) = 1.72, p = .05. There is a main effect for overall FKK Chance score over
time (F(2, 50) = 4.66, p = .01), as hypothesized FKK Chance scores are higher at
admission than at six to twelve months of rehabilitation (which were equivalent to each
other) (LSD minimum mean difference = 2.46). This pattern is only descriptive for those
who used mental health services in adolescence. There is no overall main effect for
service use (F(1, 25) = 1.13, p = .30). Results of repeated measure ANOVAs and means
and standard deviations can be found in Tables 60, 67 - 68.
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Figure 3.14 Time Main Effect and Interaction Between Service Usage Groups on FKK Chance Subscale
Scores Across Treatment

There is an interaction of assessment time and service use as they relate to FKK
External Locus of Control score over time (F(2, 50) = 3.87, p = .03, Mse = 51.98).
Contrary to the hypothesis, the pattern of this interaction is that FKK External Locus of
Control scores remain the same across treatment for those who did not use mental health
services in adolescence, whereas as hypothesized FKK Chance scores are highest at
admission than at 6 months to one year (which are equivalent to each other) for those
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who did use mental health services in adolescence (LSD minimum mean difference =
5.61). While FKK External Locus of Control scores are equivalent to one another at
admission for those with and without mental health service usage prior to age 18,
contrary to the hypothesis those without service usage in adolscence had higher FKK
External Locus of Control scores at six and twelve months than those with APP. Planned
comparisons only found this difference at six months, t (46) = 1.90, p = .03. There is a
main effect for overall FKK External Locus of Control score over time (F(2, 50) = 3.77,
p = .03), as hypothesized FKK External Locus of Control scores are higher at admission
than at six to twelve months of rehabilitation (which are equivalent to each other) (LSD
minimum mean difference = 3.97). This pattern is only descriptive for those who used
mental health services in adolescence. There is no overall main effect for service use
(F(1, 25) = .74, p = .40). Results of repeated measure ANOVAs and means and standard
deviations can be found in Tables 60 and 69.

FKK Externality Scale Score Across Treatment
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Figure 3.15 Time Main Effect and Interaction Between Service Usage Groups on FKK Externality Scale
Scores Across Treatment
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There is not an interaction of assessment time and service use as they relate to
IPSAQ Internal Positive score (F(2, 30) = 2.85, p = .07, Mse = 5.67). There is no main
effect for IPSAQ Internal Positive scores over time (F(2, 30) = .39, p = .68) or for service
use (F(1, 15) = 2.15, p = .16). There is no interaction between assessment time and
service use as they relate to IPSAQ Personal Positive scores over time (F(2, 30) = .93, p
= .41, Mse = 2.25). There is a main effect for IPSAQ Personal Positive scores over time
(F(2, 30) = 4.00, p = .03), with no significant difference in scores from admission to six
months and one year (which are equivalent to each other), however scores at 12 months
are significantly less than at admission (LSD minimum mean difference = 1.0). This
result indicates at one year individuals are less likely to attribute positive events to
themselves than at admission. However, this pattern is descriptive for neither group and
is therefore misleading as a general description. A main effect for service use is not
found (F(1, 15) = .51, p = .49).

IPSAQ Personal Positive Scale Scores Across Treatment

IPSAQ Personal Positive
Scale Score

6
5
4
No Service Use

3

Service Use

2
1
0
Time 1

Time 2

Time 3

Assessment Time
Figure 3.16 Time Main Effect for Service Usage Groups on IPSAQ Personal Positive Scale Scores Across
Treatment
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There is not an interaction between assessment time and service use as they relate
to IPSAQ Situational Positive (F(2, 30) = 2.18, p = .13, Mse = 5.05). There is no main
effect for IPSAQ Situational Positive scores over time (F(2, 30) = 2.32, p = .12) or for
service use (F(1, 15) = 4.02, p = .06). However, planned comparisons found contrary to
hypothesis IPSAQ Situational Positive scores are higher for individuals without service
usage in adolescence after one year of treatment (M = 5.07) than for individuals without
service usage in adolescence (M=3.55), t (23) = 1.68, p = .05. Results of repeated
measure ANOVAs and means and standard deviations can be found in Tables 62, and 70
- 72.
There is an interaction between assessment time and service use as they relate to
IPSAQ Internal Negative scores (F(2, 30) = 3.41, p = .05, Mse = 5.97). As hypothesized,
the pattern of this interaction is that IPSAQ Internal Negative scores are highest at
admission and six months (which are equivalent to each another (LSD minimum mean
difference = 2.42) and decreases at twelve months for those without mental health service
usage in adolescence This result indicates that individuals are more likely to attribute
negative events to people or themselves after one year of treatment than at admission or
six months. However, contrary to hypotheses, for those with mental health service usage
in adolescence scores remain the same across treatment. While IPSAQ Internal Negative
scores are equivalent to each other for those with and without mental health service usage
in adolescence at admission and six months, contrary to hypotheses at twelve months
those with mental health service usage in adolescence have higher IPSAQ Internal
Negative scores than those individuals who did not use services in adolescence, t (23) = -
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2.18, p = .02.. There is no overall main effect for IPSAQ Internal Negative scores over
time (F(2, 30) = .39, p = .68) or for service use (F(1, 15) = 1.41, p = .25).
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Figure 3.17 Interaction Between Service Usage Groups on IPSAQ Internal Negative Scale Scores Across
Treatment

There is not an interaction between assessment time and service use as they relate
to IPSAQ Personal Negative scores (F(2, 30) = .47, p = .63, Mse = 5.01). There is no
main effect for IPSAQ Personal Negative scores over time (F(2, 30) = .33, p = .72) or for
service use (F(1, 15) = .63, p = .44). There is not an interaction between assessment time
and service use as they relate to IPSAQ Situational Negative scores (F(2, 30) = 2.14, p =
.14, Mse = 5.18). There is no main effect for IPSAQ Situational Negative scores over
time (F(2, 30) = .45, p = .64) or for service use (F(1, 15) = .69, p = .42). When planned
comparisons were completed, contrary to hypothesis IPSAQ Situational Negative scores
were lower for individuals with service usage in adolescence (M = 3.27) than for
individuals who did not use services in adolescence (M=6.21), t (23) = 3.16, p < .01.
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Results of repeated measure ANOVAs and means and standard deviations can be found
in Tables 62, and 73 - 75.
There is not an interaction of assessment time and service use as they relate to
CST Social Support scores (F(2, 40) = .74, p = .48, Mse = 44.41). There is a main effect
for overall CST Social Support scores over time (F(2, 40) = 4.83, p = .01). As
hypothesized CST Social Support scores are higher after one year of treatment than at
admission or six months (which are equivalent to each other) (LSD minimum mean
difference = 4.06). However, this pattern is only descriptive for individuals who used
services in adolescence and is misleading. There is no main effect for service use (F(1,
20) = .21, p = .65).
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Figure 3.18 Time Main Effect for Service Usage Groups on CST Social Support Scores Across Treatment

There is not an interaction between assessment time and service use as they relate
to CST Self-Controlling scores (F(2, 40) = .24, p = .79, Mse = 31.86). There is no main
effect for CST Self-Controlling scores over time (F(2, 40) = .14, p = .87). There is a
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main effect for service use (F(1, 20) = 7.05, p = .02). Contrary to hypotheses, those
individuals without mental health service usage in adolescence have overall higher CST
Self-Controlling scores than individuals with mental health service usage in adolescence
and this pattern is consistent across assessment times. However, when planned
comparisons were completed individuals without mental health service usage in
adolescence only demonstrate higher CST Self-Controlling scores after one year of
treatment, t (35) = 1.77, p = .04.

CST Self-Controlling Scores Across Treatment
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Figure 3.19 Service Usage Group Main Effect for Service Usage Groups on CST Self-Controlling Scores
Across Treatment

There is not an interaction of assessment time and service use as they relate to
CST Escape Avoidance scores (F(2, 40) = 1.92, p = .16, Mse = 35.23). There is no main
effect for CST Escape Avoidance scores over time (F(2, 40) = 1.74, p = .19) or for
service use (F(1, 20) = .13, p = .72). Also, there is not an interaction between assessment
time and service use as they relate to CST Planful Problem Solving scores (F(2, 40) =
.57, p = .57, Mse = 40.89). There is no main effect for CST Planful Problem Solving
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scores over time (F(2, 40) = .47, p = .63) or for service use (F(1, 20) = 1.16, p = .29).
Results of repeated measure ANOVAs and means and standard deviations can be found
in Tables 61, 76 - 79.
When 4 (APP Severity Level) x 3 (assessment time) repeated measures ANOVAs
are conducted no interactions, assessment time main effects, or APP severity level main
effects are found for the following social cognition measures: FKK Internal Locus of
Control, FKK Self Concept, FKK Self Efficacy, FKK Powerful Others, IPSAQ Internal
Positive, IPSAQ Personal Positive, IPSAQ Personal Negative, IPSAQ Situational
Negative, CST Social Support, CST Escape Avoidance, and CST Planful Problem
Solving (all Fs < 2.71, all ps > .06) (Tables 80 – 99).
There is no interaction between assessment time and APP severity level as they
relate to Hinting Task scores (F(6, 98) = .90, p = .50, Mse = 6.26) (Table 81, 83). There
is a main effect for Hinting scores over time as hypothesized (F(2, 98) = 5.87, p < .01),
with improvement on scores from admission to six months and one year (which are
equivalent to each other) (LSD minimum mean difference = .97). This pattern is
descriptive for those with no APP. A main effect for APP severity level is not found
(F(3, 49) = .80, p = .50).
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Hinting Task Scores Across Treatment
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Figure 3.20 Time Main Effect for APP Severity Levels on Hinting Task Scores Across Treatment

There is an interaction between assessment time and APP severity level as they
relate to FKK Chance score (F(6, 46) = 2.88, p = .02, Mse = 19.09). Although contrary
to hypotheses FKK Chance scores remain the same across treatment for those without
APP, as hypothesized FKK Chance scores are highest (more external locus of control) at
admission than at 6 months to one year (which are equivalent to each other) for those
with low and medium APP (LSD minimum mean difference = 3.47). For individuals in
the high APP group, FKK Chance scores remain the same from admission to six months
and from six months to one year, but scores at one year are lower than at admission as
hypothesized. While FKK Chance scores are equivalent to one another at admission
amongst the groups, those without APP have higher FKK Chance scores at six months
than those in the low and medium APP groups. Individuals in the high APP group have
higher FKK Chance scores at six months than those in the low and medium APP groups.
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However, there is partial support for hypotheses as those individuals with more severe
symptomatology have higher FKK Chance scores (more external locus of control) at six
months than those with medium APP. At one year, FKK Chance scores for those in the
low, medium, and high APP severity groups are equivalent while those in the no APP
group have higher FKK Chance scores than those in the low and high APP groups. There
is a main effect for overall FKK Chance score over time (F(2, 46) = 7.81, p = .001). As
hypothesized FKK Chance scores are higher at admission than at six to twelve months of
rehabilitation (which are equivalent to each other) (LSD minimum mean difference =
2.40). This pattern is only descriptive for those with low APP. There is no overall main
effect for APP severity level (F(3, 23) = .35, p = .79). Results of repeated measure
ANOVAs and means and standard deviations can be found in Tables 80, 84 - 89.

FKK Chance Scale Scores Across Treatment
35

FKK Chance Scale Score

30
25

No APP

20

Low APP

15

Med APP

10

High APP

5
0
Time 1

Time 2
Assessment Time

Time 3

Figure 3.21 Time Main Effect and Interaction between APP Severity Levels on FKK Chance Scores Across
Treatment
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There is an interaction between assessment time and APP severity level as they
relate to FKK External Locus of Control score (F(6, 46) = 2.30, p = .05, Mse = 50.17).
Although, the pattern of this interaction is that FKK External Locus of Control scores
remain the same across treatment for those without APP, partial support for hypotheses is
demonstrated as FKK Chance scores are highest at admission than at 6 months to one
year (which are equivalent to each other) for those with low or medium APP (LSD
minimum mean difference = 7.79). For individuals with high APP, FKK External Locus
of Control scores at one year are lower than at admission or six months (which are
equivalent to each other). This result still supports hypothesizes that those in the high
APP group demonstrate a decrease in external locus of control after one year of
treatment. While FKK External Locus of Control scores are equivalent to one another at
admission and one year for those with and without APP, contrary to the hypothesis those
without APP have higher FKK External Locus of Control scores at six months than those
with low or medium APP. However, partial support for hypotheses is found as
individuals in the high APP group have higher FKK External Locus of Control scores at
six months than individuals with low or medium APP. There is a main effect for overall
FKK External Locus of Control score over time (F(2, 46) = 5.47, p = .01). As
hypothesized FKK External Locus of Control scores are higher at admission than at six to
twelve months of rehabilitation (which are equivalent to each other) (LSD minimum
mean difference = 3.90). This pattern is only descriptive for those with low or medium
APP. There is no overall main effect for APP severity level (F(3, 23) = .29, p = .83).
Results of repeated measure ANOVAs and means and standard deviations can be found
in Tables 80 and 89.
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FKK Externality Scores Across Treatment
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Figure 3.22 Time Main Effect and Interaction between APP Severity Levels on FKK Externality Scores
Across Treatment

There is not an interaction between assessment time and APP severity level as
they relate to IPSAQ Situational Positive scores (F(6, 26) = 1.77, p = .15, Mse = 4.74).
There is no main effect for IPSAQ Situational Positive scores over time (F(2, 26) = 1.05,
p = .37). There is a main effect for APP severity level (F(1, 13) = 4.23, p = .03). Overall
IPSAQ Situational Positive scores, attributing positive events to situational factors, are
highest for those without APP and with high APP (which are equivalent to each other)
than for individuals in medium APP groups. Individuals in the low APP groups have the
lowest overall IPSAQ Situational Positive scores (LSD minimum mean difference =
1.40). Results of repeated measure ANOVAs and means and standard deviations can be
found in Tables 82 and 92.
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IPSAQ Situational Positive Subscale Scores Across Treatment
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Figure 3.23 APP Severity Levels Main Effect on IPSAQ Situational Positive Subscale Scores Across
Treatment

There is an interaction between assessment time and APP severity level as they
relate to IPSAQ Internal Negative scores (F(6, 26) = 3.21, p = .02, Mse = 4.85). The
pattern of this interaction is that IPSAQ Internal Negative scores remain the same across
treatment for those with no APP and medium APP (LSD minimum mean difference =
3.15). IPSAQ Internal Negative scores for those in the low APP group remain the same
from admission and six months but increase by one year. For individuals with high APP,
scores increase from admission to six and twelve months (which are equivalent to each
other), indicating as treatment progresses those in the high APP severity group are more
likely to attribute negative events to themselves or others than at admission. While
IPSAQ Internal Negative scores are equivalent to each other for those with and without
APP at admission, at six months those with no APP have higher scores than those in the
low APP group. Those in the medium and high APP groups have higher scores at sixth
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months than those in the low APP group. Contrary to hypotheses, by one year of
treatment, those in the low, medium, and high APP groups have higher scores than those
in the no APP group. There is no overall main effect for IPSAQ Internal Negative scores
over time (F(2, 26) = 1.20, p = .32) or for APP severity level (F(3, 13) = .66, p = .59).
Results of repeated measure ANOVAs and means and standard deviations can be found
in Tables 82 and 93.
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Figure 3.24 Interaction between APP Severity Levels on IPSAQ Internal Negative Subscale Scores Across
Treatment

There is not an interaction between assessment time and APP severity as they
relate to CST Self-Controlling scores (F(6, 36) = 1.81, p = .13, Mse = 27.52). There is no
main effect for CST Self-Controlling scores over time (F(2, 36) = .48, p = .62). There is
a main effect for APP severity level (F(3, 18) = 3.39, p = .04). Those individuals without
APP have overall higher CST Self-Controlling scores than individuals with low, medium,
and high APP. Contrary to hypotheses, those with high APP have lower overall CST
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Self-Controlling scores, indicating these individuals may utilize other coping strategies.
However, this pattern is not consistent across treatment times except for after one year of
treatment (Tables 81 and 97).
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Figure 3.25 APP Severity Levels Main Effect on CST Self-Controlling Subscale Scores Across Treatment

In summary, results of analyses between those who used mental health services
prior to age 18 and those who did not use services and socialcognitive functioning over
the course of treatment suggest that improvements in sociocognitive functioning are
evident for both groups over the course of treatment on the Hinting Task and for those
with mental health service usage on CST Social Support. Contrary to hypotheses, there is
not a decrease in FKK Powerful Others (a subscale of FKK External Locus of Control)
over treatment. Furthermore, contrary to hypotheses there is not an increase in FKK
Internal Locus of Control or FKK Self Concept or FKK Self Efficacy (both subscales of
FKK Internal Locus of Control) over the course of treatment. As hypothesized, FKK
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External Locus of Control and FKK Chance, a subscale of FKK External Locus of
Control, do decrease over treatment; however, this only occurred for those who used
mental health services in adolescence. Additionally, IPSAQ Internal Negative scores,
part of a personalizing bias, decrease across treatment for those without mental health
service usage in adolescence; however, this remains constant across treatment for those
who used mental health services in adolescence.
Results of analyses between assessment time and APP severity level indicate
improvements in sociocognitive functioning are over the course of treatment on the
Hinting Task. Contrary to hypotheses, there is not a decrease in FKK Powerful Others (a
subscale of FKK External Locus of Control) over treatment. Furthermore, contrary to
hypotheses there is not an increase in FKK Internal Locus of Control or FKK Self
Concept or FKK Self Efficacy (both subscales of FKK Internal Locus of Control) over
the course of treatment. As hypothesized, FKK External Locus of Control decrease over
treatment, however this only occurs for those in the low, medium, and high groups. For
FKK Chance, a subscale of FKK External Locus of Control, decreases over treatment
only occur for those with low or medium APP. Additionally, IPSAQ Internal Negative
scores, part of a personalizing bias, increase across treatment for those with low or high
APP and remain constant across treatment for those with medium or no APP.
As hypothesized, when analyses are conducted between those without and
without mental health service usage in adolescence, no differences exist between groups
after one year of psychiatric rehabilitation on the following measures: Hinting Task, FKK
Internal Locus of Control, FKK Self Concept, FKK Self Efficacy, FKK Powerful Others,
IPSAQ Internal Positive, IPSAQ Situational Positive, IPSAQ Personal Negative, IPSAQ
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Situational Negative, CST Social Support, CST Escape Avoidance, and CST Planful
Problem Solving. Contrary to hypotheses, individuals without mental health service
usage prior to age 18 demonstrate higher scores on the FKK Chance scale and FKK
External Locus of Control measures after one year of treatment than those without mental
health service usage in adolescence. Also, contrary to hypotheses those without mental
health service usage demonstrate lower scores after one year of treatment on the IPSAQ
Internal Negative and higher scores on the CST Social Support scale than those with
APP.
Finally, as hypothesized, when analyses are conducted utilizing APP severity
level, as hypothesized no differences exist between groups after one year of psychiatric
rehabilitation on the following measures: Hinting Task, FKK Internal Locus of Control,
FKK Self Concept, FKK Self Efficacy, FKK Powerful Others, FKK External Locus of
Control, IPSAQ Internal Positive, IPSAQ Personal Positive, IPSAQ Personal Negative,
IPSAQ Situational Negative, CST Social Support, CST Escape Avoidance, CST Self
Controlling, and CST Planful Problem Solving. Contrary to hypotheses, individuals
without APP demonstrate higher scores on the FKK Chance scale after one year of
treatment than those with low or high APP. Also, contrary to hypotheses those without
APP demonstrate lower IPSAQ Internal Negative scores after twelve months than
individuals with low, medium, or high APP (which are all equivalent).

Insight Over the Course of Treatment
It is anticipated that adults with SMI who had mental health services before the
age of 18 have more insight into their mental illness over the course of treatment than
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those that did not have mental health services prior to the age of 18. Furthermore, it is
predicted that difference in insight across treatment will not remain after one year of
treatment. A 2 (service use) x 3 (time) repeated measure ANOVA with follow-up
analyses using the LSD procedure (p = .05) was completed for each measure. Analyses
utilizing 2 (service use) x 3 (assessment time) repeated measure ANOVAs and 4 (APP
Severity Level) x 3 (assessment time) repeated measure ANOVAs were attempted for
each SAIQ subscale. However, based on when this assessment was administered at CTP,
no group based on these distinctions had more than 10 people and one group had as few
as zero. Therefore, no repeated measures analyses were undertaken based on SAIQ
subscales and only analyses of the Insight Scale and its subscales will be discussed
below.
There is an interaction between assessment time and service use on Insight Scale
total score (F(2, 114) = 3.26, p = .04, Mse = 6.82). Insight total score remain the same
over treatment for those individuals who used mental health services in adolescence,
whereas for those individuals who did not use services prior to age 18 Insight Total
scores are highest at admission and six months (which are equivalent to each other) and
decrease after one year of treatment (LSD minimum mean difference = 1.36). Partial
support for hypotheses is found, as those who did not use mental health services prior to
age 18 have higher Insight Total scores at admission and six months and scores become
equivalent for both groups after one year of treatment. However, contrary to hypotheses,
those that had contact with mental health services before age 18 do not receive higher
Insight Total scores at admission than those who did not use services prior to age 18.
There is no main effect for Insight Total scores over time (F(2, 114) = 2.37, p = .10).
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There is a significant main effect for service use (F(1, 57) = 5.47, p = .02). Individuals
who did not use mental health services in adolescence have higher overall Insight Total
scores across treatment than individuals who did use mental health services in
adolescence; however, this pattern is only descriptive for both groups at admission and
six months (LSD minimum mean difference = .96). Results of repeated measure
ANOVAs and means and standard deviations can be found in Tables 100 and 104.
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Figure 3.26 Service Main Effect and Interaction between Service Usage Groups on Birchwood Insight
Total Scores Across Treatment

There is an interaction between assessment time and service use on Insight
Relabel scale score (F(2, 114) = 3.98, p = .02, Mse = .97). Insight Relabel scale scores
are highest at admission and six months (which are equivalent to each other) and decrease
at one year for individuals without mental health service usage in adolescence, whereas
for those individuals with mental health service usage in adolescence Insight Relabel
scale scores remain the same over treatment (LSD minimum mean difference = .51).
Contrary to hypotheses, no differences are found between individuals with and without
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mental health service usage in adolescence on Insight Relabel scale scores at admission,
and six months. As hypothesized, no differences are found between groups after twelve
months. There is no main effect for Insight Relabel scale scores over time (F(2, 114) =
2.40, p = .10) or for service use (F(1, 57) = .52, p = .48). Results of repeated measure
ANOVAs and means and standard deviations can be found in Tables 100 and 101.
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Figure 3.27 Interaction between Service Usage Groups on Birchwood Relabel Symptoms Scores Across
Treatment

There is not an interaction between assessment time and service use as they relate
to Insight Awareness scale scores (F(2, 114) = 2.52, p = .09, Mse = 1.25). There is no
main effect for Insight Awareness scale scores over time (F(2, 114) = 1.37, p = .26).
Contrary to hypotheses, individuals with mental health service usage in adolescence do
not have higher IS Awareness scores at admission than those without mental health
service usage in adolescence. There is a main effect for service use (F(1, 57) = 8.42, p =
.01). Individuals without mental health service usage in adolescence have higher overall
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Insight Awareness scale scores across treatment than individuals with mental health
service usage in adolescence, however this pattern is only descriptive for both groups at
admission and six months (LSD minimum mean difference = .42). When planned
comparisons were completed, Insight Awareness scores were lower for individuals with
service usage in adolescence (M = 1.93) than for individuals who did not use services in
adolescence (M = 2.41), t (125) = 2.16, p = .02. Results of repeated measure ANOVAs
and means and standard deviations can be found in Tables 100 and 102.
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Figure 3.28 Service Usage Group Main Effect on Birchwood Relabel Symptoms Scores Across Treatment

There is not an interaction of assessment time and service use as they relate to
Insight Need for Treatment scale scores (F(2, 114) = 1.96, p = .15, Mse = 1.12). There is
a main effect for overall Insight Need for Treatment scale scores over time (F(2, 114) =
3.22, p = .04). Overall Insight Need for Treatment scale scores remain the same from
admission to six months and from six months to one year of treatment, however overall
scores after one year of treatment are lower than at admission (LSD minimum mean
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difference = .39). However, this pattern is descriptive for neither group and is therefore
misleading. There is no main effect for service use (F(1, 57) = 2.77, p = .10). Results of
repeated measure ANOVAs and means and standard deviations can be found in Tables
100 and 103.
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Figure 3.29 Time Main Effect for Service Usage Groups on Birchwood Need For Treatment Scores Across
Treatment

In addition, 4 (APP Severity Level) x 3 (assessment time) repeated measure
ANOVAs were conducted for each insight measure. There is an interaction between
assessment time and APP severity level on Insight Scale total score (F(6, 110) = 3.38, p =
.004, Mse = 6.31). Insight total score remain the same over treatment for those
individuals with high APP, whereas for those individuals without APP Insight Total
scores remain the same from admission to six months and decrease after one year of
treatment to scores consistent with those at admission (LSD minimum mean difference =
1.85). Insight total scores for individuals with low APP decrease from admission to six
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and twelve months (LSD minimum mean difference = 1.85). Insight scores for
individuals with medium APP increase from admission to six and twelve months (which
are equivalent to each other). At admission, those with medium APP have lower Insight
total scores than those without APP or low APP. After six months, individuals without
APP have the highest Insight totals (all other groups have scores equivalent to each
other). As hypothesized, after one year of psychiatric rehabilitation all groups have
equivalent Insight total scores. There is no main effect for Insight Total scores over time
(F(2, 110) = 1.98, p = .14). There is not a significant main effect for APP severity level
(F(3, 55) = .43, p = .73). Results of repeated measure ANOVAs and means and standard
deviations can be found in Tables 105 and 109.
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Figure 3.30 Interaction between APP Severity Levels on Birchwood Insight Total Scores Across Treatment

There is an interaction between assessment time and APP severity level on Insight
Relabel scale score (F(6, 110) = 2.90, p = .01, Mse = .93). Insight Relabel scale scores
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are highest at admission and six months (which are equivalent to each other) and decrease
at one year for individuals without APP, whereas for those individuals with high APP
Insight Relabel scale scores remain the same over treatment (LSD minimum mean
difference = .71). Insight Relabel scale scores for individuals with low APP are highest at
admission, contrary to hypotheses, and decrease from six to twelve months (which are
equivalent to each other). At admission, individuals in the low APP group have higher
scores than those in the medium APP group. As hypothesized, no differences are found
between individuals without APP and various severities of APP on Insight Relabel scale
scores at six and twelve months. There is no main effect for Insight Relabel scale scores
over time (F(2, 110) = .91, p = .41) or for APP severity level (F(3, 55) = .43, p = .73).
Results of repeated measure ANOVAs and means and standard deviations can be found
in Tables 105 and 106.
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Figure 3.31 Interaction between APP Severity Levels on Birchwood Relabel Symptoms Scale Scores
Across Treatment
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There is an interaction between assessment time and APP severity level as they
relate to Insight Awareness scale scores (F(6, 110) = 2.48, p = .03, Mse = 1.20). Insight
Awareness scores remain the same across treatment for those without APP and
individuals in the medium and high APP group. Insight Awareness scores for individuals
with low APP are higher at admission than at six to twelve months (which are equivalent
to each other) (LSD minimum mean difference = .81). At admission, contrary to
hypotheses, those with low APP have higher Insight Awareness scores than those with
medium or high APP. At six months, those without APP have higher Insight Awareness
scores than individuals with low or high APP. As hypothesized, by one year of treatment
all groups have equivalent Insight Awareness scores. There is no main effect for Insight
Awareness scale scores over time (F(2, 110) = 2.16, p = .12). There is a main effect for
APP severity level (F(3, 55) = 2.89, p = .04). Individuals without APP have higher
overall Insight Awareness scale scores across treatment than individuals with each
severity of APP, whereas individuals with low or high APP (which are equivalent to each
other) have higher overall Insight Awareness scores than individuals with medium APP.
However this pattern is not descriptive for any assessment time and is therefore
misleading (LSD minimum mean difference = .61). Results of repeated measure
ANOVAs and means and standard deviations can be found in Tables 105 and 107.
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Figure 3.32 APP Severity Level Main Effect and Interaction between APP Severity Levels on Birchwood
Awareness Scale Scores Across Treatment

There is not an interaction of assessment time and APP severity level as they
relate to Insight Need for Treatment scale scores (F(6, 110) = 1.79, p = .11, Mse = 1.10).
There is a main effect for overall Insight Need for Treatment scale scores over time (F(2,
110) = 3.14, p = .04). Overall Insight Need for Treatment scale scores are highest at
admission and decrease at six months and from six months to one year of treatment (LSD
minimum mean difference = .39). However, this pattern is not completely descriptive for
any group APP at all assessment times and is therefore misleading. There is no main
effect for APP severity level (F(3, 55) = .91, p = .44). Results of repeated measure
ANOVAs and means and standard deviations can be found in Tables 105 and 109.
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Figure 3.33 Time Main Effect for APP Severity Levels on Birchwood Need For Treatment Scale Scores
Across Treatment

In summary, results of analyses on insight measures at admission and over the
course of treatment suggest that hypothesized improvements in insight did not occur over
the course of treatment for the all of the CTP population. Contrary to the hypothesis
those adults who used mental health services in adolescence do not endorse differing
Insight Totals or ability to relabel symptoms scores over the course of treatment.
Furthermore, individuals without mental health service usage in adolescence endorse
lower Insight Total scores and their ability to relabel symptoms as part of their illness
decreases over the course of treatment. Furthermore, in general the CTP participants
endorse lower Insight Need For Treatment scores across treatment. While differences do
not exist after one year of treatment between those with and without service usage in
adolescence on insight measures, this suggests neither groups’ insight changed more than
the others after participating in psychiatric rehabilitation.
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When results of analyses on insight measures at admission and over the course of
treatment utilize APP severity levels, results suggest that contrary to the hypothesis only
individuals with low APP endorse increases in Insight Totals over the course of
treatment. Insight Totals for individuals with no or low APP decrease over treatment
while Insight Total scores remain the same across treatment for those with high APP. As
hypothesized, ability to relabel symptoms increases over treatment for those with medium
APP but remains the same for those with high APP. In contrast, individuals with no or
low APP experience decreases in Insight Relabel scores across treatment. Insight
Awareness scores remain the same across treatment for those with no, medium, or high
APP while it decreases for those with low APP. Furthermore, insight into need for
treatment decreases across treatment for individuals with no, low, or high APP but
remains stable across treatment for those with medium APP. However, as hypothesized,
there are no differences between those with no, low, medium, and high APP on Insight
measures after one year of psychiatric rehabilitation.

Behavioral Functioning Across Treatment
It is hypothesized that as a result of psychiatric rehabilitation, there will be an
increase in behavioral functioning for all CTP participants over the course of psychiatric
rehabilitation. Although differences across treatment are hypothesized, it is predicted
that differences will not remain after one year. A 2 (service use) x 3 (assessment time)
repeated measure ANOVA was completed for each measure. There is not an interaction
between assessment time and service use as they relate to NOSIE Daily Schedule
Competence scores, F(2, 188) = .57, p = .57, Mse = 14.53. As hypothesized, the 2
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(service) x 3 (time) repeated measures ANOVA reveals a significant main effect for time
on the NOSIE Daily Schedule Competence scale scores, F (2, 188) = 26.86, p < .001
indicating that, overall, improvements in NOSIE Daily Schedule Competence occur with
treatment for both individuals with and without mental health service usage in
adolescence (LSD minimum mean difference = 1.10). There is no main effect for service
use, F(1, 94) = 2.54, p = .11 (Tables 110 and 111). Planned comparisons indicate after six
months of treatment NOSIE Daily Schedule Competence scores were lower for
individuals with service usage in adolescence (M = 32.65) than for individuals who did
not use services in adolescence (M=34.83), t (115) = 1.84, p = .03.
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Figure 3.34 Time Main Effect for Service Usage Groups on NOSIE Daily Schedule Competence Scores
Across Treatment

There is not an interaction between assessment time and service use as they relate
to NOSIE Social Interest scores, F(2, 188) = 1.30, p = .28, Mse = 14.73. As
hypothesized, repeated measures ANOVA reveal a significant main effect for time on the
NOSIE Social Interest scale scores, F (2, 188) = 39.51, p < .001 indicating that, overall,
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improvements in NOSIE Social Interest scores occur with treatment for both individuals
with and without mental health service usage in adolescence (LSD minimum mean
difference = 1.10). There is no main effect for service use, F(1, 94) = .06, p = .80 (Tables
110 and 111).
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Figure 3.35 Time Main Effect for Service Usage Groups on NOSIE Social Interest Scores Across
Treatment

There is not an interaction between assessment time and service use as they relate
to NOSIE Neatness scores, F(2, 188) = .33, p = .72, Mse = 8.19. As hypothesized,
analyses reveal a significant main effect for time on the NOSIE Neatness scale scores, F
(2, 188) = 20.89, p < .001 indicating that, overall, improvements in NOSIE Neatness
scores occur with treatment for both individuals with and without mental health service
usage in adolescence (LSD minimum mean difference = .82). There is no main effect for
service use, F(1, 94) = 1.20, p = .28. Results of repeated measure ANOVAs and means
and standard deviations can be found in Tables 110 and 111.
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Figure 3.36 Time Main Effect for Service Usage Groups on NOSIE Neatness Scores Across Treatment

There is not an interaction between assessment time and service use as they relate
to NOSIE Irritability scores, F(2, 188) = .15, p = .86, Mse = 16.27. Analyses reveal a
significant main effect for time on the NOSIE Irritability scale scores, F (2, 188) = 3.78,
p = .03 indicating partial support for hypotheses. NOSIE Irritability scores increase from
admission to six months and, as hypothesized, scores decrease from six months to one
year of treatment for individuals with and without mental health service usage during
adolescence (LSD minimum mean difference = 1.15). There is no main effect for service
use, F(1, 94) = 1.38, p = .24. Results of repeated measure ANOVAs and means and
standard deviations can be found in Tables 110 and 111.
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Figure 3.37 Time Main Effect for Service Usage Groups on NOSIE Irritability Scores Across Treatment

There is not an interaction between assessment time and service use as they relate
to NOSIE Psychoticism scores, F(2, 188) = .96, p = .38, Mse = 3.56. Contrary to
hypotheses, results reveal a significant main effect for time on the NOSIE Psychoticism
scale scores, F (2, 188) = 7.47, p = .001 indicating that, overall, NOSIE Psychoticism
scores increase from admission to six months and one year of treatment (LSD minimum
mean difference = .54). There is no main effect for service use, F(1, 94) = .87, p = .35
(Tables 110, 111).
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Figure 3.38 Time Main Effect for Service Usage Groups on NOSIE Psychoticism Scores Across Treatment

There is not an interaction between assessment time and service use as they relate
to NOSIE Motor Retardation scores, F(2, 188) = .34, p = .72, Mse = 7.03. As
hypothesized, results reveal a significant main effect for time on the NOSIE Motor
Retardation scale scores, F (2, 188) = 15.93, p < .001 indicating that, overall, NOSIE
Motor Retardation scores are not significantly different from admission to six months,
however scores decrease by one year of treatment (LSD minimum mean difference =
.76). There is no main effect for service use, F(1, 94) = 1.50, p = .22. Results of
repeated measure ANOVAs and means and standard deviations can be found in Tables
110 and 111.
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Figure 3.39 Time Main Effect for Service Usage Groups on NOSIE Motor Retardation Scores Across
Treatment

There is not an interaction between assessment time and service use as they relate
to NOSIE Total Assets scores, F(2, 188) = .21, p = .81, Mse = 206.89. As hypothesized,
results reveal a significant main effect for time on the NOSIE Total Assets scores, F (2,
188) = 21.68, p < .001 indicating that, overall, improvements in NOSIE Total Assets
scores occur with treatment for both individuals with and without mental health service
usage in adolescence (LSD minimum mean difference = 4.11). There is no main effect
for service use, F(1, 94) = 1.97, p = .16 (Tables 110 and 111).
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Figure 3.40 Time Main Effect for Service Usage Groups on NOSIE Total Scores Across Treatment

Results were also analyzed using a 4 (APP Severity Level) x 3 (assessment time)
repeated measure ANOVA for each NOSIE measure. Results indicate there is not an
interaction between assessment time and APP severity level as they relate to NOSIE
Daily Schedule Competence scores, F(6, 184) = .85, p = .54, Mse = 14.54. As
hypothesized, the 4 (APP severity level) x 3 (time) repeated measures ANOVA reveals a
significant main effect for time on the NOSIE Daily Schedule Competence scale scores,
F (2, 184) = 23.33, p < .001 indicating that, overall, improvements in NOSIE Daily
Schedule Competence occur with treatment (LSD minimum mean difference = 1.09)
(Tables 112, 113). This pattern is descriptive for all groups except individuals with high
APP, for which scores decrease from admission to six months but are highest at one year.
There is no main effect for APP severity level, F(3, 92) = 1.10, p = .35.
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Figure 3.41 Time Main Effect for APP Severity Levels on NOSIE Daily Schedule Competence Scores
Across Treatment

There is not an interaction between assessment time and service use as they relate
to NOSIE Social Interest scores, F(6, 184) = 1.83, p = .10, Mse = 14.40. As
hypothesized, results reveal a significant main effect for time on the NOSIE Social
Interest scale scores, F (2, 184) = 36.58, p < .001 indicating that, overall, improvements
in NOSIE Social Interest scores occur with treatment (LSD minimum mean difference =
1.08). There is no main effect for APP severity level, F(3, 92) = .73, p = .54. Results of
repeated measure ANOVAs and means and standard deviations can be found in Tables
112 and 113.
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Figure 3.42 Time Main Effect for APP Severity Levels on NOSIE Social Interest Scores Across Treatment

There is an interaction between assessment time and APP severity level as they
relate to NOSIE Neatness scores, F(6, 184) = 3.14, p = .01, Mse = 7.62. For individuals
without APP, NOSIE neatness scores remain the same from admission to six months but
improve from six months to one year, whereas for individuals with low or medium APP
scores continue to improve throughout treatment (LSD minimum mean difference =
1.58). For individuals with high APP, scores decrease from admission to six months but
improve from six months to one year of treatment. At admission, individuals with high
APP have the highest NOSIE neatness scores followed by those without APP. At six
months, individuals without APP have higher scores than those with low or high APP.
As hypothesized, after one year of treatment all groups have equivalent NOSIE neatness
scores. As hypothesized, results reveal a significant main effect for time on the NOSIE
Neatness scale scores, F (2, 184) = 19.85, p < .001 indicating that, overall, scores remain
the same from admission to six months but improvements in NOSIE Neatness scores
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occur from six months to one year (LSD minimum mean difference = .79). However,
this pattern is only descriptive for those without APP and is therefore misleading. There
is no main effect for APP severity level, F(3, 92) = .73, p = .54. Results of repeated
measure ANOVAs and means and standard deviations can be found in Tables 112 and
113.
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Figure 3.43 Time Main Effect and Interaction between APP Severity Levels on NOSIE Neatness Scores
Across Treatment

There is not an interaction between assessment time and APP severity level as
they relate to NOSIE Irritability scores, F(6, 184) = .40, p = .88, Mse = 16.44. As
hypothesized, results reveal a significant main effect for time on the NOSIE Irritability
scale scores, F (2, 184) = 3.40, p = .04 indicating that, overall, NOSIE Irritability scores
increase from admission to six months and decrease from six months to one year of
treatment (LSD minimum mean difference = 1.16) (Tables 112, 113). This pattern is
descriptive for all groups except the high APP group, for which NOSIE Irritability scores
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remain the same across treatment. There is no main effect for APP severity level, F(3, 92)
= 1.30, p = .28.
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Figure 3.44 Time Main Effect for APP Severity Levels on NOSIE Irritability Scores Across Treatment

There is not an interaction between assessment time and APP severity level as
they relate to NOSIE Psychoticism scores, F(6, 184) = 1.58, p = .16, Mse = 3.49.
Analyses reveal a significant main effect for time on the NOSIE Psychoticism scale
scores, F (2, 184) = 8.07, p < .001 indicating that, overall, NOSIE Psychoticism scores
increase from admission to six months and one year of treatment (which are equivalent to
each other) (LSD minimum mean difference = .53). However, this pattern is only
descriptive for those with low APP (Tables 112, 113). There is no main effect for APP
severity level, F(3, 92) = .36, p = .78.
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Figure 3.45 Time Main Effect for APP Severity Levels on NOSIE Psychoticism Scores Across Treatment

There is not an interaction between assessment time and APP severity level as
they relate to NOSIE Motor Retardation scores, F(6, 184) = 2.03, p = .06, Mse = 6.76.
Results reveal a significant main effect for time on the NOSIE Motor Retardation scale
scores, F (2, 184) = 13.55, p < .001 indicating that, overall, NOSIE Motor Retardation
scores are not significantly different from admission to six months, however as
hypothesized scores decrease across treatment (LSD minimum mean difference = .74).
However, this pattern is only descriptive for individuals with high APP and is misleading.
There is no main effect for APP severity level, F(3, 92) = 1.63, p = .19. Results of
repeated measure ANOVAs and means and standard deviations can be found in Tables
112 and 113. One tailed planned comparisons indicate contrary to hypotheses NOSIE
Motor Retardation scores were higher for individuals with service usage in adolescence
(M = 5.35) than for individuals who did not use services in adolescence (M=4.18), t (94)
= -1.66, p = .05.
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Figure 3.46 Time Main Effect for APP Severity Levels on NOSIE Motor Retardation Scores Across
Treatment

There is an interaction between assessment time and APP severity level as they
relate to NOSIE Total Assets scores, F(6, 184) = 2.20, p = .05, Mse = 197.68. NOSIE
Total Assets scores increase across treatment for individuals with low or medium APP
(LSD minimum mean difference = 8.04). For individuals without APP, scores do not
change from admission to six months and from six months to one year, at which time
scores are greater than at admission (Table 112, 113). NOSIE Total Assets score for
individuals with high APP do not change from admission to six months but increase from
six months to one year (which is equivalent to scores at admission). At admission,
NOSIE Total Assets scores are equivalent for those without APP and those with high
APP. However, those without APP or with high APP have higher NOSIE Total Assets
than individuals with low or medium APP. At six months, individuals without APP or
medium APP have higher scores than those with low or high APP. As hypothesized,
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after one year of treatment no differences between groups exist on NOSIE Total Assets.
As hypothesized, the 4 (APP severity level) x 3 (time) repeated measures ANOVA reveal
a significant main effect for time on the NOSIE Total Assets scores, F (2, 184) = 22.23, p
< .001 indicating that, overall, improvements in NOSIE Total Assets scores occur with
treatment (LSD minimum mean difference = 4.02). There is no main effect for APP
severity level, F(3, 92) = 1.48, p = .23. Results of repeated measure ANOVAs and
means and standard deviations can be found in Tables 112 and 113.
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Figure 3.47 Time Main Effect for APP Severity Levels on NOSIE Total Scores Across Treatment

Overall, these results suggest that improvements in behavioral functioning do
occur across treatment on almost all NOSIE subscales and NOSIE Total Assets for those
with and without mental health service usage. However, partial support for hypotheses is
found for NOSIE Irritability and NOSIE Psychoticism. When service use is utilized in
analyses, all participants’ NOSIE Irritability scores contrary to hypotheses increase from
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admission to six months but, as hypothesized, do decrease by 12 months of treatment.
Furthermore, contrary to hypotheses NOSIE Psychoticism scores for all participants
continued to increase over the course of treatment. When results are analyzed with
regards to APP severity level, the above results are again found. However, NOSIE Motor
Retardation scores improve for all APP severity levels. Finally as predicted, no
differences exist on NOSIE measures amongst groups after one year of psychiatric
rehabilitation.

Symptomatology Across Treatment
It is hypothesized that as a result of psychiatric rehabilitation, improvements will
occur in symptomatology across treatment. While differences may exist amongst groups
at admission or six months, it is predicted that individuals who used mental health
services in adolescence demonstrate higher symptomatology after one year of treatment.
However, when different levels of APP are used in analyses, it is predicted that as APP
becomes more severe there will be more severe symptomatology. A 2 (service use) x 3
(assessment time) repeated measure ANOVA and a 4 (APP Severity Level) x 3
(assessment time) repeated measure ANOVA was completed for each measure.
There is not an interaction between assessment time and service use as they relate
to BPRS Total scores, F(2, 128) = .86, p = .43, Mse = 97.89. There is no main effect for
BPRS Total scores over time (F(2, 128) = 1.23, p = .30) or for service use (F(1, 64) =
.23, p = .64) (Table 114, 116).
There is an interaction between assessment time and service use on BPRS
Psychotic Disorganization Factor score, F(2, 128) = 3.17, p = .05, Mse = 3.87. BPRS
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Psychotic Disorganization Factor scores remain stable over treatment except for those
who used mental health services in adolescence whose score at one year of treatment are
lower than at admission as hypothesized (LSD minimum mean difference = .96).
Individuals with mental health service usage in adolescence have higher BPRS Psychotic
Disorganization Factor scores at admission than individuals without mental health service
usage in adolescence. However, contrary to hypotheses this difference does not persist at
6 months to one year of treatment. There is no main effect for BPRS Psychotic
Disorganization Factor scores over time (F(2, 128) = 2.16, p = .32) or for service use
(F(1, 64) = 1.20, p = .28). Results of repeated measure ANOVAs and means and
standard deviations can be found in Tables 114 and 117.
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Figure 3.48 Interaction Between Service Usage Groups on BPRS Psychotic Disorganization Factor Scores
Across Treatment

There is not an interaction between assessment time and service use as they relate
to BPRS Hallucination/Delusions Factor scores, F(2, 134) = .85, p = .43, Mse = 7.97.
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There is no main effect for BPRS Hallucinations/Delusions Factor scores over time (F(2,
134) = .82, p = .44) or for service use (F(1, 67) = .47, p = .50) (Tables 114, 118). Also,
there is not an interaction between assessment time and service use as they relate to
BPRS Paranoia Factor scores, F(2, 134) = .05, p = .95, Mse = 6.88. There is no main
effect for BPRS Paranoia Factor scores over time (F(2, 134) = .04, p = .96) or for service
use (F(1, 67) = 1.75, p = .19) (Tables 114, 119).
There is not an interaction between assessment time and service use as they relate
to BPRS Emotional Blunting Factor scores, F(2, 134) = .19, p = .83, Mse = 4.41. There
is no main effect for BPRS Emotional Blunting Factor scores over time (F(2, 134) =
1.03, p = .36) or for service use (F(1, 67) = 1.20, p = .28). However, planned
comparisons indicate BPRS Emotional Blunting Factor scores are higher at six months of
treatment for individuals with service usage in adolescence (M = 6.17) than for
individuals who did not use services in adolescence (M =5.22), t (119) = -1.85, p = .03.
In addition, there is not an interaction between assessment time and service use as
they relate to BPRS Anxiety/Depression Factor scores, F(2, 134) = .27, p = .77, Mse =
6.82. There is no main effect for BPRS Anxiety/Depression Factor scores over time
(F(2, 134) = .50, p = .61) or for service use (F(1, 67) = .64, p = .43). However, planned
comparisons indicate BPRS Anxiety/Depression Factor scores are higher at six months of
treatment for individuals with service usage in adolescence (M = 9.20) than for
individuals who did not use services in adolescence (M =7.82), t (118) = -2.09, p = .02.
Finally there is not an interaction between assessment time and service use as they
relate to BPRS Agitation/Elation Factor scores, F(2, 134) = 1.08, p = .34, Mse = 1.51.
There is no main effect for BPRS Agitation/Elation Factor scores over time (F(2, 134) =
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.06, p = .94) or for service use (F(1, 67) = .02, p = .90). Results of repeated measure
ANOVAs and means and standard deviations can be found in Tables 114, 120 - 122.
Because isolated differences between groups on individual BPRS items are found
at admission, those analyses are repeated here to determine whether there is a consistent
pattern over time on any particular BPRS items. No interactions, assessment time main
effects, or service use main effects are found for the following BPRS items: Somatic
Concern, Anxiety, Depression, Guilt, Hostility, Elevated Mood, Grandiosity,
Suspiciousness, Disorientation, Conceptual Disorganization, Blunted Affect, Emotional
Withdrawal, Tension, Uncooperativeness, Excitement, Distractibility, Motor
Hyperactivity, and Mannerisms and Posturing (all Fs < 3.71, all ps > .06).
However, planned comparisons indicate several differences between individuals
who used services in adolescence and those without a history of adolescent service usage.
Results indicate BPRS Depression item scores are higher at six months of treatment for
individuals with service usage in adolescence (M = 2.28) than for individuals who did not
use services in adolescence (M =1.85), t (119) = -1.89, p = .03. Results also indicate
BPRS Guilt item scores are higher at six months of treatment for individuals with service
usage in adolescence (M = 2.10) than for individuals who did not use services in
adolescence (M =1.55), t (118) = -2.49, p < .01. Additionally, planned comparisons
indicate BPRS Hostility item scores are higher at six months of treatment for individuals
with service usage in adolescence (M = 2.81) than for individuals who did not use
services in adolescence (M = 2.32), t (119) = -1.89, p = .04. As previously stated, t-tests
at admission found a difference between groups on BPRS Grandiosity item scores. This
result is also found after one year of treatment, when again results indicate scores are
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lower for individuals with service usage in adolescence (M = 1.57) than for individuals
who did not use services in adolescence (M = 2.26), t (77) = 1.71, p = .05. Results
indicate BPRS Blunted Affect item scores are higher at six months of treatment for
individuals with service usage in adolescence (M = 2.77) than for individuals who did not
use services in adolescence (M = 2.32), t (119) = -1.91, p = .03. Analyses also indicate
BPRS Tension item scores are lower after one year of treatment for individuals with
service usage in adolescence (M = 1.33) than for individuals who did not use services in
adolescence (M = 1.76), t (77) = 2.07, p = .02. Finally, results indicate BPRS Motor
Hyperactivity item scores are lower after one year of treatment for individuals with
service usage in adolescence (M = 1.18) than for individuals who did not use services in
adolescence (M = 1.51), t (77) = 1.72, p = .05. The previously stated results obtained
from planned comparisons indicate analyses utilizing ANOVAs over the course of
treatment sometimes did not have enough power to detect significant differences amongst
the groups.
There is not an interaction between assessment time and service use as they relate
to BPRS Suicidality scores, F(2, 136) = .14, p = .87, Mse = .64. There is no main effect
for BPRS Suicidality scores over time (F(2, 136) = .55, p = .58). As hypothesized, there
is a main effect for service use (F(1, 68) = 6.62, p = .01), with individuals with mental
health service usage in adolescence receiving higher overall BPRS Suicidality scores than
those without mental health service usage in adolescence at all assessment times (Table
124). When planned comparisons were completed, results indicate BPRS Suicidality
item scores are higher at six months of treatment for individuals with service usage in
adolescence (M = 1.73) than for individuals who did not use services in adolescence (M =
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1.16), t (119) = -3.35, p < .001. Additionally, after one year of treatment results indicate
contrary to hypothesis BPRS Suicidality item scores remain higher for individuals with
service usage in adolescence (M = 2.28) than for individuals who did not use services in
adolescence (M = 1.85), t (77) = -.87, p = .01.

BPRS Suicidality Item
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BPRS Suicidality Item Scores Across Treatment
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Figure 3.49 Service Usage Group Main Effect on BPRS Suicidality Item Scores Across Treatment

There is an interaction between assessment time and service use on BPRS
Hallucinations item score, F(2, 136) = 3.97, p = .02, Mse = 1.87. BPRS Hallucination
items scores remain stable over treatment for those without mental health service usage in
adolescence, whereas BPRS Hallucination items scores, contrary to hypotheses, decrease
over treatment for those with mental health service usage in adolescence (LSD minimum
mean difference = .59). As hypothesized, individuals with mental health service usage in
adolescence have higher BPRS Hallucination item scores at admission than individuals
without mental health service usage in adolescence; however, contrary to hypotheses, this
difference does not persist at 6 months to one year of treatment. There is no main effect
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for BPRS Hallucination item scores over time (F(2, 136) = .08, p = .93) or for service use
(F(1, 68) = .61, p = .44). Results of repeated measure ANOVAs and means and standard
deviations can be found in Tables 124.
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Figure 3.50 Interaction Between Service Usage Groups on BPRS Hallucinations Item Scores Across
Treatment

There is not an interaction between assessment time and service use as they relate
to BPRS Unusual Thought Content item scores, F(2, 134) = .51, p = .60, Mse = 1.57.
There is a main effect for assessment time, F(2, 134) = 4.14, p = .02. Scores remain the
same from admission to six months, and from six months to one year, however as
hypothesized scores after one year of treatment generally decrease from scores at
admission. However, this pattern is only descriptive for individuals who used mental
health service use in adolescence. There is no main effect for service use, F(1, 67) = .57,
p = .45 (Table 124).
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BPRS Unusual Thought Content Item Scores Across Treatment
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Figure 3.51 Time Main Effect for Service Usage Groups on BPRS Unusual Thought Content Item Scores
Across Treatment

There is an interaction between assessment time and service use on BPRS Bizarre
Behavior item score, F(2, 136) = 3.24, p = .04, Mse = 1.22. BPRS Bizarre Behavior items
scores remain stable over treatment for those with and without mental health service
usage in adolescence; however BPRS Bizarre Behavior items scores at one year are less
than scores at admission for those who used mental health services in adolescence (LSD
minimum mean difference = .52). Individuals who used mental health services in
adolescence have higher BPRS Bizarre Behavior item scores at admission than
individuals without mental health service usage in adolescence; however, contrary to
hypotheses, this difference does not persist at 6 months to one year of treatment. There is
no main effect for BPRS Bizarre Behavior item scores over time (F(2, 136) = 1.00, p =
.37) or for service use (F(1, 68) = 1.99, p = .16) (Table 124).
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BPRS Bizarre Behavior Item Scores Across Treatment
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Figure 3.52 Interaction Between Service Usage Groups on BPRS Bizarre Behavior Item Scores Across
Treatment

There is an interaction between assessment time and service use on BPRS Self
Neglect item score, F(2, 136) = 4.46, p = .01, Mse = .61. As hypothesized, BPRS Self
Neglect items scores remain stable from admission to six months and then decrease for
individuals who used mental health services in adolescence. However, contrary to
hypotheses, scores increase from admission to six and twelve months (which are
equivalent to each other) for those without mental health service usage in adolescence
(LSD minimum mean difference = .37). As hypothesized, individuals who used mental
health services in adolescence have higher BPRS Self-Neglect item scores at admission
than individuals without mental health service usage in adolescence; however, contrary to
hypotheses, this difference does not persist at 6 months to one year of treatment. There is
an overall main effect for BPRS Self Neglect item scores over time, F(2, 136) = 5.68, p <
.01. Self Neglect items scores increase from admission to six months and then decrease
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at one year of treatment (LSD minimum mean difference = .26). However, this pattern is
not descriptive for those with or without mental health service usage in adolescence and
is therefore misleading. There is no main effect for service use, F(1, 68) = .07, p = .80.
Results of repeated measure ANOVAs and means and standard deviations can be found
in Tables 124.
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Figure 3.53 Time Main Effect and Interaction Between Service Usage Groups on BPRS Self-Neglect Item
Scores Across Treatment

There is not an interaction between assessment time and service use as they relate
to BPRS Motor Retardation item scores, F(2, 134) = .11, p = .90, Mse = .61. There is a
main effect for assessment time, F(2, 134) = 4.65, p = .01. Scores decrease from
admission to six months and one year (which are equivalent to each other) for individuals
with and without mental health service usage in adolescence (LSD minimum mean
difference = .26). There is no main effect for service use, F(1, 67) = .77, p = .38 (Table
124).
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BPRS Motor Retardation Item Scores Across Treatment
2.5

BPRS Motor Retardation
Item Score

2
1.5

No Service Use
Service Use

1
0.5
0
Time 1

Time 2
Assessment Time

Time 3

Figure 3.54 Time Main Effect for Service Usage Groups on BPRS Motor Retardation Item Scores Across
Treatment

When 4 (APP Severity Level) x 3 (assessment time) repeated measures ANOVAs
were conducted using APP severity levels, no interactions, assessment time main effects,
or APP severity level main effects are found for the following assessments: BPRS Total,
BPRS Psychotic Disorganization Factor, BPRS Hallucinations/Delusions Factor, BPRS
Paranoia Factor, BPRS Emotional Blunting Factor, BPRS Anxiety/Depression Factor,
BPRS Agitation/Elation Factor, BPRS Somatic Concern item, BPRS Anxiety item, BPRS
Depression item, BPRS Guilt item, BPRS Hostility item, BPRS Elevated Mood item,
BPRS Grandiosity item, BPRS Suspiciousness item, BPRS Hallucinations item, BPRS
Unusual Thought Content item, BPRS Conceptual Disorganization item, BPRS Blunted
Affect item, BPRS Emotional Withdrawal item, BPRS Tension item, BPRS
Uncooperativeness item, BPRS Excitement item, BPRS Distractibility item, BPRS Motor
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Hyperactivity item, and BPRS Mannerisms and Posturing item (all Fs < 2.51, all ps >
.06).
Results of repeated measure ANOVAs and means and standard deviations can be
found in Tables 115, 123, and 125. Again, there are several significant differences on
BPRS items when analyses assess differences amongst APP severity levels. There is not
an interaction between assessment time and APP severity level as they relate to BPRS
Suicidality scores, F(6, 132) = .51, p = .80, Mse = .64. There is no main effect for BPRS
Suicidality scores over time, F(2, 132) = .89, p = .41. There is a main effect for APP
severity level, F(3, 66) = 4.64, p = .01, with individuals with each level of APP having
equivalent overall BPRS Suicidality scores, however as hypothesized those with high
APP have higher overall BPRS Suicidality scores than those with no or low APP. This
pattern is descriptive for all assessment times (Table 125).
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Figure 3.55 APP Severity Levels Main Effect on BPRS Suicidality Item Scores Across Treatment
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There is an interaction between assessment time and APP severity level on BPRS
Bizarre Behavior item score, F(6, 132) = 2.19, p = .05, Mse = 1.20. BPRS Bizarre
Behavior items scores remain stable over treatment for those with no, low, and medium
APP whereas for individuals with high APP Bizarre Behavior item scores at one year are,
as hypothesized, less than scores at admission (LSD minimum mean difference = .73).
Individuals without APP and with medium APP have lower BPRS Bizarre Behavior item
scores at admission than those in the low and high APP groups (which are equivalent to
each other). At six months, BPRS Bizarre Behavior item scores are equivalent for each
group. After one year of treatment, contrary to hypotheses, Bizarre Behavior item scores
are highest for individuals with low APP, with those with no, medium, and high APP
receiving equivalent BPRS Bizarre Behavior scores. There is no main effect for BPRS
Bizarre Behavior item scores over time (F(2, 132) = .17, p = .84) or for APP severity
level (F(3, 66) = 1.22, p = .31). Means and standard deviations are in Tables 125.
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Figure 3.56 Interaction between APP Severity Levels on BPRS Bizarre Behavior Item Scores Across
Treatment
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There is an interaction between assessment time and APP severity level on BPRS
Self Neglect item score, F(6, 132) = 2.56, p = .02, Mse = .60. BPRS Self Neglect items
scores remain stable from admission to six months and then, as hypothesized, these
scores decrease for individuals with high APP. Contrary to hypotheses, scores increase
from admission to six months and remain the same from six to twelve months for those
without APP (LSD minimum mean difference = .52). BPRS Self Neglect item scores
remain the same across treatment for individuals with low or medium APP.

No

differences are found between groups on BPRS Self-Neglect item scores at admission or
at six months, however as hypothesized individuals with high APP have lower BPRS Self
Neglect scores than all other groups after one year or treatment. There is not an overall
main effect for BPRS Self Neglect item scores over time (F(2, 132) = 1.43, p =.24) or for
APP severity level (F(3, 66) = .50, p = .68) (Table 125).
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Figure 3.57 Interaction between APP Severity Levels on BPRS Self-Neglect Item Scores Across Treatment
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There is not an interaction between assessment time and APP severity level as
they relate to BPRS Disorientation item scores, F(6, 130) = .58, p = .75, Mse = .41.
There is not a main effect for assessment time, F(2, 130) = .31, p = .74. There is an
overall main effect for APP severity level, F(3, 65) = 4.97, p < .01. Overall, contrary to
hypotheses individuals with low APP have higher BPRS Disorientation item scores than
those with no, medium, or high APP at all assessment times (LSD minimum mean
difference = .52) (Table 125).
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Figure 3.58 APP Severity Levels Main Effect on BPRS Disorientation Item Scores Across Treatment

There is not an interaction between assessment time and APP severity level as
they relate to BPRS Motor Retardation item scores, F(6, 130) = .34, p = .92, Mse = .62.
There is a main effect for assessment time, F(2, 130) = 3.12, p = .05. Scores remain the
same from admission to six months and from six months to one year. However, as
hypothesized scores at one year are lower than scores at admission (LSD minimum mean
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difference = .27). However, this pattern is only descriptive for individuals with high APP
and is therefore misleading. There is no main effect for APP severity level, F(3, 65) =
1.04, p = .38.
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Figure 3.59 Time Main Effect for APP Severity Levels on BPRS Motor Retardation Item Scores Across
Treatment

Overall, results of analyses using the BPRS total, BPRS factor scores, and BPRS
items suggest that differences amongst groups exist for several symptomatology
measures as they relate to assessment time and service use. Contrary to hypotheses,
symptomatology for individuals with and without mental health service usage in
adolescence does not improve over the course of treatment as measured by BPRS Total
Assets, BPRS Hallucination/Delusions factor, BPRS Paranoia factor, BPRS Emotional
Blunting factor, BPRS Anxiety/Depression factor, and BPRS Agitation/Elation factor.
Partial support for hypotheses is found with the BPRS Psychotic Disorganization factor,
as improvements across treatment are only descriptive for those who used mental health
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services in adolescence. As hypothesized, individuals with mental health service usage in
adolescence demonstrate more symptomatology at admission on the BPRS Psychotic
Disorganization factor, however no other differences between groups at admission exist
for other BPRS factor scores. In addition, contrary to hypotheses, individuals with
mental health service usage in adolescence do not demonstrate more symptomatology
after one year of treatment on the BPRS Total Assets score and BPRS factor scores.
When BPRS items are analyzed across time, partial support for hypotheses is found. For
individuals who used mental health services in adolescence, scores on BPRS
Hallucinations/Delusion item, BPRS Unusual Thought Content item, BPRS Bizarre
Behavior item, and BPRS Self-Neglect item improve by one year of treatment. However,
scores on these same measures remain the same across treatment for those without mental
health service usage in adolescence. However, as hypothesized, BPRS Motor
Retardation scores improve over the course of treatment for those with and without
mental health service usage in adolescence. As hypothesized, individuals who did use
mental health services in adolescence demonstrate more symptomatology at admission on
the BPRS Suicidality item, BPRS Hallucination/Delusions item, BPRS Bizarre Behavior
item, and BPRS Self-Neglect item. However, by one year of treatment the only
difference that remains between groups is that individuals who used mental health
services in adolescence receive higher suicidality scores than those without mental health
service usage in adolescence.
In summary, when analyses were conducted between APP severity level and
BPRS total, BPRS factor scores, and BPRS items only significant differences emerge on
individual BPRS items. Again, partial support for hypotheses is found. Improvement in
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symptomatology across treatment is found only for those with high APP on BPRS SelfNeglect item, BPRS Bizarre Behavior item, and BPRS Motor Retardation item. As
hypothesized, differences exist between the groups at various assessment times. As
hypothesized, individuals with high APP demonstrate more symptomatology at
admission on the BPRS Bizarre behavior item, however individuals with high APP
demonstrate equivalent scores to those with low APP at admission. As hypothesized,
individuals with high APP exhibit more symptomatology after one year of treatment on
BPRS Suicidality item and BPRS Self-Neglect item. However, contrary to hypotheses
individuals with low APP receive the highest BPRS Bizarre Behavior item and BPRS
Disorientation item scores after one year of treatment and therefore demonstrate more
symptomatology on these measures compared to those with high APP.

Hypothesis 2
Outcome
A pattern of differential outcome was hypothesized for those who used services
during adolescence versus individuals who did not use services and for each APP severity
level. Specifically, it is predicted that that discharge disposition differs between the two
groups in that individuals with severe adolescent psychiatric pathology are discharged to
a more restrictive setting. In addition, it is predicted that there is a greater rate of
rehospitalization for those who used mental health services in adolescence than those
without mental health services in adolescence. Furthermore, when analyses are
conducted between the different APP severity groups, it is predicted that those
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individuals in the medium and highest APP severity groups have a greater rate of
rehospitalization than those in the low to no APP severity groups.
Also, it is predicted that those in the highest APP severity group have the greatest
rate of rehospitalization, as these individuals may represent a subgroup experiencing
more severe and refractory symptoms that can be potential barriers to living in the
community for extended periods.
Discharge Location
It was predicted that people who used services during adolescence are discharged
to more restrictive levels of care than those who did not use services. Chi square
analyses reveal there is no significant relationship between the level of restrictiveness of
discharge setting and service use in adolescence, X2 (3) = 1.85, p =0.60 (See Table 126).
It was also predicted that when APP severity level is examined, discharge
disposition differs between the groups in that individuals with severe adolescent
psychiatric pathology are discharged to a more restrictive setting than individuals in the
no, low, or medium APP groups. Chi square analyses reveal there is no significant
relationship between the level of restrictiveness of discharge setting and APP severity
level, X2 (9) = 5.86, p =0.75 (See Table 127). Contrary to the hypothesis, those
individuals with severe adolescent psychiatric pathology are not discharged to more
restrictive settings than individuals with less severe adolescent pathology.
Rehospitalization Rate
Following discharge, CTP participants spent an average of 94.86% of days during
the first six months after discharge in the community rather than in the hospital, 95.20%
of days within the first year, 93.22% of days within eighteen months, and 93.20% of days

141
within the first two years after discharge. Ninety-three of the 123 people, or 75.6%, with
rehospitalization data available are not rehospitalized from the time of discharge through
the time the outcome data was collected. There are no significant differences between
those who did or did not use services during adolescence on the percentage of days in the
first six months after CTP discharge spent in the community (F(1,122) = .03, p = 0.86),
the percentage of days in the first year after CTP discharge spent in the community
(F(1,109) = .22, p = 0.64), the percentage of days within eighteen months after CTP
discharge spent in the community (F(1, 88) = .30, p = 0.58), or the percentage of days
within two years after CTP discharge spent in the community (F (1, 73) = .02, p = 0.90).
Furthermore, when APP severity level is examined, there are no significant
differences between APP severity level on the percentage of days in the first six months
after CTP discharge spent in the community (F(3,122) = .72, p = 0.54), the percentage of
days in the first year after CTP discharge spent in the community (F(3,109) = 1.02, p =
0.39), the percentage of days within eighteen months after CTP discharge spent in the
community (F(3, 88) = .67, p = 0.58), or the percentage of days within two years after
CTP discharge spent in the community (F (3, 73) = .55, p = 0.65).
As described in the methods section, the rehospitalization data is skewed and
could not be transformed or windsorized into an acceptable skewness range. This is
largely a function of the large proportion of people who were never rehospitalized during
the follow-up period. In order to substantiate the above results since the data used in the
above analyses is skewed, categorical variables of “rehospitalized” and “not
rehospitalized” were created based on all or none cutoff levels.

Chi square analysis

reveals no significant relationship between whether or not someone used services in
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adolescence and rehospitalization categorization, X2(1) = .62, p = .43. Likewise,
rehospitalization categorizations were made based on rehospitalization in six-month
intervals following discharge. At six months post-discharge, there is not a significant
relationship between service use and rehospitalization categorization, X2(1) = .62, p = .43.
At 12 months post-discharge, again no significant relationships between service use and
rehospitalization categorization are found, X2(1) = .30, p = .59. Again, at 18 months postdischarge, there remains no relationship between the two variables, X2(1) = .88, p = .35.
Finally, at 24 months post-discharge, there remains no relationship between the two
variables, X2(1) = .05, p = .82.
When APP severity level is examined, Chi square analysis again reveals no
significant relationship between APP severity level and whether or not they are
rehospitalized after discharge from CTP, X2(3) = 2.87, p = .41. Likewise,
rehospitalization categorizations for each APP severity level are made based on
rehospitalization in six-month intervals following discharge. At six months postdischarge, there is not a significant relationship between the various APP severity levels
and rehospitalization categorization, X2(3) = 3.32, p = .35. At 12 months post-discharge,
again no significant relationships between APP severity level and rehospitalization
categorization are found, X2(3) = 4.03, p = .26. Again, at 18 months post-discharge, there
remains no relationship between the two variables, X2(3) = 4.21, p = .24. Finally, at 24
months post-discharge, there remains no relationship between the two variables, X2(3) =
5.21, p = .16.
In summary, results of analyses of outcome data with regard to service use
indicate that at the time of discharge and during the follow-up period after discharge, no
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differences between individuals who used services in adolescence and those who did not
use services are evident. Moreover, no differences between APP severity groupings are
noted. Contrary to all outcome hypotheses, there is no evidence that APP severity levels
differ in terms of rehospitalization outcomes.
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CHAPTER 5 – DISCUSSION
The primary purpose of this study was to assess the relationship of adolescent
psychiatric pathology with insight before, during, and after treatment. In addition, a
secondary relationship between adolescent psychiatric pathology and functioning in a
variety of domains before, during, and after treatment were assessed. The participants
with adolescent psychiatric pathology were compared to those without to determine if
any differences existed. Also, when adolescent psychiatric pathology was separated into
three separate groups by the amount and type of services utilized during adolescence,
these three different levels of adolescent psychiatric pathology were also be compared to
those without. Univariate and multivariate analyses were conducted within and between
the two groups and four groups with respect to overall functioning using multiple
measures described below. To date, only one study on this topic is known to exist
(Wynne, 2009). Because of the paucity of research in this area, this study was highly
exploratory in nature, giving a first look at the clinical correlates across treatment
between individuals with and without adolescent psychiatric pathology. Furthermore,
these clinical correlates across treatment in adulthood were also studied between
individuals with various severities of adolescent psychiatric pathology.
Overall, there was mixed support for the hypotheses of the study. In summary
results suggest individuals with service use during adolescence were found to be younger
at admission to CTP, have slightly lower levels of education, and have an earlier age of
onset and more previous hospitalizations, as expected. The results are consistent with
earlier work (Herron, 1962) on the process reactive distinction in schizophrenia. The
process reactive distinction analyzed the developmental sequence of schizophrenia
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spectrum disorders. Specifically, research in this area is concerned with individuals’
premorbid patterns, the timeline preceding the onset of the disorder, the precipitant(s) that
may engender the onset of the disorder, and symptom presentation during the course of
the disorder. Results from this study indicate those who used services in adolescence, as
specifically the medium and high APP groups closely resemble the traditional
psychopathology “process” group from research in the 1950s-1980. Process type has
been associated with an insidious onset, gradual emotional blunting, and withdrawing
from daily activities. Research found individuals identified in the process group had poor
performance in school, deterioration in functioning in a variety of domains including
neurocognitive, hospitalization during adolescence, poor response to treatment,
awareness of change in self, and a family history of mental illness. Individuals without
mental health service usage in adolescence may represent the reactive type again from
research in the 1950s-1980s. Reactive type is usually characterized by a sudden onset of
the disorder after the person experiences a particular stressor, have an onset later in life,
functioning within normal limits in most domains in life prior to onset, good academic
performance in school, good response to treatment, and “no sensation of change” (Haas
& Sweeney, 1992). While it is interesting to note analyses utilizing the service use prior
to age 18 vs. no service use prior to age 18 found similar results to research using
process-reactive distinctions, utilizing either of these promotes a dichotomous typology
rather than analyzing adults with SMI on a continuum. Thus, further research utilizing
APP severity levels may be able to further delineate differences in premorbid
functioning, onset of illness, clinical correlates, and influence favorable treatment
outcomes for each individual at all levels of the continuum.
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A relationship between Axis I and Axis II diagnoses and service use was
identified. Those diagnosed with Schizophrenia, Chronic/Undifferentiated Type,
Schizoaffective Disorder, and “other” appear more likely to have used mental health
services during adolescence than those diagnosed with Schizophrenia, Paranoid Type.
Those diagnosed with Paranoid Personality Disorder appear less likely to have received
services during adolescence than those diagnosed with Borderline Personality Disorder;
whereas those diagnosed with Borderline Personality Disorder appear more likely to have
received services during adolescence. Those who used services and did not use services
were more likely to be diagnosed with “other” than to have a diagnosis of Borderline
Personality Disorder. Those diagnosed with Borderline Personality Disorder appear more
likely to have received services during adolescence than not whereas those without an
Axis II diagnosis were more likely to have not used services during adolescence. The
differences between groups corroborate previous findings and indicate that exploration of
these differences in participant characteristics needs to continue to be explored in future
studies. The finding that Axis I and Axis II diagnoses are associated with service use
may be a sign those that receive mental health services during adolescence may be more
likely to develop comorbid disorders that greatly influence their functioning in adulthood.
This may also indicate that those individuals who did not receive services during
adolescence were experiencing less severe symptomatology than those who received
services and thus these individuals may not have been perceived as high risk or needing
services during adolescence by mental health professionals. This finding may have
important implications for screening tools used by mental health professionals serving
adolescents transitioning into adulthood.
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Contrary to all hypotheses, participants with service usage in adolescence do not
significantly differ from those without at the time of admission, with respect to
neurocognitive, social cognitive functioning, or insight. In addition, there do not appear
to be substantial differences in neurocognitive functioning, social cognitive functioning,
or insight at admission for the various APP severity levels. Overall, results of NOSIE
analyses do not support hypotheses that those with service use in adolescence
demonstrate poorer behavioral functioning upon admission than those without, nor were
hypotheses supported that differences in behavioral functioning at admission existed
between the different APP severity groups. Although a significant difference occurred on
the NOSIE Motor Retardation subscale, results were opposite to hypothesized and the
high APP severity group received lower scores than individuals in the low and medium
APP severity groups.
It was anticipated that individuals with service usage in adolescence would have a
higher level of symptomatology at admission than those without, and specifically those
individuals with the most severe APP would demonstrate a higher level of
symptomatology than those with less severe APP. Individuals with service usage in
adolescence received higher suicidality and hopelessness scores at admission than those
without. Indeed, as research has indicated, symptoms such as suicidality and depression
may all influence or be manifestations or outcomes of various levels of insight (Amador
et al., 1991; Amador et al., 1993; Amador et al., 1996; Caldwell & Gottesman, 1990;
Lysaker et al., 2005; McGlashan et al., 1975). These results indicate future studies may
utilize cluster analysis in order to study the unique differences amongst groups in
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variables, as a consistent pattern of differences in performance was not found by the
current study.
When analyses were conducted between APP severity levels two significant
differences emerged. Again as hypothesized, those individuals with medium or high APP
received higher suicidality scores on multiple measures than those without APP or in the
low APP severity group. Individuals without service use in adolescence were rated as
more uncooperative than individuals with various levels of APP severity, indicating that
prior contact with services may actually aid in working with treatment providers upon
rehospitalization.
Results of analyses between those who used mental health services prior to age 18
and those who did not use services and neurocognitive functioning over the course of
treatment suggest that improvements in neurocognitive functioning are evident over the
course of treatment on strategic planning and organized searching, for individuals without
service use in adolescence on a measure of verbal memory, for individuals with service
use in adolescence on a measure of visuocontructional ability and nonverbal memory, for
both groups in nonverbal memory, for individuals with service use in adolescence on a
task assessing attention and information processing, for those with service use in
adolescence on verbal fluency and word generating ability, and for both groups on a
neurocognitive screening assessment measuring overall cognitive functioning.
Results of analyses between assessment time and APP severity level indicate
improvements in neurocognitive functioning are over the course of treatment on a task of
verbal memory for those without APP, for those with low or high APP on a task of
immediate nonverbal memory and visuocontructional ability, for those with none or high
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APP on delayed nonverbal memory, and for those in the none, low, or high groups on a
neurocognitive screener measuring overall cognitive functioning.
As hypothesized, when analyses were conducted between those without service
usage before age 18 and those with service usage in adolescence, no differences existed
between groups on most measures of neurocognitive functioning. Contrary to
hypotheses, individuals with service usage in adolescence were better able to rapidly
generate and organize verbal information after one year of treatment than those without
service usage in adolescence. However, individuals without APP demonstrated poorer
overall cognitive functioning after one year of treatment than those with APP.
Finally, as hypothesized, when analyses were conducted utilizing APP severity
level, as hypothesized no differences existed between groups after one year of psychiatric
rehabilitation on most neurocognitive measures. Contrary to hypotheses, individuals with
high APP demonstrated better verbal memory performance at admission and six months,
however as hypothesized this difference did not remain after one year of treatment. As
hypothesized, those individuals with high APP demonstrated poorer overall cognitive
functioning at admission. However, contrary to hypotheses differences remained
between the groups at twelve months and those without APP or low APP performed
better on a measure of overall cognitive functioning than those in the medium or high
APP severity groups.
Improvements in sociocognitive functioning were also evident over the course of
treatment on participant’s ability and facility of comprehension and interpretation of
social limitations and for those with service usage prior to age 18 on social support
coping cognitions. Contrary to hypotheses, there was not a decrease in participant’s
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beliefs being effected by their beliefs that others are powerful, a component of external
locus of control. Furthermore, contrary to hypotheses there was not an increase in internal
locus of control, in individual’s self-concept of their own competence or participant’s
self-efficacy (both components of internal locus of control) over the course of treatment.
As hypothesized, overall external locus of control and the role of chance in determining
one’s fate, a subscale of external locus of control, did decrease over treatment. However,
this only occurred for those with service usage in adolescence.
When social cognitive was assessed amongst the various APP severity groups
results indicate improvements in sociocognitive functioning are inconsistent over the
course of treatment on theory of mind abilities. As previously indicated, there was not a
decrease in participant’s beliefs in powerful others over treatment. Furthermore, contrary
to hypotheses there was not an increase in internal locus of control or participant’s selfconcept or self-efficacy over the course of treatment amongst the various APP severity
groups. As hypothesized, external locus of control decreased over treatment, however
this only occurred for those in the low, medium, and high groups. For beliefs that chance
controls one’s fate, decreases over treatment only occurred for those with low or medium
APP.
Contrary to the hypothesis those adults with service usage in adolescence did not
endorse differing overall insight or ability to relabel symptoms scores over the course of
treatment. However, as hypothesized, there were no differences between those with and
without service usage in adolescence on any measure of insight after one year of
psychiatric rehabilitation. Furthermore, individuals without service usage prior to age 18
endorsed lower overall insight total scores and their ability to relabel symptoms as part of
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their illness decreased over the course of treatment. In general, the CTP participants
endorsed lower insight into need for treatment scores across treatment, possibly
indicating an increased desire to be discharged as length of stay increased.
When results of analyses on insight measures at admission and over the course of
treatment utilize APP severity levels, results suggest that differences in insight across
treatment existed between groups. However, contrary to hypotheses only individuals
with low APP endorsed increases in total insight over the course of treatment. Total
insight for individuals with no or low APP decreased over treatment while total insight
scores remained the same across treatment for those with high APP. As hypothesized,
ability to relabel symptoms increased over treatment for those with medium APP but
remained the same for those with high APP. Individuals with no or low APP experienced
decreased ability to relabel symptoms across treatment. Insight awareness scores
remained the same across treatment for those with no, medium, or high APP while it
decreased for those with low APP. Furthermore, insight into need for treatment again
decreased across treatment for individuals with no, low, or high APP groups but
remained stable across treatment for those with medium APP. However, as
hypothesized, there were no differences between those with and without APP on insight
measures after one year of psychiatric rehabilitation.
Overall, results suggest that improvements in behavioral functioning do occur
across treatment in almost all domains measured within the current study for those with
and without service usage in adolescence. However, partial support for hypotheses was
found for irritability and psychoticism scores. When service use was utilized in analyses,
all participants’ irritability scores increased from admission to six months but decreased
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by 12 months of treatment. Furthermore, contrary to hypotheses psychoticism scores for
all participants continued to increase over the course of treatment. When results were
analyzed with regards to APP severity level, the above results were again found.
However, motor retardation improved for all APP severity levels. However, as predicted,
no differences existed amongst groups after one year of psychiatric rehabilitation.
Results also suggest that differences amongst groups exist for several
symptomatology measures as they relate to assessment time and service use. Contrary to
hypotheses, symptomatology for individuals with and without service usage in
adolescence did not improve over the course of treatment. Partial support for hypotheses
was found with the BPRS Psychotic Disorganization factor, as improvements across
treatment were only descriptive for those with service usage in adolescence. As
hypothesized, individuals with service usage prior to age 18 demonstrated more
symptomatology at admission on the BPRS Psychotic Disorganization factor, however no
other differences between groups at admission existed for other BPRS factor scores.
Also contrary to hypotheses, individuals with service usage in adolescence did not
demonstrate more symptomatology after one year of treatment. When specific
symptomatology items were analyzed across time, partial support was found. For
individuals with mental health service usage in adolescence, items assessing
hallucinations/delusions, unusual thought content, bizarre behavior, and self-neglect
improved by one year of treatment. However, on scores on these same measures
remained the same across treatment for those without service usage in adolescence.
However, as hypothesized, BPRS Motor Retardation scores improved over the course of
treatment for those with and without service usage in adolescence. As hypothesized,
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individuals with service usage in adolescence demonstrated more suicidality,
hallucinations/delusions, bizarre behavior, and self-neglect. However, by one year of
treatment the only difference that remained between groups was that individuals with
service usage in adolescence received higher suicidality scores than those without service
usage in adolescence.
Results also suggest that differences amongst groups exist for several
symptomatology measures as they relate to assessment time and APP severity level.
Again, partial support for hypotheses were found. Improvement in symptomatology
across treatment was found only for those with high APP on items measuring selfneglect, bizarre behavior, and motor retardation. As hypothesized, differences existed
between the groups at various assessment times. As hypothesized, individuals with high
APP demonstrated more symptomatology at admission on items assessing bizarre
behavior, however individuals with high APP demonstrated equivalent scores to those
with low APP at admission. As hypothesized, individuals with high APP exhibited more
suicidality and self-neglect. However, contrary to hypotheses individuals with low APP
received the highest bizarre behavior and disorientation item ratings after one year of
treatment.
Differences in level of discharge restrictiveness and rehospitalization rates were
predicted for those with and without service usage in adolescence and for the various
APP severity levels. Contrary to the hypothesis, those individuals with severe adolescent
psychiatric pathology were not discharged to more restrictive settings than individuals
with less severe adolescent pathology. There were no significant differences between
those who did or did not use services during adolescence on the percentage of days spent
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in the community in the first six, twelve, eighteen, and twenty-four months after CTP
discharge. Furthermore, when APP severity level is examined, there are no significant
differences between APP severity level on the percentage of days in the first six, twelve,
eighteen, and twenty-four months after CTP discharge spent in the community.
Again, contrary to hypotheses, analyses revealed no significant relationship
between whether or not someone used services in adolescence and rehospitalization
categorization. Likewise, rehospitalization categorizations were made based on
rehospitalization in six-month intervals following discharge. At six, twelve, eighteen,
and twenty-four months post-discharge, there was not a significant relationship between
service use and rehospitalization categorization.
When APP severity level was examined, analyses again revealed no significant
relationship between whether or not someone used services in adolescence and whether
or not they were rehospitalized after discharge from CTP at all assessment time periods.
Thus, contrary to all outcome hypotheses, there is no evidence that with or with APP
differ in terms of rehospitalization outcomes or discharge location restrictiveness.
Overall, similar discharge patterns between those with and without APP were
found with discharges from CTP. Treatment teams may be aware of the social history of
each person and it is likely that failure at previous discharge locations impact future
discharge planning. Of note, several measures of symptomatology and behavioral
functioning (i.e. those with service usage in adolescence were rated higher on items of
self-neglect and suicidality) were unable to maintain adequate self-care or an appropriate
level of care needed for some discharge locations. Based on past rates of
rehospitalization, treatment teams may be more likely to discharge to locations seen as
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transitional, or intermediate levels of care. Perhaps even more likely, discharges may be
dictated by the community providers themselves based on prior working with participants
from the program. Therefore, participants from CTP may only be accepted by a limited
range of providers leading to the non-significant discharge findings.
The second part of the outcome hypothesis pertained to rate of rehospitalization.
Results of this study cannot be used to fully substantiate nor disprove the notion that
people with APP have higher rates of rehospitalization and that those with high APP may
represent a more population with more treatment refractory symptoms. A possible
confound was the community agencies for which rehospitalization data was available.
Records were not available if individuals resided or were hospitalized in another state, if
they did not use the local CMHC, or if they were rehospitalized anywhere else besides
the state hospital. This may have significantly skewed the rehospitalization data that was
available, therefore more qualitative analyses or case studies regarding rehospitalization
rate for those with and without APP may be warranted to further evaluate this hypothesis.
The inconsistent pattern of results and partial support of hypotheses in this study
may be explained by the nature of the population from which the sample was drawn.
Because of the severity and chronicity of psychiatric disorder within the CTP population,
some of the non-significant differences between groups can be attributable to the overall
high level of impairment present in the population at CTP, thus creating a “leveling
effect” that may obscure some findings that would occur in other treatment environments.
The CTP participants represent a particularly treatment-refractory population and
differences in functioning between groups with various amount and types of service use
during adolescence may be less apparent than they would be in a less severe or less
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chronic psychiatric population with more variability. Discriminating between any groups
within the CTP population may require not only the existence of differences, but
substantial differences. That is not to say that there is not considerable heterogeneity
within this group, but it may mean that fine, subtle differences between groups may be
hard to detect, and these differences may or may not be meaningful. This conclusion is
congruent with studies which have had difficulty detecting treatment effects between
groups in the CTP setting (Spaulding, Reed, Sullivan, Richarson, & Weiler, 1999;
Wynne, 2009). A similar study across treatment settings and/or populations may be
warranted.

Limitations of the Present Study
The goal of identifying between a developmental conceptualization of insight
based on contact with adolescent psychiatric pathology and various domains of
functioning while hospitalized and outcomes in the community resulted in a myriad of
findings. The lack of consistent patterns of differences between groups may be because
of varied conceptualizations of the construct of insight, constitutes service use during
adolescence, and the unknown quality of services received. One weakness of this study
is that included measures of insight that do not reflect recent advances in
multidimensional insight assessments. Furthermore, insight assessments may be
influenced by practice effects, as participants are given the same self-report form over the
course of treatment. Since this study utilized archival clinical data, only measures that
are part of routine assessment at CTP were available. While poor cognitive functioning
has been linked to insight (e.g., Amador et al., 1991; Frith, 1992; Lysaker et al., 1994;
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Lysaker et al., 1995; McGlynn & Schacter, 1989; Prigatano & Schacter, 1991 as cited in
Rusch and Corrigan, 2002) and this study found inconsistent results between groups on
neurocognitive functioning. It may be that a more global measurement of insight
reflecting current conceptualizations of insight, or a variable derived of various domains
from assessments in other domains, would better capture the relationship between service
use during adolescence and changes in insight and neurocognitive functioning across
treatment.
The current archival database does not lend itself to pre-post analyses. Future
studies may consider reformatting the archival database so as to have an admission data
point and a discharge data point (or the assessment closest to discharge) as an
approximation of pre- and post- rehabilitation functioning. Furthermore, the use of a
flexible assessment battery with this clinical population meant there was an unusually
large amount of missing data that prevented some use of appropriate statistical analyses.
The amount of significant results was also close to that expected to occur by chance, thus
lowering confidence in complete interpretation of results. For most analyses examining
the between-group differences and within group difference there was enough power to
detect differences. Effect size estimates were examined in addition to the statistical
significance tests to determine there was enough power to detect all differences.
At any rate, this study explored the relationship between various domains of
functioning during the course of psychiatric rehabilitation and service use, APP severity
and insight such that future studies in this area can make more informed research
hypotheses using stricter constraints in research design to circumvent problems related to
possible confounds.
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Future Directions
Areas of needed research have already been alluded to in the above discussion.
Specifically, a replication or study similar to the one undertaken here, with more defined
hypotheses and changes in assessment measures is needed to further clarify the
characteristics of those with various amounts of service use during adolescence and the
differences in several domains of functioning across treatment after the age of 18 and
once discharged into the community. Likewise, a similar study in a broader population
would allow for more generalizability of results. Finally, a study or a series of case
studies examining different events and service use during adolescence, possibly a
longitudinal study following subjects from adolescence to adulthood, is necessary to
better understand why some people improve their insight across treatment and others do
not given the different trajectories or trends in insight scores and other domains of
functioning across treatment for the various severity levels of APP.
While the Birchwood Insight Scale is theoretically based on a multidimensional
view of insight (David, 1990), this measure may not be indicative of current
multidimensional conceptualizations of insight, or other conceptualizations such as the
view that insight is the degree to which an individual agrees with their treatment
provider, or insight as a coping mechanism. The current study sought to determine
relationships between individual’s insight and domains of functioning, however a
consistent pattern could not be established. Therefore, using measures of insight to
identify correlates to clinical functioning, or insight across treatment, is unresolved until a
relationship between the psychological construct of insight and other biopsychosocial
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measures is better understood. Studies identifying correlates of insight to various clinical
variables have not been conducted within a population whose historical use of services
during adolescence has been investigated. Or, if they have, the effect of contact with
mental health providers earlier in life on insight into treatment after the onset of illness
has not been considered in analyses. Such a study might simply include different
biopsychosocial measures within a population such as the one in this study to determine
if the measures make distinctions or can predict different APP severity level groups
across treatment.
In general, more empirical, as opposed to theoretical investigations, of the
concepts found within the prodromal research and service use during adulthood are
needed in order to prevent or decrease the revolving door phenomenon commonly found
in mental health settings. The current study continues to take essential steps towards
identifying the relationship between the access to and use of mental health services by
adolescents and the subsequent clinical functioning of those individuals with an onset of
mental illness later after transitioning into adulthood.
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CTP Information Gathering Sheet pg. 1
Name:____________________________________
ID number (please write down if you find they have more than 1 ID #):____________
Date(s) the file was looked at:_________________
Clinical Assistant who checked file:________________

Please write down any information about mental health services the patient received
before the age of 18 (therapy, medicine, services from other mental health practitioners
such as social works, etc; being in-patient hospitalized, whether they were in adolescent
services here at the regional center or in another state, etc):
Prior Therapy before the age of 18:

Medicine before the age of 18:

Services form other mental health providers (social workers, OT, psychiatrists, etc.):
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CTP Information Gathering Sheet pg. 2
Were they in-patient hospitalized before the age of 18?

Any other information that is useful for determining how many and what type of mental
health services they received prior to the age of 18?

Is more information needed to determine the amount or type? If so, what do you feel is
needed?

Was there any vague information that did not allow you to accurately rate the amount of
previous mental health services? If so describe the information.
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Table 1
Demographic and Clinical Characteristics of Participants
Demographic and Clinical Variables
Age (range: 18 to 71)
Education, # of years in school (range: 6 to 20 years)
Length of stay at CTP in days (range:57-2545)
Age of onset (range: 4 to 63 )
Number of hospitalizations in lifetime (range: 0 to 105)
Gender (n=317)
Male
Female
Race/Ethnicity (n=288)
Caucasian
African American
Hispanic
Native American
Asian American
Other
Marital Status (n=272)
Single
Married
Divorced
Widowed
Separated
Legal Status (n=280)
Mental Health Board Commitment (MHB)
Voluntary per guardian (VpG)
Not responsible by reason of insanity (NRRI)
Voluntary (V)
Primary Axis I Diagnosis (n=282)
Schizophrenia, Paranoid Type
Schizophrenia, Chronic/Undifferentiated Type
Schizoaffective
Bipolar
Psychotic Disorder NOS
Dementia / Organic Brain Disease
Impulse Control Disorder
Other
Axis II Diagnoses (n=284)
None
Borderline
Paranoid
Antisocial
Schizoid
Borderline Intellectual Functioning / Mild Mental Retardation

NOS
Other

308
283
137
248
298

Mean (SD) or
Percentage
37.91 (12.62)
12.23 (2.03)
637.28 (452.97)
19.92 (8.60)
9.69 (9.77)

203
114

64.0%
36.0%

238
30
6
4
2
8

82.6%
10.4%
2.1%
1.4%
0.7%
2.8%

171
21
69
4
7

62.9%
7.7%
25.4%
1.5%
2.6%

220
34
22
4

78.6%
12.1%
7.9%
1.4%

77
66
78
35
4
4
6
12

27.3%
23.4%
27.7%
12.4%
1.4%
1.4%
2.1%
4.3%

105
20
46
13
4
19
30
47

37.0%
7.0%
16.2%
4.6%
1.4%
6.7%
10.6%
16.5%

N
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Table 2
Demographic and Clinical Characteristics of Participants according to Service
Use During Adolescence
No Service Use

Service Use

Demographic and Clinical Variables

Age (range: 19 to 71)

N

Mean (SD) or
Percentage

N

Mean (SD)
or
Percentage
33.77
(11.40)
11.69 (1.92)
699.20
(490.81)
16.03 (5.92)
10.81
(11.31)

145

42.55 (12.35)

163

Education, # of years in school (range: 6 to 20 years)
Length of stay at CTP in days (range:11-2545)

134

12.84 (1.98)

149

72

581.39 (411.34)

65

Age of onset (range: 4 to 63 )
Number of hospitalizations in lifetime (range: 0 to 105)

118

24.20 (9.07)
8.42
(7.47)

130

94
53

63.1%
35.6%

109
61

64.1%
35.9%

111
15
1
2
1
4

74.5%
10.1%
0.7%
1.3
0.7%
2.7%

127
15
5
2
1
4

82.5%
9.7%
3.2%
1.3%
0.6%
2.6%

75
10
34
3
6

58.6%
7.8%
26.6%
2.3%
4.7%

96
11
35
1
1

66.7%
7.6%
24.3%
0.7%
0.7%

103
12
11
3

69.1%
8.1%
7.4%
2.0%

117
22
11
1

77.5%
14.6%
7.3%
0.7%

51
23
35
15
1
2
3
3

38.3%
17.3%
26.3%
11.3%
0.8%
1.5%
2.3%
2.3%

26
43
43
20
3
2
3
9

17.4%
28.9%
28.9%
13.4%
2.0%
1.3%
2.0%
6.1%

58
4
20
4
1
6
14
27

43.3%
3.0%
14.9%
3.0%
0.7%
4.4%
10.4%
20.1%

47
16
26
9
3
13
16
20

31.3%
10.7%
17.3%
6.0%
2.0%
8.1%
10.7%
13.3%

Gender (n=317)
Male
Female
Race/Ethnicity (n=288)
Caucasian
African American
Hispanic
Native American
Asian American
Other
Marital Status (n=272)
Single
Married
Divorced
Widowed
Separated
Legal Status (n=280)
Mental Health Board Commitment (MHB)
Voluntary per guardian (VpG)
Not responsible by reason of insanity (NRRI)
Voluntary (V)
Primary Axis I Diagnosis (n=282)
Schizophrenia, Paranoid Type
Schizophrenia, Chronic/Undifferentiated Type
Schizoaffective
Bipolar
Psychotic Disorder NOS
Dementia / Organic Brain Disease
Impulse Control Disorder
Other
Axis II Diagnoses (n=284)
None
Borderline
Paranoid
Antisocial
Schizoid
Borderline Intellectual Functioning to Mild Mental Retardation
NOS
Other

139

159
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Table 3
Demographic and Clinical Characteristics of Participants according to APP
Severity Level

No APP
Demographic and Clinical
Variables

Mean (SD)
or
Percentage

N

Age (range: 19 to 71)
Education, # of years in school
(range: 6 to 20 years)
Length of stay at CTP in days
(range:11-2545)
Age of onset
(range: 4 to 63 )
Number of hospitalizations in
lifetime (range: 0 to 105)
Gender (n=317)
Male
Female
Race/Ethnicity (n=288)
Caucasian
African American
Hispanic
Native American
Asian American
Other
Marital Status (n=272)
Single
Married
Divorced
Widowed
Separated
Legal Status (n=280)
Mental Health Board
Commitment (MHB)
Voluntary per guardian (VpG)
Not responsible by reason of
insanity (NRRI)
Voluntary (V)
Primary Axis I Diagnosis (n=282)
Schizophrenia, Paranoid Type
Schizophrenia,Chronic/
Undifferentiated Type
Schizoaffective
Bipolar
Psychotic Disorder NOS
Dementia/Organic Brain Disease
Impulse Control Disorder
Other
Axis II Diagnoses (n=284)
None
Borderline
Paranoid
Antisocial
Schizoid
Borderline Intellectual
Functioning – Mild Mental
Retardation
NOS
Other

145
134
72
118
139

42.55
(12.35)
12.84
(1.98)
581.39
(411.34)
24.20
(9.07)
8.42
(7.47)

Low APP

N

23
22
19
20
22

Mean (SD)
or
Percentage
40.04
(10.68)
12.23
(1.77)
781.68
(633.89)
20.20
(6.41)
11.00
(7.57)

Med APP

N

34
31
17
31
33

Mean (SD)
or
Percentage
33.04
(10.23)
11.87
(1.82)
698.18
(382.86)
17.68
(6.91)
7.45
(6.32)

High APP

N

106
96
29
79
104

Mean
(SD) or
Percentag
e
32.64
(11.53)
11.51
(1.97)
645.76
(448.31)
14.33
(4.60)
11.83
(12.95)

94
53

63.1%
35.6%

13
10

56.5%
43.5%

27
8

77.1%
22.9%

69
43

61.6%
38.4%

111
15
1
2
1
4

74.5%
10.1%
0.7%
1.3
0.7%
2.7%

18
1
1
1
1

81.8%
4.5%
4.5%
4.5%
4.5%

31
1
1
-

93.9%
3.0%
3.0%
-

78
13
3
2
3

78.8%
13.1%
3.0%
2.0%
3.0%

75
10
34
3
6

58.6%
7.8%
26.6%
2.3%
4.7%

11
1
8
-

55.0%
5.0%
40.03%
-

19
5
6
1
-

61.3%
16.1%
19.4%
3.2%
-

66
5
21
1

71.0%
5.4%
22.6%
1.1%

103

69.1%

15

68.2%

22

66.7%

80

83.3%

12

8.1%

6

27.3%

9

27.3%

7

7.3%

11

7.4%

1

4.5%

2

6.1%

8

8.3%

3

2.0%

-

-

-

-

1

1.0%

51

38.3%

3

13.6%

8

25.0%

15

15.8%

23

17.3%

9

40.9%

12

37.5%

22

23.2%

35
15
1
2
3
3

26.3%
11.3%
0.8%
1.5%
2.3%
2.3%

10
-

45.5%
-

2
3
1
2
4

6.3%
9.4%
3.1%
5.9%
12.5%

31
17
2
2
1
5

32.6%
17.9%
2.1%
2.1%
1.1%
5.3%

58
4
20
4
1

43.3%
3.0%
14.9%
3.0%
0.7%

7
6
2
-

31.8%
27.3
9.1%
-

8
2
9
1
-

25.8%
6.5%
29.0%
3.2%
-

32
14
11
6
3

33.0%
14.4%
11.3%
6.2%
3.1%

6

4.4%

1

4.5%

3

9.7%

9

9.3%

14
27

10.4%
20.1%

2
4

9.1%
18.2%

2
6

6.5%
19.3%

12
10

12.4%
10.3%
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Table 4
Relationship Between Axis I Diagnosis and Service Use (N=282)

Axis I Diagnosis
Schizophrenia, Paranoid Type
Schizophrenia, Chronic/Undifferentiated Type
Schizoaffective
Other2
Total

2

No
Service

Service Use

Total

51

26

77

23

43

66

35

43

78

24

37

61

133

149

282

Other includes diagnoses such as, but not limited to, the following: Bipolar Disorder, Dementia, Psychotic
Disorder NOS, Pervasive Developmental Disorder, Impulse Control Disorder, and Asperger’s.
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Table 5
Relationship Between Axis II Diagnosis and Service Use (N=284)

Axis II Diagnosis
Borderline
Paranoid
Antisocial
Other4
NOS
No Axis II diagnosis (None)
Total

4

No
Service

Service
Use

Total

4

16

20

20

26

46

4

9

13

34

36

70

14
58

16
47

30
105

134

150

284

Other includes diagnoses such as, but not limited to, the following: Histrionic Personality Disorder,
Schizoid, and Borderline Intellectual Functioning.
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Table 6
Relationship Between Race and Service Use (N=288)
Race

No Service

Service Use

Total

111

127

238

23

27

50

134

154

288

Caucasian
Non-white
Total

Table 7
Relationship Between Marital Status and Service Use (N=272)
Marital Status
Single
Married
Divorced
Widowed
Separated
Total

No Service

Service Use

Total

75

96

171

10
34
3

11
35
1

21
69
4

6

1

7

128

144

272
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Table 8
Mean Scores and Standard Deviations for Demographic and Clinical Variables as a
Function of Service Use
No Service

Service Use

M

SD

M

SD

Age*

42.55

12.35

33.77

11.38

Length of Stay

581.39

411.34

699.20

490.81

Years of Education*

12.84

1.98

11.69

1.92

Age of Onset*

24.20

9.07

16.03

5.92

8.42

7.47

10.81

11.31

Number of Previous
Hospitalizations*
* P<.05
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Table 9
Bivariate Correlations for Neurocognitive Variables
1a

a

2

3

4

5

6

7

8

9

10

11

12

13

1 - RAVLT Trial
5

-

2 – NAB Total

.74

-

3 - COGLAB
Total Correct

.10

-a

-

4 - Card Sort
Random Errors

-.41
**

-.15

-.41
**

-

5 - Card Sort
Perseverative
Errors

-.36
**

-.05

-.43
**

.58
**

-

6 – Card Sort
Consolidation
Index

.23

-1.0
**

-.10

-.13

.12

-

7 - RCFT Copy

1.0
**

.24

a

-.30
*

-.03

.53

-

8 - RCFT
Immediate
Memory

1.0
**.

.55
**

a

-.53
**

-.42
**

-.26

.38
**

-

9 - RCFT
Delayed
Memory

. 1.0
**

.66
**

a

-.48
**

-.40
**

-.16

.41
**

.95
**

-

10 - RCFT
Recognition

-1.0
**

.36

a

-.29
*

-.17

-.45

-.05

.48
**

.50
**

-

11 - Trails A

.10

-.54
**

a

.22

.29
*

-.25

.01

-.23
*

-.30
*

-.06

-

12 -Trails B

-.45

-.61

a

.33
**

.32
*

.20

-.14

-.32
**

-.38
**

-.03

.54
**

-

13 –
COWAT/FAS

-.56

.56
**

a

-.38
**

-.23

-.17

.35
**

.37
**

.34
**

.08

-.32
**

-.27
**

-

14 - RBANS
Total

.30

.53
*

a

-.31
*

-.22

.06

.48
**

.52
**

.55
**

.25
*

-.15

-.29
**

.41
**

14

-

Note: The RAVLT was phased out of regular use at CTP when the Rey Complex Figure Test and RBANS battery
were added. As can be seen here, there were no participants with assessments from both time periods from which to
compute correlations.
** Correlation is significant at the 0.01 level (1-tailed).
* Correlation is significant at the 0.05 level (1-tailed).
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Table10
Service Use by Neurocognitive Variables at Admission
One-Way Analyses of Variance (ANOVAs)
Univariate
Neurocognitive Variables
RAVLT
No Service
Service Use
NAB Total
No Service
Service Use
WCST Correct
No Service
Service Use
WCST Perseverative Errors
No Service
Service Use
WCST Random Errors
No Service
Service Use
WCST Consolidation Index
No Service
Service Use
RCFT Copy
No Service
Service Use
RCFT Immediate Memory
No Service
Service Use
RCFT Delayed Memory
No Service
Service Use
RCFT Recognition
No Service
Service Use
Trails A
No Service
Service Use
Trails B
No Service
Service Use
COWAT/FAS
No Service
Service Use
RBANS Total
No Service
Service Use

M(SD)

F

df

p

8.07 (3.73)
8.47 (3.30)

.18

1, 55

.68

82.10 (17.06)
79.08 (18.00)

.53

1, 76

.47

24.63 (2.01)
24.75 (1.02)

.09

1, 60

.77

22.13 (13.01)
20.51 (12.26)

.44

1, 106

.51

23.58 (16.65)
22.85 (18.27)

.05

1, 106

.83

3.46 (4.64)
2.57 (4.31)

.61

1, 60

.44

29.03 (7.21)
29.33 (6.00)

.04

1, 71

.84

12.76 (7.09)
14.32 (9.60)

.63

1, 71

.43

12.68 (6.68)
13.80 (9.55)

.34

1, 71

.56

20.54 (6.16)
18.17 (4.87)

3.33

1, 71

.07

41.71 (14.59)
42.99 (25.71)

.11

1, 114

.74

105.14 (47.61)
125.24 (81.07)

2.65

1, 114

.11

30.97 (11.19)
29.32 (10.57)

.66

1, 113

.42

75.50 (16.89)
69.74 (14.06)

3.13

1, 92

.08
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Table 11
APP Severity Level by Neurocognitive Variables at Admission

One-Way Analyses of Variance (ANOVAs)
Univariate

Neurocognitive Variables
RAVLT
No APP
Low APP
Med APP
High APP
NAB Total
No APP
Low APP
Med APP
High APP
WCST Correct
No APP
Low APP
Med APP
High APP
WCST Perseverative Errors
No APP
Low APP
Med APP
High APP
WCST Random Errors
No APP
Low APP
Med APP
High APP
WCST Consolidation Index
No APP
Low APP
Med APP
High APP
RCFT Copy
No APP
Low APP
Med APP
High APP
RCFT Immediate Memory
No APP
Low APP
Med APP
High APP
RCFT Delayed Memory
No APP
Low APP
Med APP
High APP
RCFT Recognition
No APP

M(SD)
8.07 (3.73)
8.71 (4.07)
9.57 (2.76)
7.88 (3.22)
82.10 (17.06)
70.00 (13.11)
87.25 (18.66)
78.95 (18.25)
24.63 (2.01)
25.00 (0.00)
25.00 (0.00)
24.50 (1.41)
22.13 (13.01)
21.50 (11.02)
17.25 (14.87)
21.45 (11.68)
23.58 (16.65)
23.88 (7.79)
13.25 (11.23)
26.09 (20.98)
3.46 (4.64)
1.31 (1.23)
4.50 (6.58)
2.03 (3.38)
29.03 (7.21)
30.07 (3.40)
28.06 (8.38)
29.57 (5.84)
12.76 (7.09)
14.21 (4.72)
18.56 (16.09)
12.74 (7.36)
12.68 (6.68)
12.14 (4.72)
17.56 (16.10)
12.91 (7.39)
20.54 (6.16)
18.14 (3.08)

F

df

p

.45

3, 53

.72

.73

3, 74

.54

.29

3, 58

.83

.49

3, 104

.69

1.66

3, 104

.18

1.04

3, 58

.38

.15

3, 69

.93

1.15

3, 69

.34

.85

3, 69

.47

2.18

3, 69

.10
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Low APP
Med APP
High APP
Trails A
No APP
Low APP
Med APP
High APP
Trails B
No APP
Low APP
Med APP
High APP
COWAT/FAS
No APP
Low APP
Med APP
High APP
RBANS Total
No APP
Low APP
Med APP
High APP

21.13 (8.11)
17.05 (3.28)

41.71 (14.59)
52.25 (25.14)
35.08 (15.67)
45.71 (30.05)
105.14 (47.61)
122.75 (80.44)
111.21 (70.12)
134.48 (88.39)
30.97 (11.19)
28.11 (9.61)
30.67 (12.93)
28.87 (9.50)
75.50 (16.89)
75.00 (15.04)
70.91 (14.80)
67.35 (13.43)

1.72

3, 112

.17

1.36

3, 112

.26

.36

3, 111

.78

1.53

3, 90

.21
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Table 12
Bivariate Correlations for Socialcognitive Variables
1
1 - Hinting
Task
2 – FKK
Internal

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

-.03

-

3 - FKK Self
Concept

.06

.28
*

-

4 - FKK Self
Efficacy

..01

.86
**

.73
**

-

5 - FKK
Powerful
Others

.09

.07

-.11

-.01

-

6 – FKK
Chance

-.01

.09

-.45
**

-.21

.66
**

-

7 - FKK
Externality

.05

.08

-.33
**

-.12

.92
**

.91
**

-

8 - IPSAQ
Internal
Positive

-.00

.25
*

.25
*

.31
*

.09

.02

.06

-

9 - IPSAQ
Personal
Positive

.
.26
*

-.15

-.12

-.17

.15

.22

.20

-.13

-

10 - IPSAQ
Situational
Positive

.19

.22

.19

.26
*

.08

-.05
*

.02

-.39
**

-.30
*

-

11 - IPSAQ
Internal
Negative

-.03

.10

-.18

-.03

.05

.24
*

.16

.48
**

.09

-.22

-

12 - IPSAQ
Personal
Negative

.30
*

.004

.30
*

.17

-.09

-.17

-.14

.16

.41
**

-.09

-.37
**

-

13 – IPSAQ
Situational
Negative

.02

.31
*

.23

.34
**

.32
*

.07

.21

-.03

-.22

.56
**

-.35
**

-.24

-

14 - CST
Social
Support
Seeking

.03

-.03

-.11

-.08

-.18

-.12

-.17

.06

.19

-.10

.18

-.12

-.01

-

15 - CST
SelfControlling

.04

.05

.41
**

.26
*

.01

-.22

-.12

.26
*

-.01

-.12

-.07

.13

.15

-.11

-

16 - CST
Escape
Avoidance

.16

.08

.28
*

.20

-.39
**

-.47
**

-.47
**

-.21

.05

.14

-.16

.10

.03

.10

.37
**

-

17 - CST
Planful
Problem
Solving

-.01

.09

.40
**

.28
*

-.13

-.45
**

-.31
*

.02

.12

.15

-.23

.16

.31
*

.34
*

.43
**

.30
*

** Correlation is significant at the 0.01 level (1-tailed).
* Correlation is significant at the 0.05 level (1-tailed).

-
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Table 13
Service Use by Theory of Mind, Social Cognition at Admission One-Way Analyses of Variance (ANOVAs)

Theory of Mind Measure
Hinting Task
No Service
Service Use
Socialcognition Measures
FKK Internal
No Service
Service Use
FKK Self Concept
No Service
Service Use
FKK Self Efficacy
No Service
Service Use
FKK Powerful Others
No Service
Service Use
FKK Chance
No Service
Service Use
FKK Externality
No Service
Service Use
IPSAQ Internal Positive
No Service
Service Use
IPSAQ Personal Positive
No Service
Service Use
IPSAQ Situational Positive
No Service
Service Use
IPSAQ Internal Negative
No Service
Service Use
IPSAQ Personal Negative
No Service
Service Use
IPSAQ Situational Negative
No Service
Service Use
CST Social Support Seeking
No Service
Service Use
CST Self-Controlling
No Service
Service Use
CST Escape Avoidance
No Service
Service Use
CST Planful Problem Solving
No Service
Service Use

M(SD)

F

df

p

15.12 (3.32)
14.36 (3.81)

1.06

1, 92

.31

34.41 (7.18)
34.00 (5.33)

.04

1, 43

.84

33.56 (4.71)
32.94 (5.16)

.17

1, 43

.68

67.96 (9.95)
66.94 (7.80)

.13

1, 43

.72

25.96 (8.80)
24.78 (6.51)

.24

1, 43

.63

23.48 (7.20)
25.17 (7.80)

.55

1, 43

.46

49.44 (15.53)
49.94 (11.60)

.01

1, 43

.91

8.19 (3.50)
7.89 (2.78)

.09

1, 43

.77

3.52 (2.39)
3.56 (1.92)

.00

1, 43

.96

3.26 (2.35)
3.78 (2.90)

.44

1, 43

.51

5.89 (3.77)
5.89 (2.93)

.00

1, 43

1.0

4.89 (3.48)
4.89 (2.83)

.00

1, 43

1.0

4.07 (2.80)
4.50 (3.13)

.23

1, 43

.64

35.58 (9.99)
36.61 (10.03)

.11

1, 42

.74

52.65 (6.97)
48.44 (10.44)

2.58

1, 42

.12

37.12 (6.73)
35.44 (4.53)

.84

1, 42

.36

42.08 (8.85)
41.89 (10.02)

.00

1, 42

.95
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Table 14
APP Level by Theory of Mind and Social Cognitive Functioning at Admission
One-Way Analyses of Variance (ANOVAs)
F
df
M(SD)
Theory of Mind Measure
Hinting Task
No APP
15.12 (3.32)
Low APP
13.71 (1.98)
0.52
3, 90
Med APP
15.00 (3.46)
High APP
14.31 (3.55)
Socialcognition Measures
FKK Internal
No APP
34.41 (7.18)
34.43 (5.56)
.12
3, 41
Low APP
Med APP
34.67 (5.75)
High APP
32.60 (5.41)
FKK Self Concept
No APP
33.56 (4.71)
Low APP
32.71 (5.19)
.06
3, 41
Med APP
33.17 (5.95)
High APP
33.00 (5.34)
FKK Self Efficacy
No APP
67.96 (9.95)
Low APP
67.14 (7.71)
.10
3, 41
Med APP
67.83 (9.66)
High APP
65.60 (6.99)
FKK Powerful Others
No APP
25.96 (8.80)
Low APP
25.71 (4.54)
.19
3, 41
25.17 (8.31)
Med APP
High APP
23.00 (7.58)
FKK Chance
No APP
23.48 (7.20)
Low APP
24.29 (8.32)
.23
3, 41
Med APP
26.00 (9.59)
High APP
25.40 (6.11)
FKK Externality
No APP
49.44 (15.53)
.04
3, 41
Low APP
50.00 (10.61)
Med APP
51.17 (16.51)
High APP
48.40 (7.57)
IPSAQ Internal Positive
No APP
8.19 (3.50)
Low APP
9.00 (3.32)
.53
3, 41
Med APP
6.83 (2.64)
High APP
7.60 (1.95)
IPSAQ Personal Positive
No APP
3.52 (2.39)
Low APP
2.71 (2.22)
Med APP
4.50 (2.07)
.70
3, 41
High APP
3.60 (0.55)
IPSAQ Situational Positive
No APP
3.26 (2.35)
Low APP
3.29 (2.43)
.39
3, 41
3.67 (4.27)
Med APP
High APP
4.60 (1.67)
IPSAQ Internal Negative
No APP
5.89 (3.77)
Low APP
6.00 (3.37)
.01
3, 41
Med APP
5.67 (3.33)
High APP
6.00 (2.35)

p

.67

.95

.98

.96

.90

.87

.99

.67

.56

.76

1.0
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IPSAQ Personal Negative
No APP
Low APP
Med APP
High APP
IPSAQ Situational Negative
No APP
Low APP
Med APP
High APP
CST Social Support Seeking
No APP
Low APP
Med APP
High APP
CST Self-Controlling
No APP
Low APP
Med APP
High APP
CST Escape Avoidance
No APP
Low APP
Med APP
High APP
CST Planful Problem Solving
No APP
Low APP
Med APP
High APP

4.89 (3.48)
4.29 (3.04)
4.50 (3.27)
6.20 (1.92)
4.07 (2.80)
4.43 (4.35)
5.17 (2.71)
3.80 (1.64)
35.58 (9.99)
37.29 (8.40)
37.17 (13.17)
35.00 ( 10.03)
52.65 (6.97)
51.00 (5.60)
51.17 (6.08)
41.60 (16.99)
37.12 (6.73)
34.86 (2.19)
36.50 (5.58)
35.00 (6.21)
42.08 (8.85)
40.57 (3.99)
45.67 (14.50)
39.20 (10.31)

.38

3, 41

.77

.27

3, 41

.85

.09

3, 40

.96

2.49

3, 40

.07

.36

3, 40

.78

.51

3, 40

.68
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Table 15
Bivariate Correlations for Insight Variables
1
1- Total Insight

2

3

4

5

6

7

-

2 - Ability to relabel
psychotic experiences

.73
**

-

3 - Awareness of Illness

.89
**

.45
**

-

4 - Need for Treatment

.83
**

.39
**

.72
**

-

5 - SAIQ Need for Treatment

.80
**

.76
**

.76
**

.57
**

-

6 - SAIQ Worry

-.80
**

-.77
**

-.77
**

-.57
**

-.95
**

-

7 - SAIQ Presence/Outcome of
Illness

-.80
**

-.77
**

-.77
**

-.58
**

-.98
**

.95
**

** Correlation is significant at the 0.01 level (1-tailed).
* Correlation is significant at the 0.05 level (1-tailed).

-
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Table 16
Service Use by Insight Measures at Admission One-Way Analyses of Variance (ANOVAs)

Insight Measures
IS Relabel Symptoms Scale
No Service
Service Use
IS Awareness of Illness Scale
No Service
Service Use
IS Need for Treatment Scale
No Service
Service Use
IS Total Score
No Service
Service Use
SAIQ Need for Treatment
No Service
Service Use
SAIQ Worry
No Service
Service Use
SAIQ Presence/Outcome of Illness
No Service
Service Use

M(SD)

F

df

p

2.46 (1.11)
2.42 (1.15)

.05

1, 107

.82

2.34 (1.37)
2.25 (1.28)

.14

1, 107

.71

2.37 (1.17)
2.27 (1.19)

.17

1, 107

.68

7.17 (3.11)
6.86 (2.91)

.29

1, 107

.59

6.10 (6.67)
1.71 (4.54)

2.27

1, 15

.15

26.90 (8.63)
31.71 (8.69)

1.27

1, 15

.28

12.20 (3.05)
14.29 (1.89)

2.56

1, 15

.13
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Table 17
APP Level by Insight Measures at Admission One-Way Analyses of Variance (ANOVAs)

Insight Measures
IS Relabel Symptoms Scale
No APP
Low APP
Med APP
High APP
IS Awareness of Illness Scale
No APP
Low APP
Med APP
High APP
IS Need for Treatment Scale
No APP
Low APP
Med APP
High APP
IS Total Score
No APP
Low APP
Med APP
High APP
SAIQ Need for Treatment
No APP
Low APP
Med APP
High APP
SAIQ Worry
No APP
Low APP
Med APP
High APP
SAIQ Presence/Outcome of Illness
No APP
Low APP
Med APP
High APP

M(SD)

F

df

p

2.46 (1.11)
2.44 (1.60)
1.80 (.92)
2.59 (1.05)

1.29

3, 105

.28

1.19

3, 105

.32

2.37 (1.17)
2.72 (.97)
1.75 (.79)
2.31 (1.30)

1.17

3, 105

.32

7.17 (3.11)
7.83 (3.30)
5.15 (1.76)
7.10 (2.94)

1.59

3, 105

.20

6.10 (6.67)
6.00 (8.49)
0.00 (0)
0.00 (0)

1.20

3, 13

.35

1.32

3, 13

.31

1.21

3, 13

.35

2.34 (1.37)
2.67 (1.32)
1.60 (1.26)
2.32 (1.25)

26.90 (8.63)
23.50 (16.26)
35.00 (0.0)
35.00 (0.0)
12.20 (3.05)
12.50 (3.54)
15.00 (0.0)
15.00 (0.0)
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Table 18
Bivariate Correlations of NOSIE subscales
1

2

3

4

5

6

1 – NOSIE Daily Schedule
Competence

-

2 – NOSIE Social Interest

.46**

-

3 – NOSIE Neatness

.79 **

.50**

-

4 – NOSIE Irritability

-.65**

-.29**

-.49**

-

5 – NOSIE Psychoticism

-.51**

-.24**

-.39**

.50**

-

6 – NOSIE Motor Retardation

-.73**

-.52**

-.68**

.25**

.21*

-

7 – NOSIE Total

.88**

.67**

.84**

-.69**

-.54**

.74**

** Correlation is significant at the 0.01 level (2-tailed).
* Correlation is significant at the 0.05 level (2-tailed).

7

-
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Table 19
Service Use by NOSIE scales scores at Admission One-Way Analyses of Variance
(ANOVAs)

NOSIE Subscales
Daily Schedule Competence
No Service
Service Use

M (SD)

F

df

p

33.57 (6.81)
31.84 (6.72)

1.98

1, 119

.16

15.66 (6.45)
15.53 (6.92)

.01

1, 119

.92

23.77 (5.50)
22.50 (5.77)

1.54

1, 119

.22

4.00 (5.10)
5.48 (6.52)

1.95

1, 119

.17

1.41 (2.66)
1.66 (2.61)

.28

1, 119

.60

5.93 (4.13)
6.82 (4.53)

1.29

1, 119

.26

157. 68 (24.13)
150.50 (26.26)

2.46

1, 119

.12

Social Interest
No Service
Service Use

Neatness
No Service
Service Use

Irritability
No Service
Service Use

Psychoticism
No Service
Service Use

Motor Retardation
No Service
Service Use
NOSIE Total Score
No Service
Service Use
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Table 20
APP Level by NOSIE scale scores at Admission One-Way Analyses of Variance
(ANOVAs)

NOSIE Subscales
Daily Schedule Competence
No APP
Low APP
Med APP
High APP

M (SD)

F

df

p

33.57 (6.81)
31.79 (8.59)
30.96 (5.96)
32.50 (5.89)

.82

3, 117

.49

15.66 (6.45)
14.72 (6.92)
14.97 (6.79)
16.49 (7.18)

.29

3, 117

.83

23.77 (5.50)
21.60 (6.67)
20.73 (5.23)
24.40 (5.08)

2.18

3, 117

.09

4.00 (5.10)
5.67 (7.15)
4.00 (5.09)
6.38 (7.01)

1.21

3, 117

.31

1.41 (2.66)
1.57 (2.40)
1.84 (3.48)
1.60 (2.12)

.13

3, 117

.94

2.70

3, 117

.05

1.60

3, 117

.19

Social Interest
No APP
Low APP
Med APP
High APP

Neatness
No APP
Low APP
Med APP
High APP

Irritability
No APP
Low APP
Med APP
High APP

Psychoticism
No APP
Low APP
Med APP
High APP

Motor Retardation
No APP
Low APP
Med APP
High APP
NOSIE Total Score
No APP
Low APP
Med APP
High APP

5.93 (4.13)
7.61 (5.84)
8.42 (4.40)
5.14 (2.90)
157. 68 (24.13)
144.50 (32.32)
148.40 (21.92)
156.24 (24.17)
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Table 21
Bivariate Correlations of BPRS Total Scores, BPRS Factor Scores, and Symptomatology
Measures
1

2

3

4

5

6

7

8

9

10

11

12

13

14

1. BPRS Total
22 2. Psychotic
Disorganization
3.
Hallucinations/
Delusions
4. Paranoia

5. Emotional
Blunting
6.Anxiety/
Depression
7. Agitation/
Elation
8. BHS Total

9. BDI-II Total
10. SPS Total

11. SPS
Hopelessness
Scale
12. SPS
Suicidality
Scale
13. SPS
Negative SelfEvaluation
Scale
14. SPS
Hostility Scale

.75
**

-

.75
**

.53*
*

-

.75
**

.48*
*

.52
**

-

.19
*

.07

-.04

-.05

-

.56
**

.12

.24
**

.40
**

-.05

-

.44
**

.32*
*

.29
**

.27
**

-.33
**

.35
**

-

.32
**

.07

.14

.18

.25
*

.35
**

-.13

-

.26
*

.15

.13

.09

.20

.28
*

-.16

.70
**

-

.46
**

.26*

.30
*

.28
*

.21

.29
*

.15

.59
**

.62
**

-

.37
**

.15

.26
*

.21

.17

.30
*

.02

.43
**

.63
**

.80
**

-

.40
**

.27*

.23

.19

.19

.25
*

.08

.32
**

.55
**

.66
**

.74
**

-

.11

.14

.10

.08

.08

-.02

-.09

.37
**

.27
**

.50
**

.38
**

.49
**

-

.21

.08

.12

.03

.19

.16

.13

.36
**

.48
**

.64
**

.71
**

.60
**

.42
**

** Correlation is significant at the 0.01 level (2-tailed).
* Correlation is significant at the 0.05 level (2-tailed).

-
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Table 22
Service Use by BPRS Factor Scores, BPRS Total, and Symptomatology Measures at Admission
One-Way Analyses of Variance (ANOVAs)

BPRS Total
No Service
Service Use
BPRS Factor Scores
Psychotic Disorganization
No Service
Service Use
Emotional Blunting
No Service
Service Use
Paranoia
No Service
Service Use
Anxiety/Depression
No Service
Service Use
Hallucinations/Delusions
No Service
Service Use
Agitation/Elation
No Service
Service Use
BHS Total
No Service
Service Use
BDI-II Total
No Service
Service Use
SPS Total
No Service
Service Use
SPS Hopelessness Scale
No Service
Service Use
SPS Suicidality Scale
No Service
Service Use
SPS Negative Self-Evaluation Scale
No Service
Service Use
SPS Hostility Scale
No Service
Service Use

M (SD)

F

df

p

47.60 (12.15)
48.29 (14.62)

.10

1, 154

.75

6.35 (2.76)
6.84 (3.37)

.99

1, 154

.32

5.96 (3.65)
6.07 (3.29)

.04

1, 155

.85

9.00 (3.21)
8.14 (3.36)

2.65

1, 155

.11

9.03 (3.46)
9.90 (4.12)

2.03

1, 155

.16

6.71 (4.08)
6.39 (4.17)

.23

1, 155

.63

3.49 (1.55)
3.82 (1.79)

1.51

1, 155

.22

4.24 (4.55)
5.58 (5.19)

2.22

1, 118

.14

9.33 (10.10)
12.96 (13.82)

2.20

1, 99

.14

56.02 (10.19)
61.02 (10.22)

7.41

1, 122

.01

53.33 (10.42)
57.48 (13.09)

3.76

1, 122

.05

51.41 (8.74)
54.35 (13.65)

1.97

1, 122

.16

.19

1, 121

.67

3.30

1, 121

.07

59.48 (9.79)
58.60 (12.56)
52.81 (10.57)
56.88 (13.81)
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Table 23
APP Level by BPRS Factor Scores, BPRS Total, and Symptomatology Measures at
Admission One-Way Analyses of Variance (ANOVAs)
M (SD)
BPRS Total
No APP
Low APP
Med APP
High APP
BPRS Factor Scores
Psychotic Disorganization
No APP
Low APP
Med APP
High APP
Emotional Blunting
No APP
Low APP
Med APP
High APP
Paranoia
No APP
Low APP
Med APP
High APP
Anxiety/Depression
No APP
Low APP
Med APP
High APP
Hallucinations/Delusions
No APP
Low APP
Med APP
High APP
Agitation/Elation
No APP
Low APP
Med APP
High APP

47.60 (12.15)
45.96 (11.94)
46.91 (14.91)
49.34 (15.28)

6.35 (2.76)
6.70 (3.59)
6.52 (2.94)
6.98 (3.51)
5.97 (3.65)
6.92 (2.71)
5.47 (2.76)
6.06 (3.58)
9.00 (3.21)
7.58 (3.83)
8.14 (3.52)
8.28 (3.24)
9.03 (3.46)
8.42 (2.95)
9.94 (4.64)
10.25 (4.18)
6.71 (4.08)
6.15 (3.48)
5.97 (3.53)
6.59 (4.56)
3.49 (1.55)
3.23 (1.20)
4.15 (1.89)
3.86 (1.88)

F

df

p

.32

3, 152

.81

.43

3, 152

.73

.44

3, 153

.72

1.03

3, 153

.38

1.48

3, 153

.22

.19

3, 153

.91

1.26

3, 153

.29

1.54

3, 116

.21

1.84

3, 97

.14

BHS Total
No APP
Low APP
Med APP
High APP

4.24 (4.55)
5.69 (6.20)
7.38 (3.93)
4.98 (5.18)

BDI-II Total
No APP
Low APP
Med APP

9.33 (10.10)
11.71 (14.84)
18.91 (15.75)
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High APP

11.37 (12.43)

SPS Total
No APP
Low APP
Med APP
High APP

56.02 (10.19)
58.43 (11.32)
64.50 (8.40)
60.68 (10.31)

3.34

3, 120

.02

1.57

3, 120

.20

.65

3, 120

.58

.20

3, 119

.89

1.53

3, 119

.21

SPS Hopelessness Scale
No APP
Low APP
Med APP
High APP

53.33 (10.42)
56.71 (13.63)
60.29 (12.95)
56.74 (13.16)

SPS Suicidality Scale
No APP
Low APP
Med APP
High APP

51.41 (8.74)
54.64 (10.95)
54.00 (15.51)
54.37 (14.17)

SPS Negative Self-Evaluation
Scale
No APP
Low APP
Med APP
High APP

59.48 (9.79)
58.14 (9.67)
57.00 (15.58)
59.32 (12.64)

SPS Hostility Scale
No APP
Low APP
Med APP
High APP

52.81 (10.57)
57.71 (10.77)
59.92 (16.73)
55.53 (13.89)
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Table 24
Service Use by BPRS Items at admission One-Way Analyses of Variance (ANOVAs)
BPRS Items
Somatic Concern
Anxiety
Depression
Suicidality
Guilt
Hostility
Elevated Mood
Grandiosity
Suspiciousness
Hallucinations
Unusual Thought Content
Bizarre Behavior
Self-Neglect
Disorientation
Conceptual Disorganization
Blunted Affect
Emotional Withdrawal
Motor Retardation
Tension
Uncooperativeness
Excitement
Distractibility
Motor hyperactivity
Mannerisms and Posturing

*p<.05

No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use
No Service
Service Use

M (SD)
2.50 (1.63)
2.36 (1.57)
2.63 (1.40)
2.72 (1.62)
2.19 (1.19)
2.52 (1.53)
1.23 (0.62)
1.79 (1.37)
1.84 (1.24)
2.19 (1.37)
2.53 (1.59)
2.70 (1.74)
1.51 (0.96)
1.61 (1.25)
2.13 (1.82)
1.63 (1.52)
2.77 (1.80)
2.33 (1.58)
1.87 (1.55)
2.41 (1.97)
2.71 (1.99)
2.35 (1.96)
1.93 (1.49)
2.25 (1.61)
2.05 (0.94)
2.39 (1.24)
1.33 (0.70)
1.45 (0.90)
2.06 (1.40)
1.88 (1.43)
2.54 (1.48)
2.59 (1.30)
2.25 (1.41)
2.18 (1.21)
2.00 (1.17)
2.01 (1.19)
1.75 (1.16)
1.55 (0.85)
1.83 (1.23)
1.49 (0.91)
1.63 (1.12)
1.40 (0.93)
1.78 (1.15)
1.93 (1.33)
1.37 (0.88)
1.30 (0.73)
1.17 (0.55)
1.20 (0.58)

F

df

p

.30

1, 156

.59

.14

1, 156

.71

2.19

1, 156

.14

10.36

1, 156

.002*

2.85

1, 156

.09

.42

1, 156

.52

.32

1, 156

.57

3.54

1, 156

.06

2.63

1, 156

.11

3.66

1, 156

.06

1.29

1,156

.23

1.60

1, 156

.21

3.55

1, 156

.06

.92

1, 155

.34

.65

1, 155

.42

.04

1, 155

.84

.11

1, 155

.74

.01

1, 155

.94

1.53

1, 155

.22

3.91

1, 155

.05*

1.99

1, 155

.16

.54

1, 155

.46

.23

1, 155

.63

.11

1, 155

.74
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Table 25
APP Severity Level by BPRS Items at admission One-Way Analyses of Variance
(ANOVAs)

BPRS Items
Somatic Concern

Anxiety

Depression

Suicidality

Guilt

Hostility

Elevated Mood

Grandiosity

Suspiciousness

Hallucinations

Unusual Thought Content

Bizarre Behavior

Self-Neglect

Disorientation

Conceptual Disorganization

M (SD)
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP

2.50 (1.63)
1.77 (0.93)
2.12 (1.55)
2.58 (1.67)
2.63 (1.40)
2.19 (1.15)
2.74 (2.06)
2.84 (1.56)
2.19 (1.19)
2.35 (1.55)
2.38 (1.57)
2.60 (1.54)
1.23 (0.62)
1.15 (0.56)
1.94 (1.35)
1.90 (1.49)
1.84 (1.24)
1.77 (1.09)
2.29 (1.56)
2.26 (1.37)
2.53 (1.59)
2.00 (1.29)
2.68 (1.88)
2.88 (1.77)
1.51 (0.96)
1.35 (0.75)
1.76 (1.47)
1.62 (1.29)
2.13 (1.82)
1.54 (1.39)
1.65 (1.69)
1.65 (1.52)
2.77 (1.80)
2.42 (1.66)
2.24 (1.52)
2.34 (1.61)
1.87 (1.55)
1.92 (1.80)
2.29 (1.90)
2.57 (2.05)
2.71 (1.99)
2.69 (1.97)
2.03 (2.04)
2.37 (1.96)
1.93 (1.49)
2.35 (1.75)
2.12 (1.69)
2.26 (1.58)
2.05 (0.94)
2.08 (0.95)
2.71 (1.23)
2.36 (1.30)
1.33 (0.70)
2.08 (1.50)
1.21 (0.47)
1.38 (0.76)
2.06 (1.40)
2.23 (1.59)
1.88 (1.46)
1.79 (1.39)

F

df

p

1.18

3, 154

.32

.68

3, 154

.57

.91

3, 154

.44

5.34

3, 154

.002*

1.49

3, 154

.22

1.11

3, 154

.35

.45

3, 154

.72

1.18

3, 154

.32

.90

3, 154

.45

1.70

3, 154

.17

.71

3,153

.55

.59

3, 154

.63

2.01

3, 154

.11

3.73

3, 153

.01*

.55

3, 153

.65
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Blunted Affect

Emotional Withdrawal

Motor Retardation

Tension

Uncooperativeness

Excitement

Distractibility

Motor hyperactivity

Mannerisms and Posturing

*p<.05

No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP

2.54 (1.48)
3.00 (1.29)
2.38 (1.17)
2.55 (1.34)
2.25 (1.41)
2.38 (1.12)
2.03 (1.07)
2.17 (1.28)
2.00 (1.17)
2.15 (1.07)
1.82 (1.03)
2.04 (1.28)
1.75 (1.16)
1.54 (0.88)
1.56 (.97)
1.56 (.81)
1.83 (1.23)
1.62 (1.12)
1.53 (1.13)
1.45 (0.78)
1.63 (1.12)
1.23 (0.45)
1.53 (1.18)
1.40 (0.94)
1.78 (1.15)
1.54 (0.78)
1.56 (0.86)
2.14 (1.52)
1.37 (0.88)
1.31 (0.63)
1.41 (1.00)
1.27 (0.65)
1.17 (0.55)
1.31 (0.63)
1.06 (0.24)
1.23 (0.64)

.53

3, 153

.66

.22

3, 153

.88

.22

3, 153

.89

.50

3, 153

.68

1.38

3, 153

.25

.86

3, 153

.46

1.64

3, 153

.18

.21

3, 153

.89

.58

3, 152

.63

202

Table 26
Service Use by WCST Repeated Measures ANOVAs

WCST
Correct

Measures
WCST
WCST
Perseverative
Random
Errors
Errors

WCST
Consolidation
Index

F (2,72)

F (2,112)

F (2, 112)

F (2, 72)

Main Effect
Assessment Time

.66

2.53

3.66*

1.92

Main Effect
Service Use

1.35

5.13*

.71

.71

Interaction
Assessment Time * Service Use

.64

1.36

.84

.10

Variable

*p<.05, **p<.01, ***p<.001

Table 27
Service Use by Neurocognition Measures
Repeated Measures ANOVAs
Measures
RAVLT

Variable
Main Effect
Assessment Time
Main Effect
Service Use
Interaction
Assessment Time *
Service Use

NAB
Total

Trails A

Trails B

COWAT/
FAS

RBANS
Total

F (2,18)

F (2,26)

F (2, 110)

F (2, 112)

F (2, 114)

F (2, 108)

.24

1.74

.51

.12

1.91

9.82***

2.19

.28

.004

.20

.06

1.67

5.25*

.47

3.38*

.53

3.02*

3.65*

*p<.05, **p<.01, ***p<.001
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Table 28
Service Use by RCFT Repeated Measures ANOVAs

Variable
Main Effect
Assessment Time
Main Effect
Service Use
Interaction
Assessment Time *
Service Use

Measures
RCFT
Delayed
Memory

RCFT
Copy

RCFT
Immediate
Copy

F (2,60)

F (2,60)

F (2, 60)

F (2, 60)

1.75

4.62**

4.89**

.55

.32

3.60

1.69

.04

.19

1.37

.13

.63

RCFT
Recognition

*p<.05, **p<.01, ***p<.001

Table 29
Mean Scores and Standard Deviations for WCST Correct Scores at Admission, 6 Months,
and 12 Months as a Function of Service Use Before Age 18
WCST Correct Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

24.35 (2.67)

23.41 (4.23)

23.94 (3.31)

Service Use

24.86 (.66)

24.81 (.87)

24.33 (2.83)

Services Before Age 18
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Table 30
Mean Scores and Standard Deviations for WCST Perseverative Errors Scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
WCST Perseverative Errors Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

24.52 (13.52)

30.70 (18.50)

24.93 (15.98)

Service Use

22.10 (11.41)

21.52 (12.09)

17.94 (11.23)

Services Before Age 18

Table 31
Mean Scores and Standard Deviations for WCST Random Errors Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
WCST Random Error Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

27.89 (15.98)

29.81 (18.19)

21.74 (18.47)

Service Use

24.90 (18.71)

25.26 (17.51)

20.23 (17.51)

Services Before Age 18

Table 32
Mean Scores and Standard Deviations for WCST Consolidation Index Scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
WCST Consolidation Index Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

4.59 (5.77)

4.58 (8.42)

11.87 (32.49)

Service Use

2.84 (4.90)

2.74 (3.21)

7.43 (19.47)

Services Before Age 18
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Table 33
Mean Scores and Standard Deviations for RAVLT Scores at Admission, 6 Months, and
12 Months as a Function of Service Use Before Age 18
RAVLT Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

6.80 (3.19)

5.80 (3.11)

8.20 (3.27)

Service Use

9.00 (2.19)

10.33 (3.14)

8.50 (2.51)

Services Before Age 18

Table 34
Mean Scores and Standard Deviations for NAB Total Scores at Admission, 6 Months, and
12 Months as a Function of Service Use Before Age 18
NAB Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

70.00 (10.23)

75.00 (3.74)

77.75 (9.32)

Service Use

75.91 (15.98)

80.09 (14.96)

78.27 (14.16)

Services Before Age 18

Table 35
Mean Scores and Standard Deviations for Trails A Scores at Admission, 6 Months, and
12 Months as a Function of Service Use Before Age 18
Trails A Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

42.88 (14.57)

50.30 (19.59)

43.03 (14.97)

Service Use

47.04 (28.23)

42.76 (30.58)

45.24 (38.51)

Services Before Age 18

206
Table 36
Mean Scores and Standard Deviations for Trails B Scores at Admission, 6 Months, and
12 Months as a Function of Service Use Before Age 18
Trails B Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

107.84 (48.26)

112.83 (58.77)

112.03 (93.06)

Service Use

126.91 (84.19)

112.66 (94.25)

117.02 (86.00)

Services Before Age 18

Table 37
Mean Scores and Standard Deviations for COWAT/FAS Scores at Admission, 6 Months,
and 12 Months as a Function of Service Use Before Age 18
COWAT/FAS Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

30.71 (9.45)

26.75 (12.70)

28.82 (8.87)

Service Use

26.74 (9.27)

27.68 (9.86)

30.32 (9.62)

Services Before Age 18

Table 38
Mean Scores and Standard Deviations for RBANS Total Scores at Admission, 6 Months,
and 12 Months as a Function of Service Use Before Age 18
RBANS Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

73.77 (15.39)

73.19 (13.49)

80.84 (16.03)

Service Use

68.32 (13.57)

72.60 (13.45)

73.04 (14.62)

Services Before Age 18
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Table 39
Mean Scores and Standard Deviations for RCFT Copy Scores at Admission, 6 Months,
and 12 Months as a Function of Service Use Before Age 18
RCFT Copy Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

29.85 (6.85)

28.46 (5.52)

29.85 (5.97)

Service Use

28.42 (5.95)

26.92 (7.38)

29.55 (6.38)

Services Before Age 18

Table 40
Mean Scores and Standard Deviations for RCFT Immediate Memory Scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
RCFT Immediate Memory Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

11.58 (5.20)

12.31 (5.53)

16.12 (6.85)

Service Use

15.82 (1.68)

15.76 (9.97)

29.92 (29.46)

Services Before Age 18

Table 41
Mean Scores and Standard Deviations for RCFT Delayed Memory Scores at Admission,
6 Months, and 12 Months as a Function of Service Use Before Age 18
RCFT Delayed Memory Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

12.12 (4.98)

11.88 (5.14)

15.23 (6.69)

Service Use

15.17 (11.66)

15.39 (9.43)

19.71 (11.14)

Services Before Age 18
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Table 42
Mean Scores and Standard Deviations for RCFT Recognition Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
RCFT Recognition Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

19.08 (2.53)

18.92 (1.71)

19.08 (2.84)

Service Use

18.21 (6.00)

19.68 (7.10)

19.95 (2.70)

Services Before Age 18

Table 43
APP Severity Level by WCST Repeated Measures ANOVAs

WCST
Correct

Variable
Main Effect
Assessment Time
Main Effect
APP Severity Level
Interaction
Assessment Time *
APP Severity Level

*p<.05, **p<.01, ***p<.001

Measures
WCST
WCST
Perseverative
Random
Errors
Errors

WCST
Consolidation
Index

F (6,68)

F (6,108)

F (6, 108)

F (6, 68)

.20

.73

1.81

.77

.54

2.66

1.87

.40

.26

1.09

1.30

.08
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Table 44
APP Severity Level by Neurocognition Measures
Repeated Measures ANOVAs
Measures
RAVLT

Variable
Main Effect
Assessment Time
Main Effect
APP Severity Level
Interaction
Assessment Time *
APP Severity Level

NAB
Total

Trails A

Trails B

COWAT/
FAS

RBANS
Total

F (4,16)

F (4,24)

F (6, 106)

F (6, 106)

F (6, 110)

F (6, 104)

.15

.39

.20

.56

1.16

6.37**

1.06

.30

1.58

.84

.09

.80

3.88*

1.40

1.28

.55

1.67

2.40*

*p<.05, **p<.01, ***p<.001

Table 45
Service Use by RCFT Repeated Measures ANOVAs

RCFT
Copy

Variable
Main Effect
Assessment Time
Main Effect
Service Use
Interaction
Assessment Time *
Service Use
*p<.05, **p<.01, ***p<.001

Measures
RCFT
RCFT
Immediate
Delayed
Copy
Memory

RCFT
Recognition

F (6,56)

F (6,56)

F (6, 56)

F (6, 56)

2.20

5.66*

6.23**

1.33

.80

1.27

.55

1.19

.25

1.76

2.14

1.46
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Table 46
Mean Scores and Standard Deviations for WCST Correct Scores at Admission, 6 Months,
and 12 Months as a Function of APP Severity Level
WCST Correct Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

24.35 (2.67)

23.41 (4.23)

23.94 (3.31)

Low APP

25.00 (.00)

25.00 (.00)

25.00 (.00)

Medium APP

25.00 (.00)

25.00 (.00)

24.80 (.45)

High APP

24.75 (.87)

24.67 (1.16)

23.92 (3.75)

APP Severity Level

Table 47
Mean Scores and Standard Deviations for WCST Perseverative Errors Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
WCST Perseverative Errors Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

24.52 (13.52)

30.70 (18.50)

24.93 (15.98)

Low APP

22.50 (11.79)

26.25 (6.19)

19.50 (12.77)

Medium APP

18.29 (11.80)

10.00 (6.56)

16.14 (14.68)

High APP

23.35 (11.52)

24.60 (12.14)

18.25 (10.18)

APP Severity Level
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Table 48
Mean Scores and Standard Deviations for WCST Random Errors Scores at Admission, 6
Months, and 12 Months as a Function of APP Severity Level
WCST Random Error Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

27.89 (15.98)

29.81 (18.19)

21.74 (18.47)

Low APP

23.00 (8.29)

40.50 (10.76)

22.00 (8.41)

Medium APP

14.00 (12.74)

9.71 (10.42)

17.71 (20.23)

High APP

29.10 (20.68)

27.65 (16.95)

20.75 (18.45)

APP Severity Level

Table 49
Mean Scores and Standard Deviations for WCST Consolidation Index Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
WCST Consolidation Index Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

4.59 (5.77)

4.58 (8.42)

11.87 (32.49)

Low APP

1.23 (.70)

1.14 (1.31)

1.85 (1.35)

Medium APP

5.31 (8.28)

4.17 (4.52)

8.87 (14.81)

High APP

2.36 (3.82)

2.67 (2.99)

8.69 (24.40)

APP Severity Level
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Table 50
Mean Scores and Standard Deviations for RAVLT Scores at Admission, 6 Months, and
12 Months as a Function of APP Severity Level
RAVLT Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

6.80 (3.19)

5.80 (3.11)

8.20 (3.27)

-

-

-

Medium APP

8.50 (2.12)

8.50 (3.54)

9.00 (1.41)

High APP

9.25 (2.50)

11.25 (2.99)

8.25 (3.10)

APP Severity Level
No APP
Low APP

Table 51
Mean Scores and Standard Deviations for NAB Total Scores at Admission, 6 Months, and
12 Months as a Function of APP Severity Level
NAB Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

70.00 (10.23)

75.00 (3.74)

77.75 (9.32)

-

-

-

Medium APP

78.00 (4.24)

75.00 (4.24)

67.00 (7.07)

High APP

75.44 (17.76)

81.22 (16.42)

80.78 (14.34)

APP Severity Level
No APP
Low APP
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Table 52
Mean Scores and Standard Deviations for Trails A Scores at Admission, 6 Months, and
12 Months as a Function of APP Severity Level
Trails A Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

42.88 (14.57)

50.30 (19.59)

43.03 (14.97)

Low APP

64.75 (30.39)

65.00 (27.83)

61.26 (23.81)

Medium APP

37.78 (18.91)

31.76 (12.55)

33.03 (14.78)

High APP

48.40 (31.61)

44.08 (36.65)

48.88 (49.41)

APP Severity Level

Table 53
Mean Scores and Standard Deviations for Trails B Scores at Admission, 6 Months, and
12 Months as a Function of APP Severity Level
Trails B Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

107.84 (48.26)

112.83 (58.77)

112.03 (93.06)

Low APP

174.00 (89.80)

160.50 (30.45)

127.34 (47.63)

Medium APP

100.03 (44.58)

96.32 (50.47)

92.53 (54.13)

High APP

132.27 (99.94)

110.81
(122.80)

130.60
(108.47)

APP Severity Level
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Table 54
Mean Scores and Standard Deviations for COWAT/FAS Scores at Admission, 6 Months,
and 12 Months as a Function of APP Severity Level
COWAT/FAS Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

30.71 (9.45)

26.75 (12.70)

28.82 (8.87)

Low APP

22.50 (8.89)

30.75 (12.76)

28.25 (11.03)

Medium APP

27.90 (10.56)

26.20 (10.68)

28.80 (11.58)

High APP

27.06 (8.84)

27.82 (9.17)

31.71 (8.41)

APP Severity Level

Table 55
Mean Scores and Standard Deviations for RBANS Total Scores at Admission, 6 Months,
and 12 Months as a Function of APP Severity Level
RBANS Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

73.77 (15.39)

73.19 (13.49)

80.84 (16.03)

Low APP

70.60 (13.81)

73.80 (15.01)

81.40 (8.39)

Medium APP

68.56 (15.31)

70.22 (14.81)

67.44 (13.96)

High APP

67.09 (13.19)

74.00 (12.68)

73.82 (16.28)

APP Severity Level
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Table 56
Mean Scores and Standard Deviations for RCFT Copy Scores at Admission, 6 Months,
and 12 Months as a Function of APP Severity Level
RCFT Copy Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

29.85 (6.85)

28.46 (5.52)

29.85 (5.97)

Low APP

27.88 (2.32)

27.25 (3.40)

31.25 (5.56)

Medium APP

26.75 (9.49)

23.67 (11.42)

26.83 (7.80)

High APP

29.78 (4.14)

28.94 (4.90)

30.61 (5.81)

APP Severity Level

Table 57
Mean Scores and Standard Deviations for RCFT Immediate Memory Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
RCFT Immediate Memory Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

11.58 (5.20)

12.31 (5.53)

16.12 (6.85)

Low APP

14.75 (6.36)

14.25 (6.20)

30.00 (17.22)

Medium APP

19.33 (18.85)

18.25 (15.55)

18.42 (10.52)

High APP

13.94 (7.47)

14.78 (7.16)

37.56 (40.10)

APP Severity Level
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Table 58
Mean Scores and Standard Deviations for RCFT Delayed Memory Scores at Admission,
6 Months, and 12 Months as a Function of APP Severity Level
RCFT Delayed Memory Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

12.12 (4.98)

11.88 (5.14)

15.23 (6.69)

Low APP

10.75 (5.87)

14.00 (6.72)

22.63 (10.48)

Medium APP

18.92 (18.69)

16.83 (14.17)

15.42 (11.56)

High APP

14.63 (7.38)

15.06 (7.40)

21.28 (11.56)

APP Severity Level

Table 59
Mean Scores and Standard Deviations for RCFT Recognition Scores at Admission, 6
Months, and 12 Months as a Function of APP Severity Level
RCFT Recognition Scores
At Admission

Six Months

Twelve
Months

M (SD)

M (SD)

M (SD)

No APP

19.08 (2.53)

18.92 (1.71)

19.08 (2.84)

Low APP

16.75 (2.87)

19.25 (1.26)

20.25 (1.50)

Medium APP

21.17 (9.58)

23.50 (11.11)

19.83 (2.32)

High APP

16.89 (3.30)

17.33 (4.27)

19.89 (3.48)

APP Severity Level
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Table 60
Service Use by FKK Repeated Measures ANOVAs

Variable
Main Effect
Assessment Time
Main Effect
Service Use
Interaction
Assessment Time *
Service Use

FKK
Internal

FKK Self
Concept

Measures
FKK Self
FKK
Efficacy
Powerful
Others

FKK
Chance

FKK
Externality

F (2,50)

F (2,50)

F (2, 50)

F (2, 50)

F (2, 50)

F (2, 50)

.27

1.14

.11

1.04

4.66**

3.77*

.06

.33

.25

.33

1.13

.74

.80

.71

.48

.90

5.29**

3.87*

*p<.05, **p<.01, ***p<.001

Table 61
Service Use by Socialcognition Measures
Repeated Measures ANOVAs
Measures

Variable
Main Effect
Assessment Time
Main Effect
Service Use
Interaction
Assessment Time *
Service Use

*p<.05, **p<.01, ***p<.001

CST
Social
Support

CST Self
Controlling

CST Escape
Avoidance

CST Planful
Problem
Solving

F (2,40)

F (2, 40)

F (2, 40)

F (2, 40)

8.32***

4.83**

.14

1.74

.47

.01

.21

7.05*

.13

1.16

.21

.74

.24

1.92

.57

Hinting
F
(2,102)
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Table 62
Service Use by Socialcognition Measures
Repeated Measures ANOVAs
Measures

Variable
Main Effect
Assessment Time
Main Effect
Service Use
Interaction
Assessment Time *
Service Use

IPSAQ
Internal
Positive

IPSAQ
Personal
Positive

IPSAQ
Situational
Positive

IPSAQ
Internal
Negative

IPSAQ
Personal
Negative

IPSAQ
Situational
Negative

F (2,30)

F (2,30)

F (2, 30)

F (2, 30)

F (2, 30)

F (2, 30)

.39

4.00*

2.32

.39

.33

.45

2.15

.51

4.02

1.41

.63

.69

2.85

.93

2.18

3.41*

.47

2.14

*p<.05, **p<.01, ***p<.001

Table 63
Mean Scores and Standard Deviations for Hinting Scores at Admission, 6 Months, and
12 Months as a Function of Service Use Before Age 18
Hinting Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

14.86 (3.31)

16.48 (3.12)

16.14 (2.90)

Service Use

14.50 (3.08)

16.75 (3.35)

16.04 (3.67)

Services Before Age 18
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Table 64
Mean Scores and Standard Deviations for FKK Internal Scores at Admission, 6 Months,
and 12 Months as a Function of Service Use Before Age 18
FKK Internal Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

33.88 (7.98)

33.94 (5.64)

34.88 (5.37)

Service Use

33.36 (6.53)

35.09 (5.63)

32.82 (6.35)

Services Before Age 18

Table 65
Mean Scores and Standard Deviations for FKK Self Concept Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
FKK Self Concept Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

33.06 (5.08)

32.75 (3.84)

32.88 (3.74)

Service Use

33.55 (5.09)

31.09 (4.16)

31.55 (6.36)

Services Before Age 18

Table 66
Mean Scores and Standard Deviations for FKK Self Efficacy Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
FKK Self Efficacy Index Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

66.94 (11.11)

66.69 (7.11)

67.75 (6.90)

Service Use

66.91 (8.85)

66.18 (7.01)

64.36 (9.68)

Services Before Age 18
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Table 67
Mean Scores and Standard Deviations for FKK Powerful Others Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
FKK Powerful Others Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

26.69 (9.19)

26.88 (7.00)

25.94 (7.23)

Service Use

26.73 (7.14)

23.73 (7.88)

24.36 (7.87)

Services Before Age 18

Table 68
Mean Scores and Standard Deviations for FKK Chance Scores at Admission, 6 Months,
and 12 Months as a Function of Service Use Before Age 18
FKK Chance Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

24.69 (7.79)

25.63 (7.60)

24.19 (5.94)

Service Use

26.73 (9.09)

20.09 (6.07)

20.09 (5.19)

Services Before Age 18

Table 69
Mean Scores and Standard Deviations for FKK Externality Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
FKK Externality Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

51.38 (16.47)

52.50 (13.29)

50.13 (12.12)

Service Use

53.45 (13.84)

43.82 (13.11)

44.45 (10.31)

Services Before Age 18
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Table 70
Mean Scores and Standard Deviations for IPSAQ Internal Positive Scores at Admission,
6 Months, and 12 Months as a Function of Service Use Before Age 18
IPSAQ Internal Positive Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

8.50 (2.83)

7.37 (3.29)

7.00 (3.89)

Service Use

7.67 (2.45)

10.11 (1.69)

9.33 (2.18)

Services Before Age 18

Table 71
Mean Scores and Standard Deviations for IPSAQ Personal Positive Scores at Admission,
6 Months, and 12 Months as a Function of Service Use Before Age 18
IPSAQ Personal Positive Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

4.87 (2.36)

3.75 (1.49)

2.75 (2.82)

Service Use

3.56 (1.81)

3.44 (1.42)

2.78 (1.64)

Services Before Age 18

Table 72
Mean Scores and Standard Deviations for IPSAQ Situational Positive Scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
IPSAQ Situational Positive Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

2.63 (1.51)

4.88 (2.42)

5.38 (2.62)

Service Use

3.33 (1.94)

2.44 (1.88)

3.89 (2.32)

Services Before Age 18
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Table 73
Mean Scores and Standard Deviations for IPSAQ Internal Negative Scores at Admission,
6 Months, and 12 Months as a Function of Service Use Before Age 18
IPSAQ Internal Negative Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

5.63 (4.21)

6.50 (4.72)

4.00 (3.38)

Service Use

6.22 (2.22)

6.78 (3.42)

8.22 (3.11)

Services Before Age 18

Table 74
Mean Scores and Standard Deviations for IPSAQ Personal Negative Scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
IPSAQ Personal Negative Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

6.13 (4.19)

5.13 (3.68)

4.87 (3.60)

Service Use

4.22 (3.03)

4.56 (1.94)

4.22 (2.91)

Services Before Age 18

Table 75
Mean Scores and Standard Deviations for IPSAQ Situational Negative Scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
IPSAQ Situational Negative Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

4.25 (2.12)

4.25 (2.05)

6.25 (1.83)

Service Use

4.11 (2.62)

4.56 (4.04)

3.56 (3.21)

Services Before Age 18
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Table 76
Mean Scores and Standard Deviations for CST Social Support Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
CST Social Support Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

32.75 (10.11)

37.17 (9.16)

40.67 (8.33)

Service Use

37.10 (11.06)

36.80 (9.88)

41.50 (10.36)

Services Before Age 18

Table 77
Mean Scores and Standard Deviations for CST Self Controlling Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
CST Self Controlling Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

54.50 (5.14)

54.08 (7.10)

54.75 (4.83)

Service Use

48.90 (5.41)

48.00 (9.15)

46.90 (11.18)

Services Before Age 18

Table 78
Mean Scores and Standard Deviations for CST Escape Avoidance Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
CST Escape Avoidance Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

33.67 (5.28)

36.25 (6.08)

38.17 (3.74)

Service Use

35.60 (5.48)

39.70 (4.57)

34.90 (12.21)

Services Before Age 18
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Table 79
Mean Scores and Standard Deviations for CST Planful Problem Solving Scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
CST Planful Problem Solving Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

42.08 (8.85)

43.33 (5.03)

45.17 (6.24)

Service Use

41.40 (11.05)

39.10 (7.88)

40.90 (10.78)

Services Before Age 18

Table 80
APP Severity Level by FKK Repeated Measures ANOVAs
Measures

Variable
Main Effect
Assessment Time
Main Effect
APP Severity Level
Interaction
Assessment Time *
APP

FKK
Internal

FKK Self
Concept

FKK Self
Efficacy

FKK
Powerful
Others

FKK
Chance

FKK
Externality

F (6,46)

F (6,46)

F (6,46)

F (6,46)

F (6,46)

F (6,46)

.54

1.23

.09

1.11

7.81***

5.47**

.06

.26

.12

.25

.35

.29

1.15

1.17

1.19

1.09

2.88*

2.30*

*p<.05, **p<.01, ***p<.001
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Table 81
APP Severity Level by Socialcognition Measures
Repeated Measures ANOVAs
Measures
Hinting

CST
Social
Support

CST Self
Controlling

CST Escape
Avoidance

CST Planful
Problem
Solving

F (6,98)

F (6,36)

F (6, 36)

F (6, 36)

F (6, 36)

5.87**

2.71

.48

2.15

.21

Main Effect
APP Severity Level

.80

.12

3.39*

1.12

.67

Interaction
Assessment Time * APP

.90

.32

1.81

2.26

.52

Variable
Main Effect
Assessment Time

*p<.05, **p<.01, ***p<.001

Table 82
APP Severity Level by Socialcognition Measures
Repeated Measures ANOVAs
Measures

Variable
Main Effect
Assessment Time
Main Effect
APP Severity
Level
Interaction
Assessment Time
* APP

IPSAQ
Internal
Positive

IPSAQ
Personal
Positive

IPSAQ
Situational
Positive

IPSAQ
Internal
Negative

IPSAQ
Personal
Negative

IPSAQ
Situational
Negative

F (6,26)

F (6,26)

F (6, 26)

F (6, 26)

F (6, 26)

F (6, 26)

1.57

1.74

1.05

1.20

.13

.02

1.55

.36

4.23*

.66

.24

.64

1.30

1.18

1.77

3.21*

.46

1.85

*p<.05, **p<.01, ***p<.001
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Table 83
Mean Scores and Standard Deviations for Hinting Task Scores at Admission, 6 Months,
and 12 Months as a Function of APP Severity Level
Hinting Task Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

14.86 (3.31)

16.48 (3.12)

16.14 (2.90)

Low APP

12.33 (.58)

14.67 (3.06)

17.33 (.58)

Medium APP

14.29 (3.64)

15.86 (3.13)

14.43 (4.93)

High APP

15.07 (3.03)

17.64 (3.41)

16.57 (3.23)

APP Severity Level

Table 84
Mean Scores and Standard Deviations for FKK Internal Locus of Control Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
FKK Internal Locus of Control Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

33.88 (7.98)

33.94 (5.64)

34.88 (5.37)

Low APP

35.33 (9.50)

36.00 (6.56)

32.67 (2.52)

Medium APP

34.60 (6.43)

35.00 (6.60)

31.00 (8.25)

High APP

29.33 (2.52)

34.33 (5.13)

36.00 (6.00)

APP Severity Level
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Table 85
Mean Scores and Standard Deviations for FKK Self Concept Scores at Admission, 6
Months, and 12 Months as a Function of APP Severity Level
FKK Self Concept Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

33.06 (5.08)

32.75 (3.84)

32.88 (3.74)

Low APP

32.00 (2.65)

33.00 (1.00)

30.33 (4.73)

Medium APP

33.80 (6.42)

30.60 (2.88)

30.00 (5.00)

High APP

34.67 (5.86)

30.00 (7.81)

35.33 (10.02)

APP Severity Level

Table 86
Mean Scores and Standard Deviations for FKK Self Efficacy Scores at Admission, 6
Months, and 12 Months as a Function of APP Severity Level
FKK Self Efficacy Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

66.94 (11.11)

66.69 (7.11)

67.75 (6.90)

Low APP

67.33 (10.26)

69.00 (7.55)

63.00 (5.57)

Medium APP

68.40 (10.69)

65.60 (3.78)

61.00 (6.21)

High APP

64.00 (6.25)

64.33 (11.93)

71.33 (16.01)

APP Severity Level
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Table 87
Mean Scores and Standard Deviations for FKK Powerful Others Scores at Admission, 6
Months, and 12 Months as a Function of APP Severity Level
FKK Powerful Others Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

26.69 (9.19)

26.88 (7.00)

25.94 (7.23)

Low APP

28.33 (3.79)

21.67 (3.79)

25.67 (9.87)

Medium APP

26.20 (8.84)

21.80 (8.32)

22.60 (9.21)

High APP

26.00 (8.89)

29.00 (10.00)

26.00 (5.29)

APP Severity Level

Table 88
Mean Scores and Standard Deviations for FKK Chance Scores at Admission, 6 Months,
and 12 Months as a Function of APP Severity Level
FKK Chance Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

24.69 (7.79)

25.63 (7.60)

24.19 (5.94)

Low APP

29.00 (10.00)

20.33 (1.53)

17.67 (2.08)

Medium APP

26.20 (10.71)

18.00 (7.25)

22.20 (6.38)

High APP

25.33 (8.51)

23.33 (7.10)

19.00 (5.20)

APP Severity Level
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Table 89
Mean Scores and Standard Deviations for FKK External Locus of Control Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
FKK External Locus of Control Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

51.38 (16.47)

52.50 (13.29)

50.13 (12.12)

Low APP

57.33 (3.58)

42.00 (5.29)

43.33 (9.71)

Medium APP

52.40 (18.15)

39.80 (15.43)

44.80 (14.72)

High APP

51.33 (9.07)

52.33 (14.15)

45.00 (1.00)

APP Severity Level

Table 90
Mean Scores and Standard Deviations for IPSAQ Internal Positive Scores at Admission,
6 Months, and 12 Months as a Function of APP Severity Level
IPSAQ Internal Positive Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

8.50 (2.83)

7.37 (3.29)

7.00 (3.89)

Low APP

8.00 (4.36)

11.33 (1.53)

12.00 (1.00)

Medium APP

8.00 (1.41)

9.50 (1.92)

8.00 (.82)

High APP

6.50 (.71)

9.50 (.71)

8.00 (1.41)

APP Severity Level
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Table 91
Mean Scores and Standard Deviations for IPSAQ Personal Positive Scores at Admission,
6 Months, and 12 Months as a Function of APP Severity Level
IPSAQ Personal Positive Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

4.87 (2.36)

3.75 (1.49)

2.75 (2.82)

Low APP

2.00 (1.73)

4.00 (2.00)

2.00 (.00)

Medium APP

4.50 (1.73)

3.00 (1.41)

3.00 (2.45)

High APP

4.00 (.00)

3.50 (.71)

3.50 (.71)

APP Severity Level

Table 92
Mean Scores and Standard Deviations for IPSAQ Situational Positive Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
IPSAQ Situational Positive Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

2.63 (1.51)

4.88 (2.42)

5.38 (2.62)

Low APP

3.67 (1.53)

.67 (.58)

2.00 (1.00)

Medium APP

2.00 (1.63)

3.50 (2.08)

5.00 (2.58)

High APP

5.50 (.71)

3.00 (.00)

4.50 (2.12)

APP Severity Level
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Table 93
Mean Scores and Standard Deviations for IPSAQ Internal Negative Scores at Admission,
6 Months, and 12 Months as a Function of APP Severity Level
IPSAQ Internal Negative Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

5.63 (4.21)

6.50 (4.72)

4.00 (3.38)

Low APP

5.00 (1.00)

3.33 (4.16)

9.33 (4.73)

Medium APP

7.25 (2.63)

8.00 (.82)

7.25 (.50)

High APP

6.00 (2.83)

9.50 (.71)

8.50 (4.95)

APP Severity Level

Table 94
Mean Scores and Standard Deviations for IPSAQ Personal Negative Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
IPSAQ Personal Negative Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

6.13 (4.19)

5.13 (3.68)

4.87 (3.60)

Low APP

4.00 (2.65)

5.00 (1.73)

2.67 (2.08)

Medium APP

4.00 (4.08)

4.00 (2.58)

5.00 (3.16)

High APP

5.00 (2.83)

5.00 (1.41)

5.00 (4.24)

APP Severity Level
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Table 95
Mean Scores and Standard Deviations for IPSAQ Situational Negative Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
IPSAQ Situational Negative Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

4.25 (2.12)

4.25 (2.05)

6.25 (1.83)

Low APP

4.00 (4.58)

7.33 (5.51)

4.00 (5.29)

Medium APP

3.75 (1.89)

4.00 (2.94)

3.75 (2.75)

High APP

5.00 (.00)

1.50 (.71)

2.50 (.71)

APP Severity Level

Table 96
Mean Scores and Standard Deviations for CST Social Support Scores at Admission, 6
Months, and 12 Months as a Function of APP Severity Level
CST Social Support Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

32.75 (10.11)

37.17 (9.16)

40.67 (8.33)

Low APP

39.67 (11.24)

36.67 (3.51)

43.00 (7.21)

Medium APP

36.25 (15.90)

35.75 (16.22)

39.75 (13.15)

High APP

35.67 (5.51)

38.33 (5.13)

42.33 (12.70)

APP Severity Level
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Table 97
Mean Scores and Standard Deviations for CST Self Controlling Scores at Admission, 6
Months, and 12 Months as a Function of APP Severity Level
CST Self Controlling Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

54.50 (5.14)

54.08 (7.10)

54.75 (4.83)

Low APP

49.33 (4.04)

46.33 (5.13)

51.67 (.58)

Medium APP

48.75 (5.68)

51.25 (14.10)

51.25 (9.61)

High APP

48.67 (8.15)

45.33 (4.04)

36.33 (13.58)

APP Severity Level

Table 98
Mean Scores and Standard Deviations for CST Escape Avoidance Scores at Admission, 6
Months, and 12 Months as a Function of APP Severity Level
CST Escape Avoidance Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

33.67 (5.28)

36.25 (6.08)

38.17 (3.74)

Low APP

34.67 (2.52)

37.33 (.58)

37.00 (3.00)

Medium APP

36.25 (7.14)

41.50 (5.97)

40.75 (5.32)

High APP

35.67 (7.10)

39.67 (5.03)

25.00 (19.93)

APP Severity Level
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Table 99
Mean Scores and Standard Deviations for CST Planful Problem Solving Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
CST Planful Problem Solving Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No APP

42.08 (8.85)

43.33 (5.03)

45.17 (6.24)

Low APP

43.00 (3.61)

43.67 (2.08)

41.33 (2.08)

Medium APP

40.25 (15.13)

33.75 (8.26)

40.00 (9.27)

High APP

41.33 (13.65)

41.67 (8.62)

41.67 (19.66)

APP Severity Level

Table 100
Service Use by IS Repeated Measures ANOVAs

IS Relabel
Variable
Main Effect
Assessment Time
Main Effect
Service Use
Interaction
Assessment Time *
Service Use
*p<.05, **p<.01, ***p<.001

Measures
IS Need
IS
for
Awareness
Treatment

IS Total
Insight

F (2,114)

F (2,114)

F (2, 114)

F (2, 114)

2.40

1.37

3.22*

2.37

.52

8.42**

2.77

5.47*

3.98*

2.52

1.96

3.26*
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Table 101
Mean Scores and Standard Deviations for IS Relabel Scale Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
IS Relabel Scale Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

2.62 (1.08)

2.76 (.95)

1.97 (1.21)

Service Use

2.13 (1.07)

2.43 (.94)

2.43 (.77)

Services Before Age 18

Table 102
Mean Scores and Standard Deviations for IS Awareness of Illness Scale Scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
IS Awareness of Illness Scale Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

2.66 (1.17)

2.83 (1.20)

2.21 (1.11)

Service Use

2.00 (1.30)

1.70 (1.29)

1.97 (1.22)

Services Before Age 18

Table 103
Mean Scores and Standard Deviations for IS Need for Treatment Scale Scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
IS Need for Treatment Scale Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

2.52 (1.08)

2.47 (1.21)

1.83 (1.22)

Service Use

2.15 (1.18)

1.72 (1.32)

1.85 (1.22)

Services Before Age 18
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Table 104
Mean Scores and Standard Deviations for IS Total Insight Scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
IS Total Insight Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

7.79 (2.96)

8.05 (2.87)

6.00 (2.75)

Service Use

6.35 (2.87)

5.92 (2.88)

6.25 (2.48)

Services Before Age 18

Table 105
APP Severity by IS Repeated Measures ANOVAs

IS Relabel
F (6,110)
Variable
Main Effect
.91
Assessment Time
Main Effect
.43
Service Use
Interaction
Assessment Time *
2.90**
Service Use
*p<.05, **p<.01, ***p<.001

Measures
IS Need
IS
for
Awareness
Treatment

IS Total
Insight

F (6,110)

F (6, 110)

F (6, 110)

2.16

3.14*

1.98

2.89*

.91

1.88

2.48*

1.79

3.38**
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Table 106
Mean Scores and Standard Deviations for IS Relabel Scale Scores at Admission, 6
Months, and 12 Months as a Function of APP Severity Level
IS Relabel Scale Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

2.62 (1.08)

2.76 (.95)

1.97 (1.21)

Low APP

3.25 (.96)

2.50 (1.00)

2.00 (.00)

Medium APP

1.63 (.92)

2.75 (.89)

2.63 (.52)

High APP

2.11 (1.02)

2.28 (.96)

2.44 (.92)

APP Severity

Table 107
Mean Scores and Standard Deviations for IS Awareness of Illness Scale Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
IS Awareness of Illness Scale Scores
Twelve
At Admission
Six Months
Months
M (SD)

M (SD)

M (SD)

No Service Use

2.66 (1.17)

2.83 (1.20)

2.21 (1.11)

Low APP

3.25 (.96)

1.50 (1.00)

1.50 (1.00)

Medium APP

1.50 (1.41)

2.13 (1.13)

1.75 (1.17)

High APP

2.28 (1.18)

1.56 (1.42)

2.17 (1.30)

APP Severity
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Table 108
Mean Scores and Standard Deviations for IS Need for Treatment Scale Scores at
Admission, 6 Months, and 12 Months as a Function of APP Severity Level
IS Need for Treatment Scale Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

2.52 (1.08)

2.47 (1.21)

1.83 (1.22)

Low APP

3.13 (1.03)

1.50 (1.00)

1.38 (1.11)

Medium APP

1.69 (.88)

2.00 (1.51)

1.94 (1.08)

High APP

2.14 (1.23)

1.64 (1.34)

1.92 (1.33)

APP Severity

Table 109
Mean Scores and Standard Deviations for IS Total Insight score at Admission, 6 Months,
and 12 Months as a Function of APP Severity Level
IS Total Insight Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

7.79 (2.96)

8.05 (2.87)

6.00 (2.75)

Low APP

9.63 (2.75)

5.50 (1.00)

4.88 (1.65)

Medium APP

4.81 (1.81)

7.13 (3.40)

6.31 (2.19)

High APP

6.31 (2.77)

5.47 (2.88)

6.53 (2.74)

APP Severity
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Table 110
Service Use by NOSIE Subscales and Total Assets Repeated Measures ANOVAs
NOSIE Subscales

NOSIE
Total
Assets

Daily
Schedule
Competence

Social
Interest

Neatness

Irritability

Psychoticism

Motor
Retardation

F (2, 188)

F (2, 188)

F (2, 188)

F (2, 188)

F (2, 188)

F (2, 188)

F (2,
188)

26.86***

39.51***

20.89***

3.78*

7.47***

15.93***

21.68***

Service
Use

2.54

.06

1.20

1.38

.87

1.50

1.97

Time *
Service
Use

.57

1.30

.33

.15

.96

.34

.21

Variable
Time

*p<.05, **p<.01, ***p<.001

Table 111
Means and Standard Deviations on NOSIE Subscales and Total Assets at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
Admission
NOSIE Subscales
Daily Schedule Competence
No Service
Service Use
Social Interest
No Service
Service Use
Neatness
No Service
Service Use
Irritability
No Service
Service Use
Psychoticism
No Service
Service Use
Motor Retardation
No Service
Service Use
NOSIE Total Assets
No Service
Service Use

6 Months

12 Months

M

SD

M

SD

M

SD

32.84
31.44

6.96
6.76

34.27
31.89

5.98
7.01

36.68
35.34

3.57
5.52

15.01
15.14

5.58
6.65

18.95
18.41

5.96
6.44

19.17
20.40

5.38
6.56

23.05
22.34

5.41
5.85

24.00
22.62

5.41
5.62

25.79
24.72

4.25
4.91

4.37
5.85

5.44
6.59

5.89
7.00

6.14
6.38

4.59
5.43

4.60
5.28

1.55
1.73

2.90
2.68

2.21
3.13

3.56
4.26

2.03
2.70

2.96
3.96

6.43
7.28

4.10
4.60

6.00
6.54

3.63
4.76

4.18
5.35

2.92
3.88

154.54
148.47

23.46
25.70

159.12
152.21

22.60
26.50

167.02
162.71

16.75
23.39
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Table 112
APP Severity Level by NOSIE Subscales and Total Assets Repeated Measures ANOVAs
NOSIE Subscales

NOSIE
Total
Assets

Daily
Schedule
Competence

Social
Interest

Neatness

Irritability

Psychoticism

Motor
Retardation

F (6, 184)

F (6, 184)

F (6, 184)

F (6, 184)

F (6, 184)

F (6, 184)

F (6, 184)

23.23***

36.58***

19.85***

3.40*

8.07***

13.55***

22.23***

APP
Severity
Level

1.10

.73

.73

1.30

.36

1.63

1.48

Time *
APP

.85

1.83

3.14**

.40

1.58

2.03

2.20*

Variable
Time

*p<.05, **p<.01, ***p<.001
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Table 113
Means and Standard Deviations on NOSIE Subscales and Total Assets at Admission, 6
Months, and 12 Months as a Function of APP Severity Level
Admission
NOSIE Subscales
Daily Schedule Competence
No APP
Low APP
Med APP
High APP
Social Interest
No APP
Low APP
Med APP
High APP
Neatness
No APP
Low APP
Med APP
High APP
Irritability
No APP
Low APP
Med APP
High APP
Psychoticism
No APP
Low APP
Med APP
High APP
Motor Retardation
No APP
Low APP
Med APP
High APP
NOSIE Total Assets
No APP
Low APP
Med APP
High APP

6 Months

12 Months

M

SD

M

SD

M

SD

32.84
30.24
30.83
32.75

6.96
8.73
6.36
5.50

34.27
31.04
33.07
31.60

5.98
7.32
6.36
7.48

36.68
34.23
36.27
35.42

3.57
6.99
3.50
5.74

15.01
13.16
15.03
16.60

5.58
6.20
7.02
6.62

18.95
16.11
21.09
18.00

5.96
5.45
4.35
7.79

19.17
19.64
20.90
20.56

5.38
7.09
4.50
7.65

23.05
20.42
21.01
24.69

5.41
6.71
5.48
4.87

24.00
22.06
23.24
22.54

5.41
5.68
4.91
6.27

25.79
24.36
25.26
24.57

4.25
5.47
3.54
5.57

4.37
6.75
4.31
6.38

5.44
7.46
5.36
6.90

5.89
7.90
5.75
7.31

6.14
8.64
6.07
4.76

4.59
5.30
3.38
7.05

4.60
4.70
4.30
5.97

1.55
1.74
2.06
1.48

2.90
2.58
3.65
1.90

2.21
3.83
2.47
3.13

3.56
5.50
4.02
3.53

2.03
2.39
2.08
3.37

2.96
4.32
3.20
4.30

6.43
8.91
8.39
5.31

4.10
5.61
4.70
2.92

6.00
7.96
5.56
6.28

3.63
4.81
3.83
5.31

4.18
6.23
4.93
5.05

2.92
4.65
2.65
4.16

154.54
136.62
148.09
157.05

23.46
30.08
23.25
21.68

159.12
145.59
159.65
151.26

22.60
29.43
18.94
28.98

167.02
160.29
168.03
160.42

16.75
26.73
12.23
27.39

242

Table 114
Service Use by BPRS Factors and BPRS Total Repeated Measures ANOVAs
BPRS Factors
BPRS Psychotic
Disorganization

BPRS
Hallucination/
Delusions

F (2, 128)

BPRS
Total

BPRS
Paranoia

BPRS
Emotional
Blunting

BPRS
Anxiety/
Depression

BPRS
Agitation
/ Elation

F (2, 134)

F (2, 134)

F (2, 134)

F (2, 134)

F (2, 134)

F (2, 128)

1.16

.82

.04

1.03

.50

.06

1.23

Service
Use

1.20

.47

1.75

1.20

.64

.02

.23

Time *
Service
Use

3.17*

.85

.05

.19

.27

1.08

.86

Variable
Time

*p<.05, **p<.01, ***p<.001

Table 115
APP Severity Level by BPRS Factors and BPRS Total Repeated Measures ANOVAs
BPRS Factors
BPRS Psychotic
Disorganization

BPRS
Hallucination/
Delusions

F (6, 124)

BPRS
Total

BPRS
Paranoia

BPRS
Emotional
Blunting

BPRS
Anxiety/
Depression

BPRS
Agitation
/ Elation

F (6, 184)

F (6, 184)

F (6, 184)

F (6, 184)

F (6, 184)

F (6, 124)

.88

.52

.06

.75

.25

.07

.71

.81

.64

.79

1.53

2.22

.24

.50

1.71

.79

.46

.45

.32

.67

.57

Variable
Time
APP
Severity
Level
Time *
APP
Severity

*p<.05, **p<.01, ***p<.001
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Table 116
Mean Scores and Standard Deviations for BPRS Total scores at Admission, 6 Months,
and 12 Months as a Function of Service Use Before Age 18
BPRS Total Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

45.75 (10.47)

46.34 (13.75)

45.32 (14.75)

Service Use

49.53 (16.32)

47.13 (12.52)

44.64 (13.22)

Service Use

Table 117
Mean Scores and Standard Deviations for BPRS Psychotic Disorganization Factor
scores at Admission, 6 Months, and 12 Months as a Function of Service Use Before Age
18
BPRS Psychotic Disorganization Factor Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

5.81 (2.13)

6.31 (2.69)

6.13 (2.91)

Service Use

7.45 (3.82)

6.67 (2.80)

6.12 (2.76)

Service Use
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Table 118
Mean Scores and Standard Deviations for BPRS Hallucinations/Delusions Factor scores
at Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
BPRS Hallucination/Delusions Factor Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

6.83 (4.20)

6.99 (4.31)

6.80 (5.23)

Service Use

6.96 (4.01)

6.15 (3.87)

5.76 (3.64)

Service Use

Table 119
Mean Scores and Standard Deviations for BPRS Paranoia Factor scores at Admission, 6
Months, and 12 Months as a Function of Service Use Before Age 18
BPRS Paranoia Factor Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

8.92 (2.86)

8.88 (3.56)

8.68 (3.40)

Service Use

8.01 (3.58)

8.04 (2.95)

8.04 (3.27)

Service Use

Table 120
Mean Scores and Standard Deviations for BPRS Emotional Blunting Factor scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
BPRS Emotional Blunting Factor Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

5.99 (3.64)

5.59 (2.27)

5.63 (2.53)

Service Use

6.77 (3.62)

6.52 (3.69)

6.12 (3.39)

Service Use
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Table 121
Mean Scores and Standard Deviations for BPRS Anxiety/Depression Factor scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
BPRS Anxiety/Depression Factor Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

8.55 (2.81)

8.36 (3.24)

8.42 (3.32)

Service Use

9.41 (4.21)

9.04 (4.55)

8.65 (3.65)

Service Use

Table 122
Mean Scores and Standard Deviations for BPRS Agitation/Elation Factor scores at
Admission, 6 Months, and 12 Months as a Function of Service Use Before Age 18
BPRS Agitation/Elation Factor Scores
At Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

No Service Use

3.31 (1.18)

3.63 (2.38)

3.41 (1.78)

Service Use

3.58 (1.66)

3.28 (1.19)

3.36 (1.45)

Service Use
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Table 123
Mean Scores and Standard Deviations for BPRS Total and Factor scores at Admission, 6
Months, and 12 Months as a Function of APP Severity Level

BPRS
BPRS Total

BPRS Psychotic
Disorganization Factor

BPRS
Hallucination/Delusion
Factor
BPRS Paranoia Factor

BPRS Emotional
Blunting Factor

BPRS
Anxiety/Depression
Factor
BPRS Agitation/Elation
Factor

*p<.05

APP
Severity
Level
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP

Admission

Six Months

Twelve Months

M (SD)
45.75 (10.47)
49.19 (14.37)
42.67 (9.05)
51.52 (18.39)
5.81 (2.13)
8.00 (3.89)
5.52 (1.52)
7.77 (4.17)
6.83 (4.20)
7.25 (3.88)
6.17 (3.13)
7.07 (4.37)
8.92 (2.86)
8.68 (4.63)
7.50 (2.21)
7.92 (3.59)
5.99 (3.64)
7.75 (2.98)
4.75 (1.41)
6.96 (4.09)
8.55 (2.81)
6.63 (1.73)
9.25 (4.29)
10.41 (4.47)
3.31 (1.18)
3.13 (1.06)
3.33 (.93)
3.80 (1.95)

M (SD)
46.34 (13.75)
47.81 (9.52)
43.42(10.22)
47.90 (14.19)
6.31 (2.69)
6.80 (2.35)
5.98 (2.48)
6.80 (3.10)
6.99 (4.31)
8.31 (5.30)
4.58 (2.54)
5.80 (3.40)
8.88 (3.56)
7.90 (2.64)
8.57 (2.36)
7.95 (3.27)
5.59 (2.27)
6.75 (2.65)
4.08 (2.33)
7.08 (4.10)
8.36 (3.24)
6.78 (2.37)
9.67 (3.78)
9.67 (5.15)
3.63 (2.38)
3.16 (1.03)
3.08 (.97)
3.37 (1.32)

M (SD)
45.32 (14.75)
48.13 (14.62)
41.33 (9.37)
44.27 (13.83)
6.13 (2.91)
6.94 (3.42)
5.92 (2.25)
5.87 (2.69)
6.80 (5.23)
7.13 (5.61)
5.67 (2.80)
5.30 (2.99)
8.68 (3.40)
9.22 (3.43)
6.62 (1.95)
7.99 (3.44)
5.63 (2.53)
6.72 (2.83)
5.00 (2.86)
6.21 (3.73)
8.42 (3.32)
7.00 (1.87)
8.67 (3.92)
9.22 (3.98)
3.41 (1.78)
2.94 (.73)
3.83 (1.63)
3.39 (1.60)

247

Table 124
Mean Scores and Standard Deviations for BPRS item scores at Admission, 6 Months, and 12 Months as a
Function of Service Use Before Age 18
Admission

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

Somatic Concern

No Service
Service Use

2.78 (1.66)
2.39 (1.71)

2.58 (1.68)
2.68 (1.54)

2.59 (1.72)
2.29 (1.49)

Anxiety

No Service
Service Use

2.39 (.97)
2.54 (1.51)

2.45 (1.24)
2.53 (1.35)

2.16 (1.25)
2.37 (1.38)

Depression

No Service
Service Use

2.09 (1.11)
2.39 (1.51)

2.02 (1.16)
2.20 (1.41)

1.95 (1.07)
2.16 (1.16)

Suicidality

No Service
Service Use

1.16 (.37)
1.63 (1.26)

1.22 (.51)
1.57 (1.03)

1.09 (.30)
1.45 (1.23)

Guilt

No Service
Service Use

1.81 (1.38)
2.07 (1.29)

1.77 (1.18)
2.13 (1.51)

2.02 (1.49)
2.07 (1.47)

Hostility

No Service
Service Use

2.44 (1.36)
2.71 (1.63)

2.52 (1.45)
2.91 (1.76)

2.64 (1.42)
2.61 (1.71)

Elevated Mood

No Service
Service Use

1.44 (.91)
1.54 (1.22)

1.56 (1.30)
1.25 (.68)

1.33 (.90)
1.45 (.98)

Grandiosity

No Service
Service Use

2.14 (1.78)
1.66 (1.40)

2.14 (1.94)
1.76 (1.78)

2.39 (2.14)
1.63 (1.49)

Suspiciousness

No Service
Service Use

3.03 (1.85)
2.28 (1.73)

2.97 (2.06)
2.21 (1.46)

2.53 (1.81)
2.17 (1.45)

Hallucinations

No Service
Service Use

1.72 (1.46)
2.72 (2.10)

2.17 (1.85)
2.13 (1.68)

2.23 (1.84)
2.04 (1.60)

Unusual Thought Content

No Service
Service Use

2.97 (2.10)
2.57 (1.99)

2.68 (1.66)
2.26 (1.84)

2.17 (1.91)
2.14 (1.69)

Bizarre Behavior

No Service
Service Use

1.59 (1.34)
2.54 (1.76)

2.08 (1.31)
2.17 (1.45)

1.80 (1.32)
1.95 (1.55)

Self-Neglect

No Service
Service Use

1.97 (.83)
2.46 (1.11)

2.56 (.93)
2.46 (.90)

2.20 (1.05)
1.95 (.96)

Disorientation

No Service
Service Use

1.41 (.76)
1.54 (1.07)

1.41 (.76)
1.57 (1.13)

1.50 (1.02)
1.47 (1.12)

Conceptual Disorganization

No Service
Service Use

1.89 (1.10)
2.14 (1.65)

1.86 (1.26)
1.89 (1.16)

1.91 (1.21)
1.69 (1.15)

Blunted Affect

No Service
Service Use

2.50 (1.50)
2.78 (1.52)

2.56 (1.12)
2.97 (1.69)

2.64 (1.07)
2.82 (1.47)

Emotional Withdrawal

No Service
Service Use

2.19 (1.40)
2.42 (1.30)

2.12 (1.30)
2.22 (1.38)

2.12 (1.18)
2.11 (1.18)

Motor Retardation

No Service
Service Use

2.05 (1.19)
2.20 (1.27)

1.67 (.99)
1.93 (1.16)

1.67 (.88)
1.82 (1.06)

Tension

No Service
Service Use

1.67 (.91)
1.55 (.82)

1.52 (.91)
1.51 (.87)

1.75 (1.04)
1.30 (.78)

Uncooperativeness

No Service
Service Use

1.70 (1.09)
1.50 (.99)

1.72 (1.14)
1.49 (.80)

1.64 (1.30)
1.85 (1.16)

Excitement

No Service
Service Use

1.48 (.82)
1.27 (.73)

1.53 (1.22)
1.20 (.60)

1.63 (1.19)
1.27 (.89)

Distractibility

No Service
Service Use

1.72 (.92)
1.99 (1.42)

1.59 (1.16)
1.76 (1.23)

1.88 (1.28)
1.70 (1.10)

Motor hyperactivity

No Service
Service Use

1.30 (.49)
1.20 (.64)

1.45 (1.10)
1.23 (.63)

1.53 (1.09)
1.18 (.65)

Mannerisms and Posturing

No Service
Service Use

1.30 (.60)
1.26 (.65)

1.07 (.37)
1.14 (.54)

1.27 (.73)
1.31 (.94)

BPRS Items
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Table 125
Mean Scores and Standard Deviations for BPRS item scores at Admission, 6 Months, and
12 Months as a Function of APP Severity Level
Admission
BPRS Items
Somatic Concern

Anxiety

Depression

Suicidality

Guilt

Hostility

Elevated Mood

Grandiosity

Suspiciousness

Hallucinations

Unusual Thought
Content
Bizarre Behavior

Self-Neglect

Disorientation

APP Severity Level
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP

Six Months

Twelve Months

M (SD)

M (SD)

M (SD)

2.78 (1.66)
1.63 (.92)
2.67 (2.09)
2.58 (1.79)
2.39 (.97)
1.63 (.74)
2.33 (1.97)
2.90 (1.49)
2.09 (1.11)
1.50 (.54)
2.58 (1.56)
2.65 (1.64)
1.16 (.37)
1.00 (.00)
1.83 (.98)
1.79 (1.47)
1.81 (1.38)
1.25 (.46)
1.75 (.99)
2.42 (1.41)
2.44 (1.36)
2.38 (1.51)
2.67 (1.37)
2.83 (1.76)
1.44 (.91)
1.25 (.46)
1.42 (.67)
1.67 (1.47)
2.14 (1.78)
1.88 (1.73)
1.67 (1.63)
1.58 (1.27)
3.03 (1.85)
2.63 (2.07)
1.67 (.82)
2.31 (1.79)
1.72 (1.46)
2.13 (2.10)
2.67 (2.25)
2.94 (2.11)
2.97 (2.10)
3.25 (2.19)
1.83 (1.60)
2.52 (2.01)
1.59 (1.34)
2.81 (1.89)
1.33 (.52)
2.75 (1.84)
1.97 (.83)
2.38 (1.06)
2.67 (.52)
2.44 (1.25)
1.41 (.76)
2.63 (1.69)
1.00 (.00)
1.30 (.64)

2.58 (1.68)
2.56 (1.64)
3.33 (1.63)
2.56 (1.51)
2.45 (1.24)
2.06 (1.27)
2.67 (.98)
2.66 (1.47)
2.02 (1.16)
1.50 (1.07)
2.25 (1.41)
2.42 (1.49)
1.22 (.51)
1.19 (.53)
1.33 (.52)
1.75 (1.21)
1.77 (1.18)
1.13 (.35)
2.58 (1.74)
2.35 (1.59)
2.52 (1.45)
2.06 (1.43)
3.17 (1.72)
3.13 (1.85)
1.56 (1.30)
1.13 (.35)
1.25 (.42)
1.29 (.81)
2.14 (1.94)
3.75 (2.66)
1.00 (.00)
1.29 (1.08)
2.97 (2.06)
2.81 (2.45)
2.42 (.97)
1.96 (1.08)
2.17 (1.85)
1.63 (1.41)
2.00 (1.27)
2.33 (1.86)
2.68 (1.66)
2.94 (2.28)
1.58 (1.43)
2.20 (1.76)
2.08 (1.31)
2.13 (1.53)
1.92 (1.20)
2.25 (1.53)
2.56 (.93)
2.44 (.62)
2.42 (.92)
2.48 (.99)
1.41 (.76)
2.56 (1.80)
1.33 (.82)
1.28 (.65)

2.59 (1.72)
2.62 (1.62)
1.42 (.80)
2.40 (1.54)
2.16 (1.25)
2.31 (.88)
2.50 (1.76)
2.35 (1.47)
1.95 (1.07)
1.63 (.74)
2.42 (1.39)
2.27 (1.21)
1.09 (.30)
1.13 (.35)
1.00 (.00)
1.67 (1.50)
2.02 (1.49)
1.25 (.54)
2.08 (1.11)
2.33 (1.67)
2.64 (1.42)
3.00 (2.25)
1.92 (1.20)
2.65 (1.63)
1.33 (.90)
1.25 (.71)
2.33 (1.63)
1.29 (.75)
2.39 (2.14)
2.25 (2.32)
1.67 (1.63)
1.42 (1.09)
2.53 (1.81)
2.94 (1.78)
1.75 (1.41)
2.02 (1.31)
2.23 (1.84)
2.13 (1.81)
2.17 (2.04)
1.98 (1.49)
2.17 (1.91)
2.75 (2.14)
1.83 (1.33)
2.00 (1.62)
1.80 (1.32)
2.56 (1.99)
1.83 (1.60)
1.77 (1.40)
2.20 (1.05)
2.25 (.93)
2.67 (1.03)
1.67 (.86)
1.50 (1.02)
2.19 (1.69)
1.17 (.41)
1.30 (.93)
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Conceptual
Disorganization
Blunted Affect

Emotional
Withdrawal
Motor Retardation

Tension

Uncooperativeness

Excitement

Distractibility

Motor
hyperactivity
Mannerisms and
Posturing

*p<.05

No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP
No APP
Low APP
Med APP
High APP

1.89 (1.10)
2.75 (1.75)
1.50 (1.23)
2.09 (1.70)
2.50 (1.50)
3.25 (1.49)
1.67 (.82)
2.91 (1.58)
2.19 (1.40)
2.88 (1.13)
1.83 (1.17)
2.41 (1.37)
2.05 (1.19)
2.25 (1.04)
1.75 (.61)
2.30 (1.47)
1.67 (.91)
1.75 (1.04)
1.67 (.82)
1.46 (.75)
1.70 (1.09)
2.00 (1.31)
1.67 (1.03)
1.28 (.81)
1.48 (.82)
1.25 (.46)
1.00 (.00)
1.35 (.89)
1.72 (.92)
1.88 (.84)
1.50 (.84)
2.15 (1.68)
1.30 (.49)
1.38 (.74)
1.00 (.00)
1.20 (.69)
1.30 (.60)
1.50 (.76)
1.00 (.00)
1.25 (.69)

1.86 (1.26)
2.38 (1.41)
1.33 (.82)
1.87 (1.12)
2.56 (1.12)
2.94 (1.61)
2.00 (1.10)
3.24 (1.80)
2.12 (1.30)
2.44 (.94)
1.50 (1.23)
2.33 (1.53)
1.67 (.94)
1.88 (.84)
1.17 (.41)
2.15 (1.31)
1.52 (.91)
1.50 (1.07)
1.50 (.55)
1.52 (.90)
1.72 (1.14)
1.63 (.52)
1.50 (.55)
1.43 (.95)
1.53 (1.22)
1.00 (.00)
1.17 (.41)
1.28 (.72)
1.59 (1.16)
1.63 (.74)
1.83 (1.60)
1.78 (1.30)
1.45 (1.10)
1.44 (1.05)
1.17 (.41)
1.17 (.49)
1.07 (.37)
1.13 (.35)
1.00 (.00)
1.18 (.66)

1.91 (1.21)
2.13 (1.46)
1.50 (1.23)
1.59 (1.02)
2.64 (1.07)
3.25 (1.51)
1.92 (1.11)
2.91 (1.50)
2.12 (1.18)
2.38 (1.06)
2.08 (1.02)
2.02 (1.28)
1.67 (.88)
1.75 (.89)
1.58 (.92)
1.91 (1.17)
1.75 (1.04)
1.25 (.46)
1.17 (.41)
1.35 (.94)
1.64 (1.30)
1.88 (1.13)
1.67 (1.03)
1.89 (1.24)
1.63 (1.19)
1.31 (.70)
1.17 (.41)
1.28 (1.05)
1.88 (1.28)
1.81 (1.00)
1.50 (.84)
1.72 (1.20)
1.53 (1.09)
1.13 (.35)
1.00 (.00)
1.24 (.80)
1.27 (.73)
1.00 (.00)
1.00 (.00)
1.50 (1.18)
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Table 126
Relationship Between Level of Discharge Location Restrictiveness
and Service Use Before Age 18 (N=242)

Discharge Location Restrictiveness

Service Use
No Service
Use
Service Use
13

13

26

42

55

97

33

48

81

20

18

38

108

134

242

1 – Same or Higher Restrictiveness (LRC Transfer)
2 - Psychiatric Residential Rehabilitation
3 - Assisted Living
4 – Independent Living/Living with Family
Total

Total

Table 127
Relationship Between Level of Discharge Location Restrictiveness
and APP Severity Level (N=242)
APP Severity Level
Low Med
High

Discharge Location Restrictiveness

No

1 – Same or Higher Restrictiveness (LRC Transfer)

13

1

1

11

26

42

8

15

32

97

33

8

10

30

81

20

2

3

13

38

108

19

29

86

242

2 - Psychiatric Residential Rehabilitation
3 - Assisted Living
4 – Independent Living/Living with Family
Total

Total

